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ABSTRACT 
 
THOMAS EDWARD MULLEN, JR.:  Pathway of Histone mRNA Degradation:  
Oligouridylation Followed by Bidirectional Decay 
(Under the direction of Dr. William F. Marzluff) 
 
 Histone mRNAs are rapidly degraded at the end of S phase or when DNA 
replication is inhibited.  Histone mRNAs end in a conserved stemloop rather than a 
poly(A) tail.  Degradation of histone mRNAs requires the stemloop sequence, which 
binds the stemloop binding protein (SLBP), active translation of the histone mRNA, 
and the location of the stemloop close to the termination codon.  In this thesis I 
present evidence that the initial step in histone mRNA degradation is the addition of 
uridines to the 3’ end of the histone mRNA, both after inhibition of DNA replication 
and at the end of S-phase.  Lsm1 is required for histone mRNA degradation and is 
present in a complex containing SLBP on the 3’ end of histone mRNA after inhibition 
of DNA replication.  I cloned degradation intermediates that had been partially 
degraded from both the 5’ and the 3’ end.  RNA interference (RNAi) experiments 
demonstrate that both the exosome (3’-5’) and 5’ to 3’ decay pathway components 
are functionally required for degradation.   cRT-PCR experiments corroborate the 
findings from the functional RNAi experiments by providing direct evidence that 
individual histone mRNAs are degraded simultaneously 5’ to 3’ and 3’ to 5’ when 
DNA synthesis is inhibited.   Finally, I present evidence that SLBP protein 
expression is required for proper regulation of histone mRNA degradation when 
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DNA synthesis is inhibited, but that the underlying mechanism is due to nuclear 
retention of properly processed histone mRNA.  The latter suggests that one of the 
critical functions of SLBP in human cells is the proper export of histone mRNA to the 
cytoplasm.    
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CHAPTER 1 
 
INTRODUCTION 
 
 
THE EUKARYOTIC CELL DIVISION CYCLE 
 
 The eukaryotic cell faithfully replicates itself in a well characterized set of 
events termed the cell division cycle.  A cell that is not dividing is termed to exist in a 
resting, G0 state.  Once the proper stimuli prompt the cell to divide and duplicate 
itself, it enters the cell division cycle (or cell cycle).  The cell cycle is separated into 
four major phases:  the first growth phase (G1), the DNA synthesis phase (S), the 
second growth phase (G2), and finally mitosis (M) where the newly replicated 
chromosomes are segregated into two daughter cells.   
 The cell cycle is a highly ordered process of events that ensures proper 
completion of each phase prior to beginning the subsequent phase.  Much of this 
regulation is accomplished by cyclin-dependent kinases (CDKs).  Their regulated 
enzymatic activity functions to control cell signaling events that dictate the passage 
from each phase to the next.  The dividing cell encounters a variety of endogenous 
(e.g. oxidative stress) and exogenous (e.g. ultraviolet and ionizing radiation) 
stresses that challenge the fidelity of the cell division cycle.  The impact of the stress 
is most deleterious at the DNA level since this fundamental nucleic acid encodes the 
essential information of life and damage or alteration to it will affect, likely in the 
negative direction, the encoded information present within the subsequent 
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generations.  Fortunately eukaryotes have evolved a complex molecular surveillance 
system known as DNA damage checkpoints (or cell cycle checkpoints) that exists to 
protect the integrity of DNA.   
 
HISTONES ARE THE ARCHITECTURAL UNITS OF CHROMATIN 
 During each cell division a eukaryotic cell undertakes the arduous task of 
faithfully replicating its DNA during S phase for later segregation into two daughter 
cells. Not only must the cell replicate the entire genome but it must also 
appropriately package the newly replicated DNA into chromatin. The cell 
accomplishes this by coordinating the metabolism of histone proteins with chromatin 
assembly and DNA synthesis.    
 Histone proteins play an essential architectural role in compacting DNA 
molecules into structures we have come to know as chromosomes.  Nuclear DNA 
exists in various compacted states through the function of the various histone 
proteins that exist in the cell.  The more extended form of DNA exists as 
nucleosomes where approximately 146 bp of DNA is wrapped twice around an 
octamer containining two copies of each of the four core histone proteins H2A, H2B, 
H3 and H4.  A linker histone protein, histone H1, associates with each nucleosome 
as well as a variable length of linker DNA.  Nucleosomes can then be compacted 
into the higher order of condensation termed chromatin.   
 Two major classes of histone proteins exist.  The first class encompasses the 
replication-dependent histone genes (H2A, H2B, H3, H4 and H1), which are 
encoded by over 75 genes and expressed strictly during the DNA replication phase 
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of the eukaryotic cell cycle (Marzluff et al., 2002).  Two copies of each heterodimer 
consisting of both H2A:H2B and H3:H4 underlie the composition of the nucleosome.  
These heterodimers are deposited during the process of DNA replication in order to 
fill in the nucleosomal gaps that exist as a consequence of the progressing 
replication fork.  The replication-dependent histone genes are coordinately 
expressed and are clustered in close proximity to one another in the genome of 
metazoans (Wang et al., 1996a; Wang et al., 1996b).  Two major clusters 
encompass these genes and are present on chromosomes 1 and 6 in humans.  The 
major cluster on the short arm of chromosome 6 (HIST1) includes the majority of the 
H2A, H2B, H3 and H4 genes as well as all the H1 genes.  There are actually two 
smaller clusters of replication-dependent histone genes on chromosome 1 (HIST2 
and HIST3) that together encompass another several copies each of H2A, H2B, H3 
and H4.   
 The second class of histone genes encodes the variant (or replacement) 
histone genes where, in general, their expression is not restricted to S phase.   
These genes do not occur in clusters within the genome as do the replication-
dependent histone genes.  Examples of some histone variants include H2A.X, 
H2A.Z, H2ABbd, macroH2A, H3.3, and centromeric H3 (cenH3) (Malik and Henikoff, 
2003).  The variant histone H2A.X varies from H2A at the C-terminus and is the 
target of post-translational phosphorylation in response to DNA damage (e.g. DNA 
double strand breaks, ionizing radiation) (Rogakou et al., 1998).  Studies on H2A.Z 
have revealed that this histone variant plays an important role in maintaining a 
transcriptionally active state of chromatin (euchromatin) (Li et al., 2007).  MacroH2A 
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is enriched in the chromatin of the X-inactivated chromosome in female mammals 
(Costanzi and Pehrson, 1998).  Histone variant H2ABbd (Barr body deficient) is 
deposited within transcriptionally active chromatin and seems to be mutually 
exclusive to that of macroH2A (Gautier et al., 2004).  Histone H3.3 is unusual in that 
it differs from the canonical H3 by only four amino acid positions.  The precise 
function of these changes is still unclear but appear to affect the ability of H3.3 to be 
deposited into transcriptionally active sites of chromatin (Malik and Henikoff, 2003).  
Centromeric H3 (cenH3) is, as its name suggests, strictly localized to the 
centromeres of eukaryotic chromosomes and functions in packaging chromatin at 
these sites.  Additionally, tissue specific histones exist such as the testis specific 
histone H1t which is thought to play a role in meiotic events during spermatogenesis 
(Lin et al., 2004). Finally, it is interesting to point out that histone variants exist only 
in H2A and H3, while both H2B and H4 are invariant.  Evolutionary and structural 
determinants certainly underlie the existence of H2A and H3 variants but such a 
discussion is out of the scope of this introduction.   
 The S phase-restricted synthesis of the core histones is the main, gross 
difference distinguishing the expression of the replication-dependent histone genes 
from the variant histone genes.  The replication-dependent histone genes encode 
the only eukaryotic messenger RNAs (mRNAs) that are not polyadenylated.  
Instead, the mRNAs encoding the core histone genes end in a conserved stem-loop 
structure on their 3’ end (see below and Figure 1).  The 3’ end unique to the 
replication-dependent histone mRNAs serves important roles in the post-
transcriptional regulation of these genes, including processing and mRNA stability.  
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Variant histone genes are, like all other mRNAs, polyadenylated at the 3’ end and 
their post-transcriptional regulation is for all intents and purposes identical to other 
polyadenylated mRNAs.   
 
CHROMATIN ASSEMBLY 
 Chromosome replication is a rapid, error-prone process involving the 
coordination of the DNA synthesis machinery (e.g. DNA polymerases, helicases, 
etc.) with the molecules involved in the various types of DNA repair.   The DNA 
polymerases (DNA polymerase α/primase, δ, and ε) at the replication fork also 
require that a delicate balance of histone proteins as well as chromatin assembly 
activity is present in order to ensure proper assembly of the newly replicated DNA 
into chromatin.   During the process of DNA replication, a major chromatin assembly 
pathway exists that includes the heterotrimeric chromatin assembly factor 1 (CAF-1) 
complex.  CAF-1 is comprised of the p150, p60, and p48 subunits and together are 
present at replication foci within the nucleus of eukaryotic cells (Verreault et al., 
1996).  CAF-1 activity is restricted to DNA replication and CAF-1 associates with 
proliferating cell nuclear antigen (PCNA), which acts as the processivity factor for the 
DNA polymerase at the replication fork (Groth et al., 2007).  It performs the initial 
step in chromatin assembly, deposition of the H3-H4 tetramer.   
 HIRA is a second chromatin assembly complex that also functions to deposit 
H3-H4 tetramers, but it largely functions to assemble chromatin outside of S phase, 
or in a replication-independent manner.  HIRA contains seven WD repeat motifs as 
well as a domain distinct to itself (HIRA domain) (Tagami et al., 2004).  The WD 
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repeats allow HIRA to interact with other proteins, particularly the histone variant 
H3.3.  Chromatin assembly outside of S phase largely encompasses incorporation of 
histone variants as a consequence of local changes in chromatin due to transcription 
or normal histone protein turnover (Gunjan et al., 2005).   It is clear that HIRA 
prefers to interact with H3.3 which is often associated with active chromatin 
domains.  The reason for this specificity is not clear but recent evidence suggests 
that H3.3-H4 histone dimers act as important intermediates in the replication-
independent assembly of chromatin (Tagami et al., 2004). 
 
REPLICATION-DEPENDENT HISTONE mRNA METABOLISM 
 In this dissertation I examine specifically the molecular mechanisms 
controlling the stability of replication-dependent histone mRNAs and therefore an 
overview of histone mRNA metabolism as well as general mechanisms of histone 
mRNA stability are in order.  Additionally, general mechanisms of mRNA 
degradation will also be discussed.  The following sections examine these subjects 
in detail.   
Transcription 
 The levels of histone mRNA are tightly coupled to DNA synthesis.  When cells 
enter S-phase, the transcription of histone genes increase 3-5 fold (Figure 2) due to 
the phosphorylation of the positive transcription factor p220NPAT (NPAT) by cyclin 
E/cdk2 (Ye et al., 2003b).  Cyclin E/cdk2 is an essential cyclin-dependent kinase that 
regulates multiple aspects of the transition from G1 to S phase of the cell cycle.  
These aspects include E2F1-dependent transcription of genes involved in DNA 
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replication.  NPAT is located within subnuclear structures termed Cajal bodies that a 
foundation of literature suggests is the primary site of histone gene transcription and 
pre-mRNA processing (Handwerger and Gall, 2006).  In support of its suggested 
role in histone gene transcription, NPAT and its subsequent phosphorylation at the 
G1/S transition, is required for proper accumulation of coilin (p80) foci, a major 
structural component of Cajal bodies (Ma et al., 2000).  Although the transcriptional 
contribution is significant to increasing histone mRNA levels, there are a number of 
post-transcriptional mechanisms that ultimately result in the 35-fold increase in 
histone mRNA seen during S phase.  These mechanisms include increased pre-
mRNA processing and changes in mRNA half-life.  As I will subsequently discuss, 
histone mRNA stability and translation are intimately connected.   
Pre-mRNA Processing  
There are two cis-acting elements in histone mRNA that contribute to the 
processing of the pre-mRNA.  One is the 26 nucleotide (nt) stem-loop (SL) sequence 
that is present on the 3’ end of histone mRNA. The second is a purine-rich 
downstream sequence termed the histone downstream element (HDE) (Figure 1).  
The HDE is recognized through the complementary base pairing with the 5’ end of 
U7 snRNA, which is contained within the U7 snRNP.   The U7 snRNP is composed 
of the U7 snRNA as well as a heteroheptameric set of Sm proteins (Marzluff and 
Duronio, 2002).  Typical splicesomal snRNPs contain SmD1, SmD2, SmB/B', SmD3, 
SmE, SmF and SmG.  In contrast, the U7 snRNP contains Lsm10 and Lsm11 in 
place of SmD1 and SmD2 (Pillai et al., 2001).  The SL is recognized by a second 
trans acting factor, the stem-loop binding protein (SLBP).  This protein is required for 
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histone pre-mRNA processing in Drosophila and human cells (Dominski et al., 1999; 
Sullivan et al., 2001) and additionally functions in histone mRNA metabolism 
including translation.   
The two cis elements allow for an endonucleolytic cleavage of the pre-mRNA 
between the SL and HDE that results in the formation of the mature 3’ end of the 
message.  Importantly, replication-dependent histone genes do not contain introns, 
therefore processing of histone pre-mRNA does not require the elaborate 
mechanisms of splicing.  Instead, the final step in processing of the message is the 
endonucleolytic cleavage which occurs at the end of a conserved ACCCA sequence 
following the SL.  The endonuclease responsible for cleavage of the pre-mRNA has 
recently been identified through UV cross-linking studies as CPSF-73 (Dominski et 
al., 2005a).   CPSF-73 and the heat-labile factor Symplekin are core components of 
the histone pre-mRNA processing apparatus (Kolev and Steitz, 2005).  Recent 
evidence from the Steitz lab suggests protein components of the splicesomal U2 
snRNP plays a non-splicing role in stimulating U7-dependent histone pre-mRNA 
processing (Friend et al., 2007).   
The SL, HDE, SLBP and U7 snRNP have an inter-dependent function in 
histone pre-mRNA processing.  This relationship and the data supporting it are 
described in more detail in the Introduction of Chapter 5.  A more relevant topic to 
this discussion, is how histone pre-mRNA processing contributes to the increase in 
histone mRNA levels when cells enter S phase.  That is, if transcription contributes a 
3-5 fold increase in histone mRNA levels, where does the additional 10 fold increase 
to give the final increase of 35-fold originate?    
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Harris et al. conducted a convincing study where they set out to separate the 
contributions of transcription and pre-mRNA processing to the dramatic increase of 
histone mRNA levels at the beginning of S phase (Harris et al., 1991).  They 
constructed a transgene containing a constitutive U1 snRNA promoter, followed by 
the complete U1 coding region, and a normal histone 3’ sequence (U5H transgene). 
Using CHO cells synchronized by mitotic shake-off, they determined that the 
transgene was regulated normally in a cell cycle regulated manner and responded to 
inhibition to DNA synthesis.  More interestingly, they observed that the U5H 
transgene increased 10-fold as cells entered S phase compared to the 35-fold of a 
normal cloned H2A gene.  Therefore, it was clear the 3.5-fold difference was due to 
transcription while the 10-fold effect was likely post-transcriptional.  Indeed this was 
the case since using a different transgene construct that had two processing sites:  a 
normal histone processing site and a downstream polyadenylation site.  Therefore, 
the accumulation of each transcript reflected the efficiency of 3’ end formation.  The 
larger transcript (polyadenylated) predominated in G1 while the smaller, histone 3’ 
end-containing transcript was restricted to S phase.   The levels of the histone 3’ end 
transcript present between G1 and S phase was approximately an 8-fold difference 
supporting the notion that as cells transit from G1 to S phase, histone pre-mRNA 
processing efficiency increases from 8-10 fold.  Taken together, the processing 
efficiency of histone pre-mRNAs, like other pre-mRNAs, contributes a significant 
component in determining the abundance of the mature mRNA found in the 
cytoplasm.  As we will soon discover below, in contrast to the contribution of 
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transcription and processing, there is a remarkable decrease in the half-life of 
histone mRNA that is specific to the end of S and throughout G2 phase.   
SLBP as the Post-Transcriptional Regulator of Histone mRNA   
 SLBP plays a major role in all aspects of histone mRNA metabolism. The 
level of SLBP mRNA does not significantly change throughout the cell cycle but at 
the beginning of S phase, translation is stimulated by an unknown mechanism 
resulting in a 20-fold increase in SLBP protein (Figure 2) (Whitfield et al., 2000).  The 
increased levels of SLBP are thought to be the driving factor that stimulates histone 
pre-mRNA processing efficiency 8-10 fold.  Following pre-mRNA processing, SLBP 
remains bound to the SL as the mature message is exported to the cytoplasm for 
translation (Figure 3).   
 SLBP does not contain a nuclear export signal but instead is exported while 
being bound to the RNA.  The details of histone mRNA export have been 
investigated in both Xenopus oocytes and Drosophila S2 cells and it is clear that the 
mRNA export receptor TAP is important for translocating the histone mRNP through 
the nuclear pore complex (Erkmann et al., 2005a).  Once exported, SLBP is required 
for translation of the message (Sanchez and Marzluff, 2002).  When histone mRNAs 
are degraded, SLBP is recycled back to the nucleus through interactions with the 
import receptors Importinα/Importinβ (Erkmann et al., 2005b). SLBP contains a 
nuclear localization (import) signal and amino acid mutations within the C-terminus 
of SLBP abrogate binding to Impα/Impβ.  
 The role of SLBP in histone mRNA translation has been studied in detail 
using the Xenopus oocyte system where transcription is inactive but the translational 
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machinery is fully competent.  Unlike humans, frogs have two forms of SLBP:  
xSLBP1 and xSLBP2.   The latter is oocyte-specific and involved in translational 
repression of maternally stored histone mRNAs in frogs (Sanchez and Marzluff, 
2002, 2004).  xSLBP1 functions analogously to human SLBP and its role in 
translation has been conclusively defined using an MS2 fusion protein tethering 
system.  Recruitment of an MS2-xSLBP1 to the 3’ end of an injected histone mRNA 
containing an MS2 stem-loop sequence (also on the 3’ end) is sufficient for robust 
stimulation of translation compared to a reporter control RNA (Gorgoni et al., 2005; 
Sanchez and Marzluff, 2002).  Recently the lab has discovered a protein, termed 
SLIP1 (SLBP Interacting Protein 1), which interacts with both SLBP and the 5’ cap 
binding protein eIF4G.  SLIP1 is involved in histone mRNA translation and likely 
bridges between SLBP and the 5’ end of the mRNA (Cakmakci et al., 2008).  In 
summary, SLBP plays an integral role in histone mRNA metabolism.  Many of the 
functions of SLBP mirror that possessed by poly(A) binding protein (PABP), multiple 
molecules of which binds stoichiometrically to the approximately 200 nt 
polyadenylated 3’ end that is formed during the cleavage and polyadenylation of 
mRNAs.  PABP is important in regulating translation initiation and is a major 
determinant of mRNA degradation.    
Degradation of Histone mRNA 
 The final step in metabolism of an mRNA is degradation of the mRNA.  
Regulation of the half-life of an mRNA can be a critical regulatory step in gene 
expression.  It provides the best mechanism for irreversibly inactivating the 
translation of an mRNA, and hence halting synthesis of a particular protein until 
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more mRNA is synthesized.  The half-life of the mRNA is a critical contributor to the 
steady-state level of an mRNA, and hence potentially as important as the rate of 
transcription of the gene in determining mRNA levels.  The information for the half-
life of an mRNA, and regulation of that half-life, is encoded in the mRNA, often in the 
3’ untranslated region (3’ UTR), and is often mediated by proteins that interact with 
the 3’ UTR.  Degradation of histone mRNA plays a critical role in regulation of 
histone protein biosynthesis, helping to maintain the balance between DNA and 
histone biosynthesis (Sariban et al., 1985).  Replication-dependent histone mRNAs 
are present in large amounts only in S-phase cells; they are rapidly synthesized just 
prior to entry into S-phase and rapidly degraded at the end of S-phase or when DNA 
synthesis is inhibited.   A more detailed discussion of the known mechanisms 
controlling histone mRNA stability and general mechanisms of mRNA decay are 
detailed in subsequent sections (see below).   
 
SIGNIFICANCE OF MAINTAINING PROPER HISTONE PROTEIN LEVELS 
 The various post-transcriptional mechanisms discussed above contribute to 
the increased levels of histone mRNA at the beginning and continuing throughout S 
phase.  Maintaining the appropriate levels of histone biosynthesis is critical for 
proper chromatin formation.  This was first shown in the budding yeast 
Saccharomyces cerevisiae where Meeks-Wagner and Hartwell showed that 
overexpression of histone H2A-H2B and H3-H4 dimers results in significant 
chromosome loss (Meeks-Wagner and Hartwell, 1986).   Additional data in budding 
yeast demonstrate that Rad53 is required for the degradation of excess histone 
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proteins in the nucleus (Gunjan and Verreault, 2003).  Rad53 is a kinase that is 
required for efficient DNA replication and recovery from DNA damage.  Mutants in 
Rad53 have a loss of viability phenotype that is exacerbated by increasing histone 
gene expression.  Decreasing histone gene expression attenuates this phenotype.  
In addition, the highly net positive charge of histone proteins combined with the 
overall negative charge of nucleic acid, particularly double-stranded DNA, has been 
shown to result in chromatin aggregates when excess histone proteins are present 
(Steger and Workman, 1999).  The result of such chromatin aggregates is a 
blockage in transcription.   
 In flies, null mutants of SLBP are embryonic lethal and accumulate 
misprocessed, polyadenylated histone mRNAs that are not cell cycle regulated 
(Lanzotti et al., 2002; Sullivan et al., 2001).   Moreover, hypomorphic SLBP mutant 
flies have decreased levels of properly processed histone mRNA and examination of 
mitotic cells in developing embryos reveal dramatic malformations of the mitotic 
spindle due to improperly formed chromatin that results as a consequence of low 
maternal levels of histone proteins present in the developing embryo.  Together 
these data suggest an important role for maintaining a fine balance of histone 
biosynthesis with the changing demands of DNA synthesis.   A major mechanism 
that allows the eukaryotic cell to rapidly regulate histone biosynthesis with DNA 
synthesis is through post-transcriptional mechanisms that rely on rapidly altering the 
half-life of histone mRNA.    
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HISTONE mRNA DEGRADATION IS A REGULATED PROCESS 
 It has been appreciated for over 30 years that mRNAs encoding various gene 
transcripts have different half-lives (Perry and Kelley, 1973; Singer and Penman, 
1973), but only recently have we come to appreciate the significance.  We have 
learned from the preceding section the contributions of transcription, pre-mRNA 
processing and stability imparts to the levels that a particular mRNA accumulates in 
the cytoplasm.  Early studies on housekeeping genes that are constitutively 
expressed observed that the mRNA of the different housekeeping genes 
accumulated at variable levels (Berger and Cooper, 1975).  Detailed kinetic 
measurements of polyadenylated mRNAs revealed dramatic differences in the half-
lives of rare and abundant mRNAs in the developing sea urchin (Cabrera et al., 
1984).  Moreover, molecular studies examining the 3’ UTR of the cytokine 
granulocyte-macrophase colony-stimulating factor (GM-CSF) revealed the presence 
of specific AU-rich sequence elements (AREs) that rendered this mRNA inherently 
unstable (Shaw and Kamen, 1986).  Histone mRNAs are an excellent example of a 
class of mRNAs that are coordinately regulated by a common cis-element, the 
stemloop.   
 Histone mRNA half-life is normally regulated during the cell cycle, but the 
regulation of degradation is most easily studied by inhibiting DNA replication, which 
triggers a rapid degradation of histone mRNA.  By all the parameters studied, 
degradation of histone mRNA under these conditions is similar to histone mRNA 
degradation at the end of S-phase (Kaygun and Marzluff, 2005a, b; Mullen and 
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Marzluff, 2008).  After inhibition of deoxynucleotide synthesis, there is a short lag (5-
10 min) before histone mRNA degradation is initiated, likely as a result of depletion 
of the deoxynucleotide pool (Graves and Marzluff, 1984), and then degradation 
proceeds rapidly with a half-life of the mRNA of about 10 min., compared to the half-
life of about an hour in S-phase cells (Heintz et al., 1983).   
 A number of different studies have clearly demonstrated the cell cycle 
regulated expression of histone genes (Harris et al., 1991; Morris et al., 1991).  
Using double thymidine synchronized HeLa cells (Morris et al., 1991) or mitotic 
shake-offs of CHO cells (Harris et al., 1991), the restriction of histone mRNA 
expression to S-phase has been well documented.  In addition, pulse-chase studies 
using 3H-precursors performed over 30 years have shown in double thymidine 
synchronized HeLa cells and logarithmically growing mouse L cells, that histone 
mRNA levels rapidly disappeared from polyribosomes when DNA synthesis was 
inhibited using either hydroxyurea or cytosine arabinoside (Gallwitz, 1975; Perry and 
Kelley, 1973).  It was clear from these early mRNA stability studies that changes in 
histone mRNA levels was not a stochastic process, but instead regulated, molecular 
events were underlying the rapid changes observed in histone mRNA stability.   
These early data in combination with work by others (Graves et al., 1987) pointed to 
a translational component of this process since pre-treatment of synchronized HeLa 
cells with cycloheximide (inhibitor of translation elongation) followed by treatment 
with hydroxyurea rendered histone mRNAs stable (Gallwitz, 1975).  Moreover, 
studies using the transcription initiation inhibitor actinomycin D clearly demonstrated 
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that inhibition of transcription had only a minor effect in the levels of histone mRNA 
during S-phase (Gallwitz, 1975; Perry and Kelley, 1973).   
A landmark study in 1987 provided overdue insight into how the mRNA itself 
as well as translation contributed to the regulated degradation of histone mRNA 
(Graves et al., 1987).  Using altered transgenes of histones H2A and H3 transfected 
into mouse L cells, the investigators made two major findings.  The first was that an 
intact 3’ end (i.e. the stem-loop sequence) was necessary for efficient degradation of 
histone mRNA.  In support of this data, replacement of the poly(A) tail on a globin 
mRNA with the stem-loop resulted in an mRNA that was rapidly degraded when 
DNA replication was inhibited (Pandey and Marzluff, 1987).  The second was that 
the mRNA needed to be translated to within 300 nt of the 3’ end.  The latter 
suggested some of the early evidence for what we now understand to be an intimate 
link between translation termination at the stop codon and mRNA degradation 
(Akimitsu, 2008).   
Although the above literature provided early clues into the role of translation 
and the importance of the 3’ stem-loop of histone mRNA, the actual enzymes 
responsible for degrading histone mRNA remained elusive.  Ross and colleagues 
sought to solve this problem by developing an in vitro histone mRNA degradation 
system (Ross and Kobs, 1986).  By isolating polysomes from human K562 
erythroleukemia cells, they were able to study some of the early steps involved in 
histone mRNA degradation.  Using S1 nuclease mapping using probes to the 5’ and 
3’ end of histone H4 mRNA, they were able to demonstrate that degradation 
intermediates accumulated that were trimmed from the 3’ end but not the 5’ end 
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(Ross and Kobs, 1986).  This data suggested the involvement of a 3’-5’ 
exoribonuclease that was present in their polysome fractions.  Moreover, they could 
identify intermediates that appeared to stall early in the degradation process, 
presumably due to the presence of the structured 3’ stem-loop sequence found on 
replication-dependent histone mRNAs.  Despite extensive efforts to characterize the 
biochemical properties of this 3’-5’ exonuclease activity using this in vitro 
degradation, Ross and colleagues were never able to identify the suggestive 
enzyme.   
In 2003, Dominski and colleagues identified a 3’-5’ exonuclease (3’hExo) as a 
protein that was purified using a biotinylated stemloop RNA as an affinity ligand 
(Dominski et al., 2003).  3’hExo forms a ternary complex with the 3’ stem-loop RNA 
substrate and SLBP in vitro.  It could degrade efficiently 2-3 nucleotides from the 3’ 
end of the SL RNA and could degrade as far as 13 nucleotides into the stem of the 
30 nt RNA substrate.  In the presence of SLBP it only removed 2-3 nts from the 3’ 
end of the mRNA.  Although the 3’hExo in vitro data was suggestive of being the 
elusive 3’-5’ exonuclease Ross and coworkers were hunting, the function of 3’hExo 
on histone mRNA degradation in vivo remained to be determined.  Kupsco et al. 
attempted to use a genetic approach in Drosophila to address the biological role of 
3’hExo in histone mRNA degradation (Kupsco et al., 2006).  Following the 
identification of a 3’hExo (Snipper in flies) mutant, they were able to test if Snipper 
functioned in degrading histone mRNAs in the imaginal eye disc and developing 
embryo.  Snipper mutants were indistinguishable from wild-type flies suggesting the 
closest 3’hExo ortholog in flies did not play a role in controlling histone mRNA 
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degradation.  Despite the efforts from a number of different groups, the enzymes 
responsible for degrading histone mRNA upon inhibition of DNA synthesis and 
normally at the end of S phase remain to be determined.   
However, recent data from our lab provide more direct evidence that indeed 
translation is required for rapid destabilization of the mRNA.  By putting the 
translation of histone mRNAs under the regulation of the iron response element 
(IRE) (Hentze et al., 1987), Handan Kaygun showed that active translation is 
required for efficient degradation (Hentze et al., 1987; Kaygun and Marzluff, 2005b).  
The translation of a number of cellular mRNAs have an IRE located in their 5’ 
untranslated region (UTR), and the translation of these mRNAs is regulated by both 
iron response element binding protein (IRP) and intracellular iron levels (Klausner et 
al., 1993).  Handan’s study also carefully mapped specific distance effects of the SL 
in relation to the termination codon and found moving the SL only 30 nucleotides 
from the termination codon was sufficient for destabilizing the mRNA.  A mutant form 
of SLBP (SAVEE-SLBP) that is defective in efficiently translating histone mRNAs 
was also shown to impair histone mRNA decay.   
Handan Kaygun also demonstrated that the RNA helicase Upf1, which is 
involved in a specialized form of mRNA quality control termed nonsense-mediated 
decay (NMD, see below), was required for efficient decay of histone mRNA both in 
response to inhibition of DNA synthesis and normally at the end of S phase (Kaygun 
and Marzluff, 2005a).  This was shown by transfection of mutant forms of Upf1 and 
RNAi-mediated downregulation of Upf1 protein.  Surprisingly, a stable cell line 
expressing hemagglutinin (HA)-tagged SLBP could immunoprecipitate Upf1 protein 
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in a hydroxyurea-dependent manner.  This interaction was independent of binding to 
Upf2 and Upf3, two proteins normally found in complex with Upf1.  These data 
suggest that Upf1 specifically associates with SLBP when DNA synthesis is inhibited 
or upon completion of S phase to promote rapid degradation of histone mRNA.  
These data provided the first insights into the possibility that the eukaryotic cell uses 
the NMD surveillance machinery, once specifically thought to target only aberrant 
mRNAs, to control mRNA levels of normal intronless mRNAs.   
 
NONSENSE-MEDIATED DECAY 
 Nonsense mediated decay (NMD) was originally identified in yeast (Leeds et 
al., 1991) and was subsequently shown to be conserved in humans (Belgrader et al., 
1994).  NMD functions as a molecular surveillance system in eukaryotes to eliminate 
aberrantly spliced mRNAs containing premature termination codons (PTCs), since 
the expression of truncated forms of any mRNA might lead to aberrant proteins 
which might have activities that could be detrimental to the cell.  In fact, this is the 
case in yeast where Upf1 mutant strains accumulate PTC-containing transcripts that 
lead to cytotoxicity (He et al., 1993).  In mammals this pathway affects only mRNAs 
encoded by spliced transcripts (Maquat, 2004; Maquat and Li, 2001), and hence 
does not affect histone mRNAs (Maquat and Li, 2001), since these lack introns.  
During pre-mRNA splicing a complex of proteins, termed the exon-junction complex 
(EJC), is deposited on the mRNA to mark the removal of each intron (Le Hir et al., 
2000).  In the case that there is a termination codon greater than 50-55 nt upstream 
of an exon-exon junction, these mRNAs are rapidly degraded once the ribosome has 
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terminated (Lykke-Andersen et al., 2000), suggesting that an EJC in the 3’ UTR 
destabilizes mRNAs.  Indeed there are approximately 12-16 proteins contained 
within the exon junction complex of which Upf1, Upf2 and Upf3 are included (Schell 
et al., 2003).   
 Nonsense mediated decay results from recognition of an inefficient translation 
termination codon by Upf1.  Recent biochemical studies have revealed that Upf1 
stably exists in a complex of proteins that include SMG-1, eRF1, and eRF3 (SURF 
complex) (Kashima et al., 2006).  SMG-1 (also known as ATX) is a 
phosphoinositide-3-kinase-like kinase (PI3K-like) that plays a critical role in 
regulating Upf1 activity via phosphorylation of 16 SQ/TQ substrate sites present in 
the C-terminus of this protein.  The eukaryotic translation termination factor eRF1 
recognizes any of the three stop codons and has a multidomain structure that allows 
it to interact with the stop codon, the peptidyl transferase center of the ribosome, and 
the other release factor eRF3.  eRF3 is a small GTPase that enhances stop codon 
recognition by eRF1 and release of the growing polypeptide chain from the 
ribosome.   Upf2 binds to Upf3 in the EJC and Upf2 then binds to Upf1.  This in turn 
results in the activation of mRNA decay as a result of the activity of the SURF 
complex to the premature termination codon.   
 Additional mRNA surveillance systems exist to monitor aberrant mRNAs such 
as non-stop decay and no-go decay.  Non-stop decay functions to target mRNAs 
that lack a stop codon while no-go decay functions to eliminate mRNAs that have 
stalled ribosomes on them (Doma and Parker, 2006; Frischmeyer et al., 2002).  The 
details of these pathways are not well understood.   
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 As we have learned from the aforementioned sections, an intimate link 
between mRNA degradation and translation has been observed for many years but 
only recently (Ivanov et al., 2008; Keeling et al., 2006) have we begun to understand 
the detailed molecular mechanisms that coordinate translation termination and 
mRNA degradation.   Histone mRNAs are the only known example of degradation of 
a normal cellular mRNA, likely regulated through the efficiency of translation 
termination (Kaygun and Marzluff, 2005a, b), requiring Upf1 for its degradation.   
 
GENERAL MECHANISMS OF mRNA DEGRADATION 
 During the past decade our understanding of mRNA degradation has 
increased dramatically (Decker and Parker, 1994; van Hoof and Parker, 1999).  
Most of this information is from work done in yeast, but studies in higher eukaryotes 
are providing significant insight into the shared pathways between these organisms. 
The mechanisms in yeast are for the most part conserved in metazoans, but 
certainly exceptions exist (Gatfield and Izaurralde, 2004; Moore, 2005).  Additionally, 
recent genome-wide studies in human cells have highlighted the importance of 
mRNA stability in regulating gene expression in response to various types of cellular 
stress (UV, heat shock, and prostaglandins) or cellular signals that direct T cell 
activation (Cheadle et al., 2005; Fan et al., 2002).  These microarray-based studies 
have revealed that 40-50% of the changes in gene expression that occur in 
response to various cellular signals result due to changes in mRNA stability.   
Additionally, the impact that small RNA pathways (see below) have on mRNA 
stability and gene expression has certainly been a major scientific discovery that 
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underscores the importance of mRNA degradation.  The purpose of this section is to 
provide an overview of the various mechanisms that exist to regulate mRNA 
degradation.  The reader should come away with an understanding that mRNA 
degradation does not simply serve as a garbage disposal for tired, unwanted 
mRNAs but that nature has evolved several mRNA degradation pathways that serve 
integral functions in regulating gene expression through mRNA stability.   
Two Major mRNA Degradation Pathways Exist in Eukaryotes 
 Eukaryotic mRNAs have structural elements on their 5’ and 3’ ends that 
impart a certain level of stability to any particular mRNA.  The first is the 5’ 
hypermethylated 7-methylguanosine cap structure that is added to the mRNA 
cotranscriptionally.  The second is the 3’ poly(A) tail which is also added 
contranscriptionally.  The 5’ cap structure and poly(A) tail interact with the translation 
machinery via eIF4E and PABP, respectively.   Most, but certainly not all, mRNA 
degradation pathways begin with deadenylating the mRNA (Tucker and Parker, 
2000).  The removal of the poly(A) tail breaks the assocation of PABP with the 
scaffolding translation factor eIF4G, thereby effectively breaking the circular 
structure of translating mRNAs.  Following this the mRNA is deadenylated probably 
by CCR4/Not1/Pop2 (Goldstrohm et al., 2006; Yamashita et al., 2005), although 
other deadenylases exist such as PARN and PAN2-PAN3 (Brown et al., 1996; 
Funakoshi et al., 2007).  The deadenylation of the poly(A) tail may serve as a 
molecular clock dictating the exit of the mRNA from translational competency.  The 
5’ hypermethylated m7-GTP cap can then be removed by decapping enzymes, 
namely the Dcp1/Dcp2 complex of which Dcp2 is the catalytic subunit.  In higher 
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eukaryotes there exists an additional decapping cofactor know as hedls, or Ge-1, 
that has been shown to be an enhancer of decapping (Fenger-Gron et al., 2005).  
Once decapping has occurred the mRNA can be degraded by Xrn1, the major 
cytoplasmic 5’-3’ exonuclease.   The 5’ cap structure that has been removed is 
eventually degraded by a scavenger pyrophosphatase known as DcpS (Liu et al., 
2002).  A schematic of the mechanism of 5’-3’ degradation is outlined in Figure 5 
and Table 1 lists a number of the major enzymes involved in RNA degradation.   
 Decapping is a tightly regulated process since the 5’ cap structure serves an 
important role in specifying stability as well as participating in translation of a 
particular mRNA.  A number of accessory factors therefore exist that are known 
enhancers of decapping, and these are recruited to mRNA after deadenylation.  The 
decapping enzymes are recruited to the 5’ end by a heteroheptameric complex of 
Sm-like proteins, Lsm1-7 (Bouveret et al., 2000).  In budding yeast, Lsm1 mutant 
strains accumulate deadenylated, capped mRNAs (Tharun et al., 2000; Tharun et 
al., 2005).  Similarly, decapping enzyme mutant strains of budding yeast also 
accumulate deadenylated mRNAs, providing compelling genetic evidence for the 
Lsm1-7 complex functioning as a positive regulator of decapping activity (Tharun et 
al., 2000).  Lsm1-7 is similar to another Sm-like complex, Lsm2-8, which share 
identical subunits with the exception of course being Lsm1.   Lsm2-8 however 
functions in stabilizing U6 snRNA as well as processing of pre-tRNAs, pre-snoRNAs, 
and pre-rRNAs (Kufel et al., 2002).  Sm and Sm-like proteins are RNA binding 
protein complexes that recognize U-rich sequence elements (Schumacher et al., 
2002).  They form a ring structure that crystallographic studies have shown bind 
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RNA on one face of the complex, although it is also possible the complex assembles 
around the RNA molecule.  Lsm1-7 is similar to the Escherichia coli Sm-like protein 
Hfq, which is an important regulator of mRNA degradation in bacteria.   
 Other Lsm proteins have also been implicated in having roles in mRNA 
degradation such as Lsm14 (PABP-binding protein-1, Pbp1) and Lsm16 (enhancer 
of decapping-3, EDC3) (Kshirsagar and Parker, 2004; Morrissey et al., 1999).  
Additionally, other decapping accessory proteins exist such as the DEAD/H-box 
RNA helicase Dhh1 and Pat1, which are also recruited by Lsm1-7.  Dhh1 (or 
RCK/p54) has been well characterized in budding yeast and through elaborate 
polysome profiling by Coller and Parker has been shown to be involved in 
translational repression and mRNA degradation (Coller and Parker, 2005; Coller et 
al., 2001).  Genetic evidence of Pat1 also suggests Dhh1 and Pat1 function to 
cooperatively regulate translational repression and/or mRNA degradation.   
 The 5’-3’ degradation pathway described above represents the first of two 
predominant mRNA decay pathways in eukaryotes.  The second pathway involves 
3’-5’ mRNA degradation by a complex of proteins termed the exosome.  The 
eukaryotic exosome contains 10-11 proteins that either have 3’-5’ exoribonuclease 
activity or possess RNA recognition and binding properties.  Figure 6 depicts a 
generalized 3’-5’ pathway and Table 1 lists a number of the protein components 
involved.  There are 6 predicted exonucleases in the exosome, both phosphorlytic 
and hydrolytic enzymes.  These are Rrp41, 42, 43 (OIP2 in humans), Rrp45 
(PM/Scl-75 in humans), Rrp46, and Mtr3 (Liu et al., 2006).  These six proteins share 
close sequence homology to E. coli RNase PH and the polynucleotide 
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phosphorylase (PNPase) PH domain (Houseley et al., 2006).  Both enzymes are 
processive, hydrolytic 3’-5’ exoribonucleases.  I should point out that the 
exonuclease activity sounds contradictory to the naming of polynucleotide 
phosphorylase.  This is because PNPase was originally described as an RNA 
polymerase and indeed Severo Ochoa received the Nobel Prize for its discovery.  
However, as an exonuclease it produces diphosphates as a product in a reaction 
that is readily reversible.  Thus in high nucleotide diphosphate concentrations, 
PNPase can catalyze the polymerization of nucleotides where phosphate is 
released.  It was this latter activity that PNPase is best known for since this enzyme 
plays an important role for priming bacterial mRNA degradation by adding A’s to the 
3’ ends of transcripts for subsequent degradation by the degradosome (Garneau et 
al., 2007; Wilusz and Wilusz, 2005).   The yeast exosome contains an additional 
component Rrp44 which is another 3’-5’ exoribonuclease which is similar to bacterial 
RNase R and RNase II (Schneider et al., 2007).  Rrp44 (Dis3 in humans) has not 
been identified in human exosome preparations.   
 There are three additional components of the exosome that possess S1 or 
KH RNA binding domains that are presumed to perform the substrate recognition 
function of the complex.  These include Rrp4, Rrp40 and Csl4 (Liu et al., 2006).  The 
final component for the yeast and human exosome is Rrp6 (PM/Scl-100 in humans), 
which is a distributive hydrolytic exoribonuclease.  There still exists some contention 
surrounding whether or not PM/Scl-100 is restricted to the nuclear exosome or 
present in both the nuclear and cytoplasmic exosome.  Biochemical purification 
experiments suggest restriction of Rrp6 to the nucleus while subcellular localization 
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studies combined with functional experiments provide more compelling evidence 
that indeed Rrp6 (PM/Scl-100) is present, at least in mammals, in both cellular 
compartments (Graham et al., 2006; Lejeune et al., 2003).   
 The exosome was originally described in budding yeast (Mitchell et al., 1997).  
The nuclear exosome complex plays an important role in eliminating aberrant 
precursors of various RNAs including pre-mRNAs, pre-tRNAs and pre-rRNAs 
(Allmang et al., 1999).  Although the nuclear exosome has defined roles in 
processing and quality control, it also has a clear role in cytoplasmic mRNA decay 
where the only known substrate in the cytoplasm is mRNA.   Like the cytoplasmic 5’-
3’ degradation pathway, the exosome relies on the deadenylation of the poly(A) tail 
to render the transcript translationally inactive.  At this point the exosome’s 
numerous 3’-5’ exonucleases can function to rapidly degrade the mRNA, although 
the precise mechanisms that are responsible for this recruitment are not well 
understood.  As mentioned earlier, Rrp4, Rrp40 and Csl4 certainly impart some of 
the substrate recognition properties of the exosome but several studies implicate 3’ 
end processing complexes (TRAMP complex) and translation regulation complexes 
(Ski7, Ski2/Ski3/Ski8, EF1A, and eRF3) in specifically directing exosome activity to 
particular mRNAs (Houseley et al., 2006; LaCava et al., 2005).  The TRAMP 
complex and its components will be discussed in more detail in Chapters 3 and 6.    
 I have described the 5’-3’ and 3’-5’ pathways as separate pathways but they 
do not appear to be mutually exclusive.  Although there is evidence that the 5’-3’ 
decay pathway performs the bulk of mRNA degradation under normal laboratory 
growth conditions in budding yeast, there does not appear to be a significant effect 
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on the yeast mRNA population when either the 5’-3’ or 3’-5’ decay machinery is 
knocked out (He et al., 2003; Houalla et al., 2006).  The latter suggests some 
redundancy in the pathways.  Whether or not the two pathways cooperate to 
degrade a single mRNA molecule is a subject of debate and although some 
evidence in humans (Lejeune et al., 2003) is suggestive of cooperation, no direct 
evidence exists.   
Other Decay Pathways 
 In addition to the 5’-3’ and 3’-5’ RNA decay pathways, there exist other mRNA 
degradation pathways.  These include deadenylation-independent mechanisms and 
endonucleolytic decay.  The two examples of deadenylation-independent decapping 
and degradation in budding yeast involve an autoregulatory feedback for EDC1 and 
RPS28B mRNAs (Badis et al., 2004; Muhlrad and Parker, 2005).  Figures 7 and 8 
provide schematic representations of these two mechanisms.  Edc1 protein is an 
enhancer of decapping and binds an oligo(U) sequence in the 3’ UTR of its own 
mRNA (Muhlrad and Parker, 2005).  In contrast, Rps28B protein binds a stem-loop 
structure in the 3’ UTR, but also within its own mRNA.  Rps28B protein recruits 
another protein Edc3, which has been described previously as an enhancer of 
decapping (Badis et al., 2004).  Thus, when there is excess Rps28B or Edc1 protein, 
the cell responds by degrading these mRNAs.  These examples of deadenylation-
independent decapping and 5’-3’ degradation apply to specific mRNAs and it is 
generally thought to be an infrequent degradation pathway.  As yet there are no 
examples of RNAs degraded by this pathway in metazoans.   
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 Three enzymes PMR1, IRE1 and RNase MRP have been implicated as 
endoribonucleases involved in another deadenylation-independent mRNA 
degradation pathway (Stevens et al., 2002; Yang and Schoenberg, 2004).  However, 
a very limited number of substrates have been identified for these enzymes.  
Although their substrates are limited, these enzymes are particularly potent since 
they can by-pass both the 5’ cap structure and poly(A) tail that serve as structural 
mRNA stabilizing elements.   In Drosophila, endoribonucleases appear to play a 
more integral part in RNA degradation than in other metazoans.  For example, 
Gatfield and Izzauralde have demonstrated that the degradation of aberrant mRNAs 
harboring a premature termination codon (i.e. NMD substrates) is initiated by 
endonucleolytic cleavage (Gatfield and Izaurralde, 2004).  The subsequent 5’ and 3’ 
cleavage products are then degraded in both the 3’-5’ and 5’-3’ directions, 
respectively.   
 Probably the most fascinating example of endonucleolytic mRNA degradation 
is that carried out by the RNA interference (RNAi) and microRNA (miRNA) 
machinery.  The RNAi pathway functions to regulate gene expression at the post-
transcriptional level by silencing the expression of mRNAs through a combination of 
translational repression and mRNA degradation.  RNAi is essential in animal 
development and its significance is underlined by the presence of other small RNA 
pathways that function to regulate a variety of cellular processes (Zamore and 
Haley, 2005).  The trans factors that mediate RNAi are small (approximately 19-22 
nt long) non-coding, double-stranded RNAs.  These small RNAs are processed from 
double-stranded RNA through an elaborate set of processing steps that requires the 
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RNase III type of endonuclease Dicer (Bernstein et al., 2001; Hammond, 2005).  The 
processed miRNA (or siRNA) is delivered to the 3’ UTR of target mRNA substrates 
through a ribonucleoprotein complex termed the RNA interference silencing complex 
(RISC).  In the case of post-transcriptional gene silencing by mRNA degradation, the 
RISC complex delivers the complementary strand of the small RNA to the substrate 
mRNA and results in the endonucleolytic cleavage of the miRNA:mRNA hybrid.  The 
subsequent 5’ and 3’ cleavage products are then degraded 3’-5’ and 5’-3’, 
presumably by the exosome and Xrn1, respectively.  The RISC complex contains 
the small RNAs as well as a number of Argonaute family of proteins, particularly 
Argonaute 2 (Ago2).   Ago2 is a PIWI domain-containing endonuclease V enzyme 
that is responsible for the catalytic ‘slicer’ activity possessed by the RISC complex 
(Hammond et al., 2001).    
 Whether miRNAs function to silence gene expression by mRNA degradation 
or translational repression was recently a subject of debate, but it is clear that both 
situations exist (Bagga et al., 2005; Pillai et al., 2005) and many miRNAs form 
imperfect double-stranded sequences with their targets which would preclude 
cleavage by Ago2.  To complicate matters, Steitz and coworkers have recently 
shown that miRNAs can function to upregulate gene expression of target mRNAs in 
mammalian cells that are not undergoing cell division (Vasudevan and Steitz, 2007; 
Vasudevan et al., 2007).  Regardless, the importance of small RNA pathways in 
regulating gene expression is clear and in time the details and mechanisms by which 
they function will be elucidated.    
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Processing Bodies 
 The final subject I will cover regarding the general mechanisms of RNA 
degradation is the presence of two major subcellular structures that function to 
remodel mRNA ribonucleoprotein (mRNP) complexes.  In general, these structures 
sequester both translationally repressed mRNAs as well as the bulk of mRNAs that 
are being degraded.  In the last section we discussed the potential of miRNAs to 
translationally repress target mRNAs.  Translational repression is a common 
mechanism to inactive gene expression and a good developmental example of this 
is the repression of maternal mRNAs of flies, frogs, and worms, where localization 
factors (e.g. Me31b and Exuperantia in flies) sequester translationally repressed 
mRNAs to discrete granular foci (Nakamura et al., 2001), where they are stored for 
use during early development.     
 Processing bodies (P bodies or GW bodies) are punctate foci found in the 
cytoplasm of eukaryotic cells that contain protein components of the 5’-3’ mRNA 
degradation pathway.  Evidence suggests that the GW182 protein (identified as an 
autoantigen) functions as an essential scaffolding protein in their formation (Yang et 
al., 2004).  P bodies though are not found in all cells and are most apparent under 
conditions of stress; although they do occur, albeit to a much lesser degree, in 
conditions where stress is absent.  They were first identified in S. cerevisiae under 
conditions of arsenic exposure (Sheth and Parker, 2003).  Green-fluorescent protein 
(GFP)-tagged proteins involved in translational repression and 5’-3’ degradation 
factors were examined by immunofluorescence and found to colocalize to discrete 
foci with mRNA (Sheth and Parker, 2003).  The number and size of the P bodies 
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changed upon deletion of particular components of the mRNA decay machinery.  
For example, Pat1 mutants (which affect initiation of mRNA degradation) had 
smaller P bodies while mutants of the 5’-3’ degradation pathway (e.g. Xrn1, Dcp2, 
Lsm1), which would interfere with later steps in mRNA degradation had more P 
bodies and these were larger than wild-type yeast.  These and other data suggest 
that large amounts of cytoplasmic mRNA degradation occur in P bodies.   
 It is clear however that not all mRNA targeted to P bodies are destined for 
degradation.  For example, Pillai et al. demonstrated in an elegant study that the let-
7 miRNP inhibits cap-dependent but not cap-independent translation, suggesting 
that this miRNP might function to repress translation through recognition of the cap 
(Pillai et al., 2005).  Moreover, this repression occurred in foci that overlapped or 
were directly adjacent to P bodies and Ago2 protein.  In conjunction with other data, 
it seems clear that miRNAs function first at an early step to inhibit translation 
initiation by targeting the cap-binding complex eIF4F, and can then either remain 
repressed (and potentially be reactivated) or undergo degradation 5’ to 3’.   
 In mammalian cells, P bodies also show cell cycle regulation.  Chen and 
coworkers have shown using synchronized HeLa cells that P body components were 
small in size in G1, but increase in number during S phase and this pattern changed 
when cells entered G2 phase.  Then, the P bodies were remarkably, larger in size 
but fewer in number.  P body size and number decreased as cells progressed 
through mitosis (Yang et al., 2004).  Based on a decreased electrophoretic mobility 
of GW182 protein as cells progressed through the cell cycle, they hypothesized that 
post-translational modification(s) of GW182 play a role in regulating P body 
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accumulation.  Regardless of the precise mechanism, the data are suggestive of the 
notion that dividing human cells require bulk mRNA degradation at the end of S 
phase and that this demand is sustained throughout G2 phase.  Intriguingly, 
Whitfield and coworkers found that the greatest changes in mRNAs occurred not as 
cells progressed from G1 to S phase but as cells entered G2 (Whitfield et al., 2000). 
 Together, the literature on P bodies clearly implicates these punctate 
granules in mRNA turnover.  However, it is also clear that P body components (e.g. 
Lsm1, Dcp2, and Xrn1) occur outside of P body foci.  A working model of P body 
formation points to P body formation as a cellular state that reflects the quantity of 
degradation and/or repression that is occurring in the cytoplasm; that is, larger P 
bodies reflect P body aggregation or polymerization.  The model also incorporates 
the notion that degradation can occur outside of P body aggregates in so-called P 
body monomers.  In summary, P bodies appear to be the eukaryotic cell’s way of 
compartmentalizing mRNAs that are destined to be degraded, likely by preventing 
their reassociation with the translation machinery. 
 In summary, a number of mechanisms have evolved to regulate gene 
expression by altering mRNA stability using multiple mechanisms of mRNA 
degradation and translational repression.  In this dissertation I will describe a novel 
method of degrading histone mRNAs, which expands the known pathways of mRNA 
degradation.   
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CONNECTION BETWEEN HISTONE METABOLISM AND THE CELL CYCLE 
CHECKPOINTS 
 Eukaryotic cells have evolved a number of molecular surveillance 
mechanisms to monitor the complex processes it carries out.  We have discussed 
NMD as a molecular surveillance system to monitor the quality of mRNAs being 
exported from the nucleus.  Another molecular surveillance system known as cell 
cycle checkpoints exist to preserve the integrity of the genome.  Cell cycle 
checkpoints are complex signal transduction pathways that monitor DNA damage 
that is the consequence of external sources such as UV light, ionizing radiation, 
endogenous sources such as free-radical oxidation, or the results of the error-prone 
process of DNA replication.  Slowing progression through the cell cycle or arresting 
the cell cycle provides time for the cell to coordinate DNA repair activity to repair the 
damage or, if the damage is too severe, results in cell fate decisions such as 
apoptosis.  Collectively, the checkpoint machinery slows or arrests the progression 
of the cell cycle in order to provide time for repair and prevent any subsequent 
generations from inheriting genetic abnormalities such as mutations and 
chromosome loss or gain.   
 Checkpoints are present in all phases of the cell cycle. The PI-3K-like kinases 
(PI3K-like) ATM (ataxia telangiectasia-mutated), ATR (ATM and Rad3-related), 
DNA-PK (DNA protein-activated kinase), and most recently hSMG-1 serve as apical 
sensors in the signal transduction cascade.  ATM and ATR cooperate with mediator 
proteins sometimes referred to as adaptor proteins that modulate their activities (no 
known mediators of hSMG-1 have been identified).  Together the apical kinases 
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ATM and ATR and their mediator proteins signal downstream to the transducer 
kinases Chk1 and Chk2 which leads to further downstream signaling to effector 
proteins that ultimately target cyclin-dependent kinases or regulatory phosphatases 
responsible for preventing entry into the next cell cycle phase. Heightened interest in 
the ATM and ATR kinases has led to an ever-growing mechanistic understanding of 
their participation in cell cycle checkpoints (Kastan and Bartek, 2004). DNA-PK 
function is required for repair of double-stranded breaks as well as in maintaining 
telomere length.   
The least characterized member of this family is the ATM-like PI3K-like 
kinase, hSMG-1 (formally known as ATX).  SMG-1 metazoans is an mRNA 
surveillance protein that regulates the NMD pathway through its function in the 
SURF complex (Grimson et al., 2004) and it was first described in C. elegans 
(CeSMG-1) (Pulak and Anderson, 1993).  A recent report showed hSMG-1 kinase 
activity is increased in response to ionizing radiation and ultraviolet light and that 
hSMG-1 can also phosphorylate p53 and Upf1 in vivo (Brumbaugh et al., 2004).  
Additionally, NMD is suppressed in hSMG-1 null cells but not in ATM null cells. Upf1 
is a target of SMG-1 likely explaining its function in NMD.  These data provide 
evidence for a role of hSMG-1 in regulating both genotoxic stress response with 
mRNA quality control.  
DNA synthesis is a tightly regulated process that requires precisely regulated 
temporal and spatial firing of replication origins in order to efficiently replicate the 
genome. Active origins of replication can proceed only as quickly as there are 
sufficient levels of histone proteins.  In this way histone proteins levels, which we 
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have seen are regulated post-transcriptionally at the mRNA level, can limit the rate 
of DNA replication.  Between these two levels of regulation is chromatin assembly, 
which couples DNA synthesis with de novo histone deposition, which in turn requires 
a constant supply of histone proteins.  Recent evidence from the Stillman and 
Kaufman labs have shown that using either siRNA-mediated knockdown of CAF-1 
(Hoek and Stillman, 2003) or a dominant-negative form of CAF-1 (Ye et al., 2003a) 
results in S phase arrest, causes DNA damage, and activates a Chk1-dependent 
checkpoint response. These data provide a link between efficient replication fork 
progression and the S phase checkpoint machinery that monitors appropriate 
chromatin assembly.  In agreement with this data, Handan Kaygun in our lab 
recently showed using an inducible kinase-inactive ATR cell line that overexpression 
of the kinase-inactive ATR attenuated efficient histone mRNA degradation (Kaygun 
and Marzluff, 2005a).   
Most recently, Müller et al. provide evidence that DNA-PK may also play an 
important role in maintaining proper histone mRNA abundance with DNA replication 
(Muller et al., 2007).  Much work in the DNA replication field have shown that when 
human cells undergo replication stress, such as when cells are treated with inhibitors 
of DNA synthesis, replication fork collapse can occur following slowing and stalling 
of the replication machinery.  This can result in double-stranded breaks in the DNA 
that can be repaired by ATM or DNA-PK through homologous recombination or non-
homologous end-joining, respectively.  Using a variety of inhibitors of cell cycle 
checkpoint function, their data suggest that DNA-PK is the LY294002-sensitive 
PI3K-like kinase responsible for regulating histone mRNA levels in response to 
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inhibition to DNA synthesis (Muller et al., 2007).  Considering the above data and 
more by others (Gunjan and Verreault, 2003; Sullivan et al., 2001) it is clear that the 
eukaryotic cell requires a fine balance between histone levels and the rate of DNA 
synthesis in order to preserve the integrity of their genomes.  Cell cycle checkpoints 
function in helping coordinate these needs and likely impact directly on histone 
mRNA metabolism.    
 
SUMMARY 
 The eukaryotic cell coordinately regulates histone biosynthesis with the 
demands of DNA replication.  This tight regulation is necessary to ensure proper 
chromatin formation.  Regulation of histone protein synthesis occurs post-
transcriptionally at the mRNA level, where inhibition of DNA synthesis results in 
rapid decay of histone mRNA levels.  Therefore, altering the half-life of the mRNA 
serves as a major mechanism in regulating histone mRNA levels.  Much is known 
about the initial steps in the metabolism of histone mRNA, such as pre-mRNA 
processing and translation.  Only recently has much insight been achieved into the 
mechanisms of how the cells coordinate histone synthesis with DNA replication.  
These data suggest an exciting cooperation between two molecular surveillance 
systems that monitor mRNA quality control (NMD) and preserve the integrity of the 
genome (cell cycle checkpoints).  What remains unknown regarding histone mRNA 
degradation are the actual enzymes responsible for regulating the rapid changes in 
histone mRNA stability in vivo both in response to inhibition of DNA synthesis as well 
as normally at the end of the DNA synthesis phase of the cell cycle.  In addition, the 
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precise molecular mechanism(s) that target histone mRNAs specifically for 
degradation remain undefined.    
 The subsequent chapter (Chapter 2) of this thesis describes experimental 
data that point to a bidirectional degradation mechanism for rapidly altering histone 
mRNA levels.  In addition, I present data in Chapter 3 that identify the initial step in 
histone mRNA degradation is addition of oligouridine residues to the 3’ end of 
histone mRNA.   Following is a chapter (Chapter 4) that outlines detailed 
methodologies I have developed to detect these oligouridylated histone mRNA 
degradation intermediates.   In Chapter 5, I describe the critical functions of SLBP in 
regulating histone mRNA metabolism, including histone mRNA degradation.   
Finally, the last chapter (Chapter 6) summarizes the observations I have made 
regarding histone mRNA degradation and provides insight into a exciting field of 
RNA biology that involves a family of eukaryotic enzymes known as terminal 
uridyltransferases (TUTases) or poly(U) polymerases (PUPases).    
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Figure 1. The 3’ end of replication-dependent histone mRNAs end in an 
evolutionarily conserved stemloop.  The mammalian stemloop sequence and the 
histone downstream element (HDE), which is recognized by the U7 snRNA, are 
depicted.  A single processing reaction is required to form the mature histone mRNA 
3’ end.  Replication dependent histone mRNAs have short UTRs and do not contain 
any introns.   
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Figure 2.  Cell cycle regulation of histone mRNA, SLBP mRNA and SLBP 
protein.  The different events responsible for the cell cycle regulation of histone 
mRNA are depicted.   
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Figure 3.  Model of histone mRNA metabolism.  (CB) Cajal body. Figure from: 
(Marzluff and Duronio, 2002). 
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Figure 4.    Model of histone mRNA degradation (2004).  Depicted is the model of 
histone mRNA degradation at the time I began my dissertation work.   
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Table 1.  mRNA decay factors.  Listed are the major proteins involved in general 
mechanisms of mRNA degradation including deadenylation, 5’-3’ degradation, and 
3’-5’ degradation.     
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Decay Complex Protein Known Protein Domain, Function 
 
DEADENYLATION   
CCR4-NOT Ccr4 3’-5’ exonuclease, main 
deadenylase complex 
 Pop2/Caf1 3’-5’ exonuclease, main 
deadenylase complex 
 Not1 Unknown 
PAN2-PAN3 PAN2 WD40 repeat, involved in an 
initiating deadenylase activity 
 PAN3 3’-5’ exonuclease, involved in an 
initiating deadenylase activity 
PARN PARN 3’-5’exonuclease, 5’ cap-dependent 
activity 
5’-3’ DECAY   
Decapping  Dcp1 EVH1 
 Dcp2 MutT, catalytic component that 
produces hypermethylated GDP 
 Hedls (Ge-1) WD40 repeat 
Dhh1 Dhh1 
(RCK/p54, 
Me31B) 
DExD/H box RNA helicase, 
involved in decapping 
Pat1 Pat1 Unknown, translational repression 
Edc complex Edc1 Unknown, decapping enhancer 
 Edc2 Unknown, decapping enhancer 
 Edc3 Sm-like, decapping enhancer 
Lsm 1-7 Lsm1-7 Sm-like, required for decapping 
Xrn1 Xrn1 5’-3’ exonuclease 
3’-5’ DECAY   
Exosome  
(cytoplasmic) 
Rrp41, Rrp42, 
PM/Scl-75, 
Rrp46, Mtr3, 
OIP2 
RNase PH, 3’-5’ exonuclease, form 
the core ring structure of exosome,  
 Csl4, Rrp4, 
Rrp40 
S1 and KH, substrate RNA binding 
 Rrp6 (PM/Scl-
100) 
RNase D, 3’-5’ exonuclease 
 Ski2 DEVH RNA helicase 
 Ski3 TTP repeat 
 Ski7 EF1α-like GTPase 
 Ski8 WD40 repeat 
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Figure 5.  Eukaryotic 5’-3’ mRNA degradation pathway.  A schematic 
representation of the major regulatory steps in eukaryotic 5’-3’ degradation of 
mRNA.   
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Figure 6.  Eukaryotic 3’-5’ mRNA degradation pathway by the exosome.  A 
schematic representation of the major regulatory steps in mRNA degradation by the 
cytoplasmic exosome is shown.       
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Figure 7.  Deadenylation-independent decapping and 5’-3’ mRNA degradation.    
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Figure 8.  General mechanisms of endonucleolytic mRNA degradation.  (A) 
Endonucleolytic mRNA degradation by PMR1, IRE1, and RNase MRP.  Following 
endonucleolytic cleavage, the 5’ and 3’ fragments are degraded by the exosome and 
Xrn1, respectively.  (B)  miRNA-mediated endonucleolytic degradation by Ago1.   
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CHAPTER 2 
 
HISTONE mRNA IS SIMULTANEOUSLY DEGRADED FROM BOTH THE 5’ AND 
3’ ENDS 
 
 
INTRODUCTION 
 Replication dependent histone mRNA levels are tightly coupled to DNA 
replication.  Proper control of histone protein synthesis is essential to ensure proper 
chromatin formation.  A major step in regulation of mammalian histone mRNA is a 
rapid alteration in the half-life of histone mRNA in response to changes in the rate of 
DNA synthesis, allowing the cell to rapidly adjust the rate of histone protein 
synthesis to maintain balanced synthesis of DNA and histone protein.  The 
regulation of the half-life of histone mRNA is mediated by the unique 3’ end of 
histone mRNA (Kaygun and Marzluff, 2005b; Pandey and Marzluff, 1987).  The 
metazoan replication-dependent histone mRNAs are the only eukaryotic mRNAs 
that are not polyadenylated (Marzluff, 2005). The Stem Loop Binding Protein (SLBP) 
binds the conserved stemloop (SL) present at the 3’ end of all 5 classes of histone 
mRNAs (Martin et al., 1997; Wang et al., 1996c). SLBP is required for histone pre-
mRNA processing (Marzluff, 2005) and accompanies the histone mRNA to the 
cytoplasm (Erkmann et al., 2005a) where it is required for histone mRNA translation 
(Sanchez and Marzluff, 2002). SLBP plays a direct role in histone mRNA stability 
through an interaction with Upf1 (Kaygun and Marzluff, 2005a).  
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 Inhibition of DNA replication using pharmacologic agents results in a rapid 
degradation of histone mRNA. Degradation requires active translation of the mRNA 
and the SL at the 3’ end. The location of the SL relative to the stop codon, 45-80 nts, 
is also essential as increasing this distance results in a loss of regulated degradation 
and persistent expression (Graves et al., 1987; Kaygun and Marzluff, 2005b). These 
characteristics suggest that a terminating ribosome must be in close approximation 
to the SL and likely SLBP. Supporting this model, Handan Kaygun recently found 
that Upf1, a factor involved in translation termination and nonsense mediated decay 
(NMD) is required for histone mRNA degradation (Kaygun and Marzluff, 2005a).  
 The initial step in degradation of most polyadenylated mRNAs in eukaryotes 
is shortening of the poly(A) tail by a deadenylase complex (Parker and Song, 2004). 
Deadenylated mRNAs can subsequently return to a translationally active state on 
polysomes likely by the enzymatic action of cytoplasmic poly(A) polymerases (Coller 
and Parker, 2005) or can be degraded from either terminus using a distinct set of 
nucleases (see Chapter 1). Upon poly(A) shortening, the Lsm1-7 complex is thought 
to recruit a decapping complex (Dcp1/Dcp2) to remove the 5’ cap of the mRNA 
(Coller et al., 2001). The decapped mRNA can then be degraded 5’-3’ by the Xrn1 
exoribonuclease or can be exposed to a large complex of 3’-5’ exonucleases known 
as the exosome (Mitchell et al., 1997). A number of the proteins involved in 
catalyzing 5’-3’ degradation are localized to discrete cytoplasmic loci termed P 
bodies or GW bodies (Eystathioy et al., 2003; Sheth and Parker, 2003). Whether 5’-
3’ degradation is restricted to P bodies is not known. Exosome components are 
located in both the nucleus and cytoplasm (Lejeune et al., 2003). Whether both the 
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5’-3’ and 3’-5’ pathways can contribute to the degradation of a single mRNA 
molecule is not clear.   
 The detailed biochemical pathway of regulated histone mRNA degradation is 
not understood. In this chapter I identify the enzymes and 3’ UTR binding proteins 
that regulate histone mRNA degradation using a combination of functional RNAi and 
biochemical approaches.   The RNA interference experiments suggest a role for 
both the exosome and the decapping enzymes in degradation. In agreement with 
this result, I find decapped intermediates of histone mRNA degradation that have 
been decapped and the fragments of histone RNAs have been degraded from both 
the 5’ and 3’ end.  Additionally, I find 14% of the decapped intermediates examined 
are nearly full-length and contain 8-15 nonencoded uridines on the 3’ end.   
Moreover, biochemical studies show the Lsm1-7 complex associates with SLBP but 
that this association is likely mediated by histone mRNA itself.  Together, these data 
provide the first direct evidence for human bidirectional mRNA degradation as a 
regulatory mechanism responsible for altering the half-life of a physiologically 
important mRNA.  These data also provide preliminary evidence for the addition of 
nonencoded uridine residues to the 3’ end of histone mRNA as the initiating event 
that targets histone mRNA specifically for rapid, bidirection degradation.   
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MATERIALS AND METHODS 
RNA interference 
 HeLa cells were transfected with Lipofectamine 2000 (Invitrogen) using a two-
hit RNAi method (Wagner and Garcia-Blanco, 2002).  48 hours following the second 
RNAi transfection, cells were treated with 5 mM HU for 0, 20 or 45 minutes. Histone 
mRNA level was measured by Northern blotting or S1 nuclease assays.  siRNAs 
were synthesized by Dharmacon and the targeted sequences for the genes are 
listed in Table 2. 
Western Blot Analysis 
 Total cell lysates were prepared as described (Kaygun and Marzluff, 2005a). 
Detection of endogenous proteins was made possible by generous gifts of 
antibodies to Lsm1/CaSm, Dcp2, Xrn1, Upf1, PM/Scl-100, Rrp41 and PTB.  The 
generous gifts of antibodies used in this study were kindly provided by: Dennis 
Watson (Medical University of South Carolina) for chicken anti-Lsm1/CaSm; Mike 
Kiledjian (Rutgers University) for rabbit anti-Dcp2; Jens Lykke-Andersen (University 
of Colorado, Boulder) for rabbit anti-Xrn1; Chris Smith (Cambridge University) for 
rabbit anti-Upf1 antibody; Ger Pruijn (University of Nijmegen) for rabbit anti-PM/Scl-
100 and Rrp41 antibodies; and Mariano Garcia-Blanco (Duke University) for rabbit 
anti-PTB antibody.    
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Northern Blot and S1 Nuclease Protection Assays 
 Total RNA  was isolated using Trizol reagent (Invitrogen). For Northern blot 
assays, 2 µg of total RNA was separated on 6% acrylamide 7 M urea gels and 
transferred to Hybond N+ nitrocellulose membranes (Amersham). S1 nuclease 
protection assays to simultaneously measure the variant H3.3 and replication-
dependent H2a mRNA were performed as described (Kaygun and Marzluff, 2005a). 
Gels were dried and exposed to phosphorimager cassettes, quantified using 
ImageQuant, and normalized to the amount of 7SK RNA.  
Synchronization of HeLa cells 
 Determination of the 5’ and 3’ ends of histone mRNA is best done in a pure 
population of S-phase cells.  Since histone mRNAs are present at high levels only in 
S-phase cells, some histone mRNAs will be rapidly degraded in a subset of cells in a 
population of exponentially growing cells.  Thus to guarantee that I had a population 
of cells which have stable histone mRNA, cells were synchronized.  HeLa cells 
synchronized by double thymidine block (DTB).  This method ensures that 100% of 
the cells are synchronously progressing through S phase and therefore the entire 
population of cells will be expressing histone mRNA.  
 In a 10 cm2 tissue culture dish, 2.5 – 3.5 x 105 HeLa cells were plated in a 
total of 9.8 ml 10% FBS containing Dulbecco’s Modified Eagle’s media (DMEM, 
Gibco).  The following day (typically at 2 p.m.) I added 200 µl of 100 mM thymidine 
(Sigma) for a final concentration of 2 mM thymidine.  Plates were washed twice with 
warm PBS 18 hours following addition of thymidine (8 a.m.) and 9.8 ml warm, fresh 
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media added.  The cells blocked in S phase now resumed DNA replication.  Cells 
arrested at the G1/S border are allowed to complete DNA replication, and the cells 
arrested at other points in S-phase complete S-phase but do not progress to the 
next S-phase.  Once the cells have all completed S-phase (9 hrs after release), but 
none have re-entered S-phase, I added 200 µl of 100 mM thymidine (at 5 p.m.) after 
release from the first thymidine block.  Fifteen (15) hours following the second 
thymidine block all the cells were at the G1/S border.  I washed cells with warm PBS 
twice, making sure to remove as much of the thymidine-containing PBS as possible 
and added fresh, warm media.  All of the cells are entering S phase at this point and 
I typically harvested cells in the middle of S phase (e.g. 3 hours following release).  
The length of S-phase varies slightly from experiment to experiment, but the entire 
population typically completes S-phase synchronously in each experiment (with the 
length of S-phase being 5-7 hours).   
 To promote rapid degradation of histone mRNA, I added warm, fresh media 
containing 5 mM hydroxyurea (HU, Sigma) to parallel synchronized cultures 3 hrs 
after release.  For cRT-PCR (see below) I harvested cells 20 minutes following 
addition of HU-containing media.  Since histone mRNA degradation is initiated about 
5 minutes after addition of HU (Graves and Marzluff, 1984), cells harvested 15-20 
min after HU treatment had initiated degradation of histone mRNA, and contained 
the largest amount of any degradation intermediates. 
Circularization RT-PCR 
 A schematic diagram depicting the circularization RT-PCR (cRT-PCR) 
approach for determining the 5’ and 3’ end of an mRNA is diagrammed in Figure 15.  
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This requires only that the 5’ end have a 5’ monophosphate and the 3’ end has a 
free 3’ hydroxyl group.  If the mRNA is capped it can be decapped prior to 
circularization.  Detailed methods for the various steps are described below and are 
identical to or adapted from those previously described (Couttet et al., 1997; 
Fromont-Racine et al., 1993). 
RNA preparation for cRT-PCR 
 Total RNA was harvested according to the Chomczynski and Sacchi method 
(Chomczynski and Sacchi, 1987, 2006).  I resuspended precipitated RNA pellets in 
sterile water.  
DNase treat total cell RNA.   
 Residual DNA does come through in the above RNA preparation and DNase 
treatment will eliminate any traces of genomic DNA.  I used RQ1 DNase (Promega) 
to treat 20-50 µg of total RNA by adding 20 U of HPRI (New England BioLabs), 25 U 
of RNase-free DNase (1 U/µl for Promega RQ1 DNase), and 10 µl of 10X RQ1 
buffer (40 mM Tris-HCl pH 7.9, 10 mM NaCl, 6 mM MgCl2, and 10 mM CaCl2) for a 
total volume of 100 ml.  Reactions were incubated at 37° C for 30 minutes.  The 
reaction was stopped by adding 10 µl STOP buffer supplied by Promega and and 
incubated at 65° C for another 10 minutes.  After letting the reaction cool, I added 
100 µl of phenol:chloroform:isoamyl alcohol (25:24:1 v/v, Invitrogen). Samples were 
briefly vortexed and spun in a microcentrifuge at room temperature for 5 minutes at 
14,000 rpm.  The top layer was removed and a chloroform extraction performed with 
an equal volume and spun as above.  I ethanol precipitated the RNA by adding 
1/10th of the volume of 3 M sodium acetate to the RNA followed by 2-2.5 volumes of 
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cold 100% ethanol.  Precipitations were vortexed and put at -20° C overnight or -80° 
C for an hour.  The tubes were then spun down at 4° C in a microcentrifuge for 30 
minutes at 14,000 rpm. Visible pellets were washed with cold 80% ethanol by 
washing at full speed for 5 minutes at 4° C. RNA pellets were air-dried and 
resuspended in 15 µl of water.  
Decapping   
 To remove the cap from the mRNAs, I used 10-15 µg DNase-treated total cell 
RNA in a 20 µl total volume and treated with tobacco acid pyrophosphatase (TAP, 
Epicentre).  To obtain RNAs that have been already been decapped previously in 
the cell, I set up parallel reactions that do not contain TAP but are subjected to the 
same conditions.  To decap RNA, I added the DNase-treated total cell RNA to  2.5 U 
of TAP (dilute Epicentre stock 1:4), 20 U of HPRI (Human placental ribonuclease 
inhibitor, NEB), and 2 µl of 10X TAP buffer (0.5 M sodium acetate pH 6.0, 10 mM 
EDTA, 1% ?-mercaptoethanol, and 0.1% Triton X-100).  Decapping reactions were 
carried out at 37° C for 1 hour. Following the 1 hour incubation I brought the total 
volume up to 100 µl and added 10 µl of 3 M sodium acetate and 250 µl of cold 100% 
ethanol.  RNA was precipitated, washed, and air-dried as above.  Decapped RNA 
was resuspended in10 µl of sterile water.   
RNA circularization using T4 RNA ligase   
 RNA ligation was carried out at 16° C.  In order prevent the possibility of 
intermolecular ligations the volume I used for the ligations needed to be quite large.  
At high concentrations of RNA I could potentially obtain intermolecular ligations, but 
 64 
to prevent this, I carried out the ligation in a total volume of 400 µl where 4-6 µg of 
RNA from the decapping step was added to 20 U T4 RNA ligase (New England 
BioLabs), 20 U of HPRI (New England BioLabs), and 40 µl of 10X T4 RNA ligase 
buffer to make it 1X (50 mM Tris-HCl, 10 mM MgCl2, 1 mM ATP, and 10 mM DTT).  I 
performed the ligation for 16 hours and ligated RNA was subjected to a 
phenol:chloroform:isoamyl alcohol (25:24:1) purification followed by a chloroform 
wash as above, but using volumes appropriate for the ligation reaction (e.g. 400 µl).  
I precipitated the final top phase from the chloroform wash by adding 1/10th the final 
volume of 3 M sodium acetate and 2.5 volumes of cold, 100% ethanol.  The ligated 
RNA was precipitated at -20° C for at least 2 hours or overnight.  Precipitated RNA 
was washed twice with cold 80% ethanol, air-dried, and the RNA pellet resuspended 
in 12 µl.   
RT-PCR of circularized RNA. 
 For these experiments I used reverse transcriptase (RT) from MMLV 
(Invitrogen).    Histone mRNAs are quite short (approximately 500 bp) and I 
designed the primers to obtain ligated fragments around 200 bp.  I used 6 µl of the 
ligation (2 µg) and subjected it to reverse transcription using MMLV-RT (Invitrogen) 
and a human histone H3 oligo termed ‘H3 Oligo 1’ (5’-
CTTCTGGTAGCGCCGGATCTC-3’) targeting the open reading frame (ORF) of the 
HIST2H3A, HIST2H3C, and HIST2H3D genes (Marzluff et al., 2002).  This oligo 
primes synthesis toward the 5’ end of the histone mRNA and will proceed through 
the 3’ end if the mRNA has been circularized.  I performed a 20 µl RT reaction 
according to the manufacturer’s instructions and used 2 µl for the subsequent PCR. 
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 To PCR the ligated 5’ and 3’ ends of histone H3 genes, I used 2 µl of the RT 
reaction above and performed a 100 µl PCR reaction using 2 µl of 10 mM dNTPs 
(Amersham), 1 µl each of 10 mM ‘H3 Oligo 2’  (5’-
GACTTGCGAGCAGTCTGCTTAG-3’) and ‘H3 Oligo 3’ (5’-
GCTGTTCGAAGACACGAACCTG-3), 10 µl of 10X Taq buffer (100 mM Tris-HCl pH 
8.3, 500 mM KCl, and 20 mM MgCl2), 83 µl of water, and 1 µl recombinant Taq.  
These oligos target the ORF and amplify towards either the 5’ or 3’ UTRs, and 
hence will only amplify ligated products.  A total of 28-30 cycles is sufficient to 
observe amplicons in the TAP treated samples under the conditions of: 95°C for 30 
seconds, 52° C  for 30 seconds, and 72° C  for 30 seconds.  20 µl of each reaction 
was analyzed on a 1.5-2.0% agarose gel. 
Sample preparation for cloning the 3’ end of in vitro processed histone pre-
mRNA. 
 This experiment was carried out to demonstrate I could accurately detect 
properly processed histone mRNA by this approach.  Determination of the 3’ end of 
a histone pre-mRNA substrate requires an in vitro processing extract which 
efficiently processes histone pre-mRNA (Dominski et al., 1999).  To ensure the 
efficacy of the processing extract, two parallel reactions were performed.  Both 
reactions had the same concentration of substrate but in reactions the pre-mRNA 
was radiolabelled to allow monitoring of the processing efficiency and the other 
which is not.  The reactions that contained the labeled pre-mRNA substrate was 
monitored by denaturing urea acrylamide gel electrophoresis and autoradiography 
by Zbig Dominski as described (Dominski et al., 1999).  RNA was isolated from the 
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reaction that did not contain the radiolabelled substrate at both 0 time and after 2 hrs 
when more than 90% of the mRNA has been processed.  
Cloning of cRT-PCR and degradation intermediates   
 I used 2 µl of fresh PCR product from each reaction and ligateed it into the 
pCR4®–TOPO® vector (Invitrogen) according to the manufacturer’s instructions for 
ligation and transformation.  For the ligation reaction, I ligated the reactions for an 
extended amount of time (30 minutes) in an attempt to recover as many of the 
variety of different PCR molecules that exist in the reaction as possible.  
Transformants were plated on to Kanamycin-containing LB plates overnight.  
Colonies were screened using overnight cultures and double restriction enzyme 
digests of mini-prepped plasmid DNA to screen for inserts (SpeI and NotI, New 
England BioLabs).    
Cell cycle analysis 
 Cells were fixed in 70% ethanol, stained with propidium iodide, and DNA 
content analyzed by FACS using either a FACScan (Becton-Dickinson) or CyAn 
Scan (Dako). Populations of G1 (2N DNA content), S phase (2N < S < 4N DNA 
content), and G2/M (4N DNA content) were quantified using Summit software and 
are represented as a percentage of the total population. 
 
RESULTS 
Knockdown of 3’hExo does not affect histone mRNA degradation in vivo 
 Polyadenylated mRNAs are primarily degraded by a pathway that initiates 
deadenylation, removing most of the poly(A) tail, followed either by decapping and 5’ 
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to 3’ degradation or degradation 3’ to 5’ by the exosome (Parker and Song, 2004). 
Although it is known that the stemloop at the 3’ end of histone mRNA is the cis-
element that regulates histone mRNA degradation (Pandey and Marzluff, 1987), the 
biochemical details of histone mRNA degradation are not known. Early studies by 
Ross and coworkers suggested that degradation of histone mRNA proceeded 3’ to 
5’ (Ross and Kobs, 1986; Ross et al., 1986). Since Zbig Dominski and coworkers 
recently identified an exonuclease, 3’hExo, that can specifically degrade histone 
mRNA from the 3’ end in vitro (Dominski et al., 2003), and which can form a ternary 
complex with the stemloop of histone mRNA and SLBP, I tested whether the 3’ hExo 
might play a role in initiating histone mRNA degradation. Since the critical cis 
element for histone mRNA degradation is also at the 3’ end of the mRNA, I tested 
known factors in decay of polyadenylated mRNAs to see if they might also be 
involved in histone mRNA degradation.  
 For all RNA interference experiments, I knocked down the targeted proteins 
using two sequential treatments with siRNA (Wagner and Garcia-Blanco, 2002), and 
used two different siRNAs for each protein. Cells were treated with a control siRNA 
(C2) which did not knock down any of the proteins. We also used siRNAs that 
targeted the splicing factor polypyrimidine tract binding (PTB) protein, as a control. 
The cells were treated with 5 mM HU and the amount of histone mRNA degradation 
was measured over a 45 minute timecourse.  
 The transfected siRNA reduced 3’hExo protein levels by 80-90% as estimated 
by Western Blot analysis of a dilution series of control treated lysates (Figure 9A). 
Total RNA from these cells was subjected to Northern blot analysis simultaneously 
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probing for both histone H2A mRNA and 7SK RNA as a loading control. Knockdown 
of 3’hExo has no effect on histone H2A mRNA degradation in HeLa cells (Figure 9B 
and 9C). There was also no change in the cell cycle distribution as determined by 
FACS (Figure 9C). The steady state levels of histone mRNA in the exponentially 
growing cells (0 time point) was similar in both the C2 (control) and 3’hExo 
knockdowns (Fig. 9B, compare lanes 1 and 4). Thus, knockdown of 3’ hExo had no 
discernable effect on histone mRNA metabolism or cell growth (Figure 9D). 
Knocking down PTB also had no effect on histone mRNA regulation or cell growth 
(Figure 3 and 2, respectively) and serves as a negative control for potential off-target 
effects for these studies.  I could knock down PTB protein to 90% of the control as 
determined from a dilution series Western blot (Figure 10A).   
Lsm1 plays an integral role in replication-dependent histone mRNA 
degradation 
 I tested a number of decay factors and enzymes involved in regulating poly(A) 
mRNA stability by RNA interference to see if any of these factors affected histone 
mRNA degradation. The Lsm1-7 complex is a heteroheptameric set of polypeptides 
that is a positive regulator of decapping in S.cerevisiae (Tharun et al., 2000; Tharun 
and Parker, 2001) and has also been shown to be important in regulating the 
stability of mRNAs containing AU-rich elements (ARE) (Mukherjee et al., 2002; 
Stoecklin et al., 2006).  I carried out a series of RNAi experiments assessing the role 
of various factors using C2 siRNA as a negative control and Upf1 as a positive 
control for a factor that reduces histone mRNA degradation. Each experiment shown 
represents an example of a panel of experiments done on parallel cultures.  
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 The downregulation of Lsm1 protein varied from 75-95% among different 
experiments as estimated from the protein dilution series of the control (C2) sample 
(Fig. 10D). Each siRNA had a similar degree of knockdown and Symplekin, a 
scaffold protein involved in mRNA 3’ end formation (Kolev and Steitz, 2005; 
Takagaki and Manley, 2000), served as a loading control in this experiment.  As 
mentioned previously, Handan Kaygun has shown that the NMD factor hUpf1 is 
important in regulating the rapid decay of histone mRNA (Kaygun and Marzluff, 
2005a) and I used this as a positive control. Transfection of either of two siRNAs 
targeting Lsm1 resulted in stabilization of histone mRNA at the 20 minute time point 
(Figure 10E; compare lanes 2, 5 and 8) and over a 2.5 fold stabilization at the 45 
minute time point (Figure 10E; compare lanes 3, 6, and 9, Figure 14) relative to C2 
siRNA transfected cells. Figure 10F summarizes three independent RNAi 
experiments. The cell cycle distributions of the cells were not significantly changed 
by the Lsm1 knockdown (Figure 11).  
 Given the apparent role of Lsm1 in histone mRNA decay, I asked whether I 
could detect Lsm1 in SLBP immunoprecipitates when histone mRNAs were being 
rapidly degraded.  Lysates were prepared 15 min after HU treatment from S-phase 
cells stably expressing HA-tagged SLBP (Erkmann et al., 2005b) and 
immunoprecipitated with anti-HA antibody. I then probed for Lsm1.  Detectable 
amounts of Lsm1 were co-immunoprecipitated with HA-SLBP. When I treated the 
cell lysates with RNase A prior to immunoprecipitation the amount of Lsm1 
coimmunoprecipitated was greatly reduced (Figure 10G, top, lanes 3 and 4).  This 
result suggests that both SLBP and Lsm1 can be bound to histone mRNA but that 
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they do not stably interact with each other, in contrast to the interaction of SLBP and 
Upf1 which is resistant to RNase digestion (Kaygun and Marzluff, 2005a). In a 
separate experiment, I did not detect association of Lsm1 with SLBP in S-phase 
cells prior to HU treatment, although it was readily detected 15 min after HU 
treatment (Fig. 10G, bottom, lanes 5 and 6).  Another RNA binding protein, PTB, 
was not present in any of the SLBP immunoprecipitates, demonstrating the 
specificity of the interaction.  Thus Lsm1 only interacts with SLBP when histone 
mRNA is being rapidly degraded.   
Downregulation of the decapping enzyme Dcp2 and the 5’-3’ exonuclease Xrn1 
reduce histone mRNA decay   
 Since the Lsm1-7 complex is a positive regulator of decapping and 5’-3 decay 
and had an effect on histone mRNA stability, I examined other components of the 5’-
3’ mRNA decay apparatus. I knocked down the catalytic subunit of the decapping 
complex Dcp2 (Wang et al., 2002) and the 5’-3’ exonuclease Xrn1 (Long and 
McNally, 2003) using targeted siRNAs to these enzymes. Each protein was knocked 
down by an estimated 80-90% (Fig. 12A and 12E).  As an alternative method to 
Northern blots, I used an S1 nuclease protection assay to monitor histone H2A 
mRNA levels (Kaygun and Marzluff, 2005a, b). HU treatment does not affect 
polyadenylated H3.3 mRNA levels and thus serves as a loading control. The 
degradation of histone mRNA was reduced by knocking down Dcp2 and Xrn1, and 
after 45 min of HU treatment there was twice as much histone mRNA remaining 
compared to control treated cells (Figure 12B,12C, 12F and 12G and Figure 14).  
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 The downregulation of both Dcp2 and Xrn1 had minimal effects on the cell 
cycle distribution of the cells (Figure 12D and 12H). There was a small increase in 
the percentage of S phase cells of the Dcp2 knockdown compared to the control 
(Figure 12D). This likely accounts for the small increase in steady state histone H2a 
mRNA levels (Figure 12B, compare lane 1 and 3) in the Dcp2 knockdown cells. 
These data leads me to conclude that components of the 5’ to 3’ degradation 
pathway play a role in histone mRNA degradation.   
Knocking down exosome components PM/Scl-100 and Rrp41 inhibits histone 
mRNA degradation 
 Polyadenylated mRNAs may also be degraded by the exosome following 
deadenylation, in addition to degradation 5’ to 3’ through the decapping pathway. It 
is possible the Lsm1-7 complex could also recruit the exosome. To determine 
whether the exosome may also play a role in histone mRNA degradation I knocked 
down two components of the exosome by RNA interference. I chose PM/Scl-100 
and Rrp41, a core exosome component (Liu et al., 2006). PM/Scl-100 has been 
shown to be present in the cytoplasm of human cells (Lejeune et al., 2003), in 
contrast to initial reports (Allmang et al., 1999). PM/Scl-100 has substantial 
homology with E.coli RNase D, a 3’-5’ exonuclease and Rrp41 has been shown to 
have 3’-5’ exonuclease activity in vitro (Mitchell et al., 1997).   
 The RNAi treatment reduced PM/Scl-100 levels by about 80% (Figure 13A), 
and two different siRNAs against Rrp41 reduced its levels by at least 80% (Figure 
3E). Knocking down either PM/Scl100 (Figure 13B) or Rrp41 (Figure 13F) had a 
significant effect on histone mRNA degradation, similar to that seen with knocking 
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down Lsm1. The average of 3 independent experiments is shown in Figures 13C 
and 13G. There was a 3-fold stabilization of histone mRNA 45 min after HU 
treatment when PM/Scl-100 is knocked down and a 2.3-fold stabilization when 
Rrp41 is knocked down (Figure 14).  Knocking down the exosome components had 
no effect on cell growth or cell-cycle distribution (Figure 13D and 13H).  
Determination of the 5’ and 3’ ends of individual histone mRNA molecules in 
vivo  
 To directly identify molecules which had been partially degraded, I utilized a 
circularization RT-PCR (cRT-PCR) strategy in which the 5’ (containing a 5’ 
phosphate) and 3’ ends (with a 3’ OH) are ligated to each other forming a circular 
RNA. One can then amplify the region containing the ligated 5’ and 3’ ends by RT-
PCR. This method allows one to determine the 5’ end and the 3’ end of individual 
molecules. The ends of molecules that have 5’ caps can be detected by first treating 
the RNA with tobacco acid pyrophosphatase (TAP). This method has been used to 
directly analyze deadenylated mRNAs in cells (Couttet et al., 1997; Fromont-Racine 
et al., 1993). A schematic of this RT-PCR strategy, adapted from Couttet and 
colleagues (Couttet et al., 1997) is depicted in Figure 15A.  I designed primers to 
target histone H3 mRNA from two identical genes (HIST2H3A and HIST2H3C) of the 
12 annotated histone H3 genes in the human genome (Marzluff et al., 2002).  
 As a control to demonstrate that I could isolate PCR products that result from 
ligating the authentic 3’ ends of the mRNAs, and to eliminate the possibility of 
nuclease contamination in my cRT-PCR reagents, I analyzed the 3’ end of histone 
H2A mRNA formed in an in vitro processing reaction.  Since the in vitro transcribed 
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substrate histone pre-mRNA contains a 5’ triphosphate, it is also necessary to treat 
these RNAs with TAP prior to ligation.  At time 0 I cloned only products 
corresponding to the synthetic pre-mRNA substrate.  After processing for 120 
minutes, when most of the substrate has been cleaved, I recovered only histone 
RNA that ended with the conserved ACCCA nts following the base of the stemloop, 
precisely where the lab and others (Dominski et al., 2005b; Scharl and Steitz, 1994) 
have mapped the cleavage site in vitro (Figure 15C). These results demonstrate that 
I was able to recover RNA molecules that had their 3’ and 5’ ends intact and hence 
nuclease activity in my reagents was minimal.  
 Figure 15B shows the results from a cRT-PCR experiment using RNAs from 
control cells and cells treated with HU for 20 minutes, at which time about 40% of 
the histone mRNA has been degraded. Two amplicons were detected (about 190 
and 235 nts) when TAP was used to decap the mRNA (Figure 15B, lanes 3 and 4) 
and these were more abundant in RNA from untreated cells compared to HU treated 
cells.  No distinct, amplified products were detected by ethidium bromide staining 
when the RNA was not treated with TAP (Fig. 15B, lanes 1 and 2). 
 I cloned these two PCR products and sequenced multiple clones from each 
fragment. The 235 nt fragment was derived from the HIST2H3A, HIST2H3C genes I 
initially set out to amplify (Marzluff et al., 2002), while the 187 nt band was a 
previously unannotated histone H3 gene also found in the minor histone cluster on 
chromosome 1q21 (nts 276048-275157), which I have named HIST2H3D (Figure 
16). Each of these genes is highly expressed in HeLa cells.  Figure 15D and 15E 
show sequences for the 5’ and 3’ regions of these two genes. The top line 
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(HIST2H3A/C or HIST2H3D) gives the genomic sequence of these genes, extending 
from the region upstream of the TATA box into the ORF, and from the stop codon 
past the HDE. The 5’ UTR of the HIST2H3A/C mRNAs is 47 nt, with the G at the 
start site located 27 nts from the TATAA box, the expected distance for a RNA 
polymerase II transcription initiation site.  This G was ligated to an ACC sequence 
that follows the stemloop in 10 of the 11 circularized clones isolated.  The 
cytoplasmic histone mRNA is thus 2 nts shorter than the mRNA formed by the in 
vitro processing reaction (Figure 15D, 15E, and 15F).  In one clone the last 2 nts of 
the stem were missing and these were followed by several non-templated U’s 
(Figure 15D, clone 2).  As suggested below, I feel that this clone likely represents a 
degradation intermediate. This clone had two additional nts, a GT which could be 
part of the non-templated 3’ UTR or result from slippage in the oligoT stretch in the 
5’ UTR. 
 Similar results were observed with the clones from the 187 nt fragment. 
These clones were also essentially identical, and correspond to the HIST2H3D 
gene. The 5’ UTR of this mRNA is extremely short, only 11 nts from the A in the 
ATG codon in 23 of the 28 clones, which is located 27 nts from the TATAA box.  The 
small amount of heterogeneity at the 5’ end of the mRNA (one clone, Figure 15E, 
clone 2) starting at the C, one nt upstream and another (Figure 15E, clone 1) at an A 
3 nts upstream from the major start site, likely represents the use of closely spaced 
transcription start sites, all of which were about 25 nts from the TATAA box. The 3’ 
end of the mRNA in 23 of the 28 clones (Figure 15E, clones 2 and 3) is 3 nts after 
the stemloop, one ends 2 nts after the stemloop (Figure 15E, clone 4), and the other 
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4 clones (Figure 15E, clone 1) may have a single non-templated U (or the U may 
represent an alternative start site and may be the first nt of the transcript).  Note that 
this gene has an unusual sequence after the stemloop ACTGC rather than the 
consensus ACCCA.   
 These results confirmed my ability to obtain full length 5’ and 3’ UTRs using 
the cRT-PCR procedure from total cellular RNA. Although the histone mRNA formed 
by cleavage of the histone pre-mRNA ends 5 nts after the stemloop, the cytoplasmic 
histone mRNAs end only 2-3 nts after the stem-loop. Thus there must be trimming of 
2 nts from the processed mRNA at some point after the processing reaction, and this 
may be a function of the 3’hExo which has this activity in vitro in the presence of 
SLBP (Dominski et al., 2003; Yang et al., 2006).  
cRT-PCR products of uncapped histone H3 mRNA identifies degradation 
intermediates containing oligouridine on the 3’ end of the mRNA  
 If decapping occurs during histone mRNA degradation, as my data suggests, 
then I could potentially circularize decay intermediates of histone mRNAs, allowing 
me to clone single molecules of partially degraded histone mRNA. Because my 
primers are located near the end of each ORF, I will preferentially isolate 
intermediates from early in the degradation process. I cloned all the products of the 
circular RT-PCR reactions starting with the RNAs not treated with TAP, although I 
could not see any defined amplified products in these reactions.  Unlike the clones 
obtained by TAP treatment these clones were heterogenous in size, accounting for 
the failure to see discrete bands. I sequenced these clones and all of them 
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represented fragments from either the HIST2H3A/C genes (Figure 17A) or 
HIST2H3D gene (Figure 17B).  
 Only 4 of the 37 clones I obtained were from full-length mRNAs (Figure 17A, 
clone 2; Figure 17B, clone 5). The remaining 33 clones encoded 28 shorter mRNAs 
(with nts removed from either the 5’ end (Figure 17A, clone 5), 3’ end (11 clones; 
Figure 17A, clones 3,4,7-9; Figure 17B, clones 6,9,10) or both (16 clones; Figure 
17A, clones 6,11-20; Figure 17B, clones 7,8, 10-12), and 5 encoded mRNAs which 
had non-templated U’s added to the 3’ end (Figure 17A, clone 1 from HIST2H3A/C 
and Figure 17B, clones 1-4 HIST2H3D).   
 Most striking were the 5 mRNAs which contained 8-15 non-templated uridines 
added to the 3’ end of the mRNA, starting 3 nts after the stemloop, the site where I 
mapped the 3’ end of the cytoplasmic mRNA (Figure 15D, 15G, and 15F). Two of 
these clones contained a single A (Figure 17B, clone 1) or C (Figure 17B, clone 4) in 
the oligo U tract.  One of these mRNAs from the HIST2H3D mRNA had lost 8 nts 
from the 5’ end. The mRNA from the HIST2H3A/C genes (Figure 17A, clone 1) 
contains at least 8 non-templated U’s at the 3’ end. Since there is also a string of 5 
U’s in the 5’ end just after the cap, it is also possible that this clone comes from a 
decapped mRNA that has lost a few nts from the 5’ end.  Figure 17C and 17D 
summarize the 3’ ends of the HIST2H3A/C (Figure 17C) and the HIST2H3D (Figure 
17D) showing the non-templated U’s as well as partial degradation of the 3’ side of 
the stem. An example of the sequence of a clone containing non-templated U’s is 
shown in Figure 17E. 
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DISCUSSION 
 mRNA degradation is an important step in regulating gene expression, and 
destabilizing an mRNA is the only way to rapidly reduce mRNA levels when 
necessary. The pathway of mRNA degradation for most polyadenylated mRNAs has 
been determined over the past decade (Garneau et al., 2007). The initial step is the 
shortening of the poly(A) tail. Once the poly(A) tail is short enough that it can no 
longer bind PABP, Lsm1-7 can bind the 3’ end and likely recruits Pat1, effectively 
inhibiting translation. The Lsm1-7 complex also stimulates decapping, allowing rapid 
degradation 5’ to 3’ by Xrn1, the cytoplasmic 5’ to 3’ exonuclease.  Following 
deadenylation, the mRNA may also be degraded 3’ to 5’ by the exosome. In yeast, 
the 5’ to 3’ and the 3’ to 5’ degradation pathways are redundant, although the major 
pathway of mRNA degradation is 5’ to 3’ using the decapping machinery. Yeast 
mutant for members of either pathway are viable but debilitation of both pathways 
results in lethality. Thus it is likely the two pathways are redundant, and that most 
mRNAs in yeast can be degraded by either pathway (Caponigro and Parker, 1996). 
 A third pathway of mRNA degradation is endonucleolytic cleavage, followed 
by 5’ to 3’ degradation of the 3’ fragment, and degradation of the 5’ fragment either 
by the exosome or by decapping followed by 5’ to 3’ exonuclease. This pathway is 
used for degradation of mRNAs by siRNAs (Orban and Izaurralde, 2005), and some 
endonucleases involved in degradation of specific mRNAs (Yang and Schoenberg, 
2004) or in NMD in Drosophila (Gatfield and Izaurralde, 2004). 
 Histone mRNAs are the only mRNAs that are not polyadenylated, ending 
instead in a conserved stemloop sequence.  A major step in regulating histone 
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mRNA levels is rapid degradation of histone mRNA, mediated by the stemloop as 
the cis element that directs the degradation of histone mRNA. Despite the fact that 
the cis element that determines histone mRNA degradation has been known for 20 
years (Pandey and Marzluff, 1987), the details of the biochemical pathway for 
degradation of histone mRNA are not known.  
 In this study I demonstrate three features of histone mRNA degradation: (1) 
both the 5’ pathway and the 3’ pathway are involved in histone mRNA degradation, 
and individual molecules of histone mRNA can be simultaneously degraded 5’ to 3’ 
and 3’ to 5’1; (2) there appears to be oligouridylation of the 3’ end of histone mRNA 
in response to inhibition of DNA synthesis; and (3) Lsm1 is essential for histone 
mRNA degradation suggesting that Lsm1-7 binds to the oligo(U) tail that is added to 
histone mRNA.  
Both the 5’ and 3’ degradation pathways contribute to histone mRNA 
degradation 
 Previous work by Jeff Ross and coworkers had implicated 3’ to 5’ degradation 
as the major pathway of histone mRNA degradation, largely based on in vitro studies 
(Ross and Kobs, 1986; Ross et al., 1986). Despite the fact that the 3’hExo can 
potentially degrade the 3’ end of histone mRNA, I find no evidence for a role of this 
enzyme in histone mRNA degradation in mammalian cells (Figure 9) or Drosophila 
(Kupsco et al., 2006). In contrast, knocking down components of both the 5’ to 3’ 
decay pathway or the exosome, resulted in a reduced rate of degradation of histone 
mRNA when DNA replication was inhibited (Figure 14).  Strikingly, knocking down 
Lsm1 had a large impact on histone mRNA degradation.  The cytoplasmic complex, 
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Lsm1-7, is essential for degradation of polyadenylated mRNAs and binds to short 
single-stranded RNAs, typically rich in U’s and A’s, at the 3’ end of deadenylated 
mRNAs (Tharun and Parker, 2001).  It functions both to block translation by 
recruitment of Pat1 (Coller and Parker, 2005), as well as to initiate degradation of 
the body on the mRNA by recruitment of the decapping complex (Tharun et al., 
2005; Tharun and Parker, 2001), and possibly also the exosome (Lehner et al., 
2004). Given that histone mRNAs lack an obvious binding site for Lsm1-7, the 
finding that Lsm1 was critical for histone mRNA degradation was surprising.   
 The cRT-PCR data from the decapped, HU-treated samples revealed direct 
evidence corroborating the functional RNAi experiments.  The presence of almost 
half (43%) of the degradation intermediates sequenced with shortened 5’ and 3’ 
ends provide compelling evidence that indeed single histone mRNA molecules are 
degraded simultaneously from both ends (Figure 17F).  The frequency of 3’ end 
shortened (5’ end intact) clones was 10 times more abundant than clones that had 
their 5’ ends shortened (but 3’ ends intact), (30% compared to 3%, respectively).  
Together these data suggest there is an initiating event(s) that recruit both 
pathways, possibly implicating Lsm1-7 as a participant in this event.  How the two 
decay machineries cooperate to rapidly degrade histone mRNA in response to 
inhibition of DNA synthesis or normally at the end of S phase is not clear.   
Histone mRNA in the cytoplasm has been trimmed   
 Although the product of the in vitro processing reaction of histone mRNAs 
ends in 5 nts, ACCCA, the 3’ end of cytoplasmic histone mRNA ends 2-3 nts 
(usually AC or ACC) after the stemloop.  Thus, following processing the 3’ end must 
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be trimmed. The properties of the 3’ hExo, which can remove 2-3 nts from the 
stemloop while SLBP is bound to the stemloop (Dominski et al., 2003; Yang et al., 
2006), suggests that the 3’hExo carries out this final reaction in histone mRNA 
maturation.  The oligo(U) stretches I detected were all added to the trimmed histone 
mRNA.    
Preliminary evidence for oligouridylation of the 3’ end of histone mRNA 
 The positive clones from the decapped, HU-treated samples revealed a high 
frequency (14%) of untemplated, uridines on the 3’ end of histone mRNA (Figure 
17F).  For a number of reasons argued below, I feel that the presence of these 
uridine residues is of high significance in histone mRNA degradation.  
 Sequencing of positive clones generated by cRT-PCR revealed the precise 5’ 
and 3’ ends of each cDNA molecule recovered.  Comparison of these ends to the 
genomic sequence revealed the orientation of the molecules and in the case of 
intact histone mRNA, there was a homogeneous population of inserts from the in 
vitro decapped (+TAP) reactions.  I observed an obvious difference in clone number 
between the plus-TAP reactions compared to the reactions without TAP, regardless 
of whether the mRNA is undergoing rapid degradation in vivo (plus or minus HU).  
Defined amplicons were only observed in the RNA samples treated with TAP 
(although it could be possible that if there are discrete degradation intermediates 
these might be observed as a defined amplicon).  For example, following a 15 
minute treatment of cells with HU, approximately one-third of histone mRNA will 
have been degraded.  For the uncapped reactions (-TAP) there will be recovery of 
cDNA molecules from the cell that had been previously decapped (and exposed to 
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HU) and these will yield heterogenous length fragments after restriction enzyme 
digestion. Only a small number of clones were obtained from cells that were not 
treated with HU from the minus TAP reactions.  These resemble those seen from the 
HU treated cells, reflecting the slow degradation (i.e. increased stability) of histone 
mRNA during S-phase.  In my hands the procedure is semi-quantitative in that I 
observed fewer clones from +TAP reactions using RNA from cells treated with HU 
(where the histone mRNA concentration is reduced).  
 An obvious concern in these experiments was whether there was a small 
amount of degradation that might occur during the decapping step and extensive 
handling of the RNA.  Two results argue that this is not the case.  First the clones 
obtained from the cellular RNAs treated with TAP were remarkably homogenous, 
and no full-length clones were observed from the RNAs not treated with TAP 
(although one RNA with an oligo(U) tail that was otherwise full-length was 
observed). Second, the four RNAs produced by in vitro processing had homogenous 
3’ ends that mapped precisely to the known cleavage site.  Since these mRNAs had 
5’ triphosphate termini (as a result of in vitro synthesis) it was necessary to treat 
these with TAP prior to ligation.   There was some heterogeneity at the 5’ end that 
has been previously documented for some T7 RNA transcripts (Pleiss et al., 1998).  
Although the cRT-PCR data, particularly the sequenced clones from the decapped 
reactions (minus TAP, plus HU), are suggestive of the presence of oligo(U) tails 
playing a new and exciting role in histone mRNA degradation, the present data are 
insufficient to convincingly stand alone.  Additional evidence is required to determine 
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the significance of the 3’ oligouridylation of histone mRNA as well as to identify the 
enzyme(s) responsible for this activity.   
Summary  
 A striking finding is that individual histone mRNA molecules are degraded 
both 5’ to 3’ and 3’ to 5’.  A recent report using the Invader RNA Assay to detect β-
globin mRNA suggests that individual ARE-containing mRNAs are also degraded 
from both ends (Murray and Schoenberg, 2007), suggesting that this may be a 
common pathway for mRNA degradation in mammalian cells.  Although we now 
know many of the requirements and the likely pathway for histone mRNA 
degradation (Figure 18), we still do not understand the molecular details of how the 
protein complex (including SLBP, Upf1, an enzyme with terminal uridylyltransferase 
activity, and Lsm1-7) is recruited to the 3’ end of histone mRNA to activate 
degradation, or the signals that activate this pathway at the end of S-phase or when 
DNA replication is inhibited.    
. 
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Table 2.  siRNA sequences.  The table below details the sequences targeting the 
open reading frames of the indicated target mRNA.  All siRNAs were synthesized 
from Dharmacon with d(T)d(T) ends.   
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Target Sequence Reference 
C2  
 
5’-GGUCCGGCUCCCCCAAAUG-3’  (Wagner and Garcia-
Blanco, 2002) 
PTB 
 
5’-GCCUCUUUAUUCUUCUCGG-3 (Wagner and Garcia-
Blanco, 2002) 
3’hExo 
 
5’-UUACGAAUGGCUGUAUUAA-3 This paper 
Lsm1-1 
 
5’-CAAACUUAGUGCUACAUCA-3’  (Stoecklin et al., 2006) 
Lsm1-2 
 
5’-CCAGCAAGUAUCCAUUGAA-3’ (Stoecklin et al., 2006)  
Upf1 
 
5’-GAUGCAGUUCCGCUCCAUU-3’  (Kaygun and Marzluff, 
2005) 
Dcp2 
 
5’-GUGGCAUGUAAUGGACAUUGC-3’   (Wang et al., 2002) 
Xrn1 
 
5’-UGAUGAUGUUCACUUUAGA-3’  (Stoecklin et al., 2006)  
PM/Scl-100 
 
5’-GCUGCAGCAGAACAGGCCA-‘3  (Lejeune et al., 2003)  
Rrp41-1 
 
5’-CUAUGCAGCUUGUGUGAAUUU-3’  This paper 
Rrp41-2 
 
5’-CGGACAGGGCCCUAGUGAAUU-3’ This paper 
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Figure 9. Knockdown of 3’hExo does not affect histone mRNA degradation. 
HeLa cells were treated with the 3’hExo (A-C) siRNAs as described in Materials and 
Methods, and then treated with 5 mM HU and total cell RNA prepared 0 and 20 or 
45 min after HU treatment.  (A) A dilution series of the control (C2) cell lysate 
together with a lysate from cells treated with the indicated siRNA was analyzed by 
Western blotting for 3’hExo and Upf1.  The asterisk indicates a cross-reacting band. 
(B) 2 µg of total cell RNA was resolved by urea acrylamide gel electrophoresis and 
transferred to N+ nitrocellulose and probed with a mixture of histone H2a mRNA and 
7SK snRNA probes. (C) The average of 3 independent experiments is shown. Panel 
C (, C2; , 3’hExo). Standard deviations are indicated by vertical bars.  (D)  Cell 
cycle analysis of knockdowns. HeLa cells were treated with siRNAs targeting the 
3’hExo and C2 used as a control.  Cells were fixed in 70% ethanol, stained with 
propidium iodide, and analyzed by FACS. Populations of G1 (2N DNA content), S 
phase (2N < S < 4N DNA content), and G2/M (4N DNA content) were quantified and 
are represented as a percentage of the total population. All experiments are paired 
samples that correspond to the protein and RNA samples analyzed by Western and 
Northern analysis in (A) and (B).   
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Figure 10. Effect of knocking down PTB and Lsm1. HeLa cells were treated with 
the PTB (A-C) or Lsm1 (D-F) siRNAs as described in Materials and Methods, and 
then treated with 5 mM HU and total cell RNA prepared 0 and 20 or 45 min after HU 
treatment.  PTB is used as a negative control in these experiments.  (A,D) A dilution 
series of the control (C2) cell lysate together with a lysate from cells treated with the 
indicated siRNA was analyzed by Western blotting for PTB and Upf1.  The asterisk 
indicates a cross-reacting band. (B,E) 2 µg of total cell RNA was resolved by urea 
acrylamide gel electrophoresis and transferred to N+ nitrocellulose and probed with 
a mixture of histone H2a mRNA and 7SK snRNA probes. (C,F) The average of 3 
independent experiments is shown. Panel C (, C2; , PTB); panel F (, C2; , 
Lsm1-1; , Lsm1-2; , Upf1). Standard deviations are indicated by vertical bars.  
(G) Lysates were prepared from S-phase cells expressing HA-SLBP 15 min after 
treatment with HU as previously described (Kaygun and Marzluff, 2005a).  (Top) A 
portion of the lysate was treated with RNase A (20 µg/ml; lane 3) for 15 minutes prior 
to immunoprecipitation with anti-HA antibody. The immunoprecipitates were 
analyzed for SLBP and Lsm1 by Western blotting.  (Bottom)  S-phase cells 
expressing HA-SLBP were treated with HU for 15 min, lysates prepared and 
subjected to immunoprecipitation with anti-myc (lanes 3 and 4) or anti-HA (lanes 5 
and 6) antibodies.  The immunoprecipitates were analyzed for SLBP, Lsm1 and PTB 
as a control by Western blotting.  The input lanes (1 and 2) show 5% of the total 
lysate.  
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Figure 11. Cell cycle analysis of Lsm1 and Upf1 knockdowns. HeLa cells were 
treated with the indicated siRNAs (C2, Lsm1, and Upf1) and cell cycle analysis 
performed by FACS.  The percent phase distribution is indicated below the 
histogram.  The FACS analysis in this figure are paired samples from the 
experiments performed in Figure 10D-10E. 
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Figure 12.  Effect of decapping complex and 5’-3’ exonuclease knockdown on 
histone mRNA degradation. HeLa cells were treated with the indicated siRNAs to 
Dcp2 (A-C) or Xrn1 (E-G) and treated with 5 mM HU as described in Figure 1. (A 
and E) Protein levels of knockdowns were measured by Western blot using 
antibodies to Dcp2 (A) and Xrn1 (E). (B and F) S1 nuclease protection assays of 5 
µg total RNA isolated from cells treated with 5 mM Hu for 0, 20 or 45 minutes from 
Dcp2 (B) or Xrn1 (F) knockdowns. Human H3.3 and H2a mRNAs were detected by 
mixing probes to detect the 3’ and 5’ ends of H3.3 and H2a mRNAs, respectively. (C 
and G) The average of 3 independent experiments from Dcp2 (C) and Xrn1 (F) 
knockdowns is shown. The vertical bars indicate the standard deviation.  (D and H) 
Cell cycle analysis of Dcp2 (D) and Xrn1 (H).   
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Figure 13.  Effect of knockdown of exosome components on histone mRNA 
degradation. (A, E) HeLa cells were treated with the indicated siRNAs to PM/Scl-
100 (A-C) or Rrp41 (E-G) and treated with 5 mM HU and levels of each protein 
determined by Western blotting as in Figure 1 and 2. (B, F) 2 µg of total cell RNA 
from cells with PM/Scl100 knocked down (B) or Rrp41 knocked down (F) with two 
siRNAs (5 and 6) to Rrp41 was resolved by urea-acrylamide gel electrophoresis and 
probed with a mixture of histone H2a mRNA and 7SK snRNA probes as in Figure 1. 
(C, G) The average of 3 independent knockdowns to PM/Scl-100 (Panel C: , C2; 
, PM/Scl-100) and Rrp41 (Panel G: , C2; , Rrp41(1); --, Rrp41(2)) is shown.  
(D and H)  Cell cycle analysis of PM/Scl-100 and Rrp41 knockdowns.   
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Figure 14.   Summary of 5’-3’ decay and exosome RNAi experiments.  Average 
fold stabilization of all independent experiments shown in Figures 1 through 3, with 
standard deviations indicated by vertical bars.  
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Figure 15.  Detection of the 5’ and 3’ ends of capped histone H3 mRNA in vivo 
by cRT-PCR. (A) The cRT-PCR strategy to determine the ends of intact histone 
mRNA and degradation intermediates is shown (adapted from Couttet et al., 1997). 
(B) cRT-PCR reactions with and without decapping from total cell RNA were 
separated on 1.5% agarose gels and amplicons detected by ethidium bromide 
staining. Two human histone H3 mRNAs are visualized in the +TAP lanes. (C) 
Control cRT-PCR experiment to determine the 3’ end of histone mRNA in vitro.  
Synthetic histone pre-mRNA was processed in a nuclear extract, and the 
unprocessed and processed RNAs were treated with TAP and subjected to cRT-
PCR, and the products cloned and sequenced.  All 4 clones of processed RNA 
sequenced ended at ACCCA.  The arrow indicates the site cleaved in vitro. (D and 
E) cRT-PCR was performed on total cell RNA, the histone H3 products amplified, 
cloned and sequenced. HIST2H3A/C (panel D) or HIST2H3D (panel E) mRNAs that 
were capped were cloned by cRT-PCR.  The number of times each sequence was 
obtained is indicated by a number in parentheses. (D) The 5’ (top) and 3’ (bottom) 
ends of capped (+TAP) HIST2H3A/C mRNAs. The genomic sequence of 
HIST2H3A/C is indicated on the top line. The sequences of the TA cloned cRT-PCR 
products are shown. (E) The 5’ (top) and 3’ (bottom) of the capped histone 
HIST2H3D mRNA. The genomic sequence of HIST2H3D is shown in the top lines.  
The number of times a particular clone was obtained is in parentheses.  (F)  The 3’ 
end of histone mRNA is trimmed 2-3 nts in vivo.   
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Figure 16.  New histone H3 gene, HIST2H3D.   A highly expressed human histone 
H3 gene was cloned.  The previously unannotated H3 gene is found in the minor 
histone gene (HIST2) cluster on chromosome 1q21 from nucleotides 276048-
275157.  The TATA box is represented in the 5’ end of the gene in bold letters.  The 
major transcriptional start site is represented by the bold A depicted in blue and start 
codon in green.  The termination codon is represented in red with the bold sequence 
following representing the conserved stemloop sequence at the 3’ end.  The 
cleavage site is represented by the two blue ‘C’s’ where cleavage in nucleus is 
presumed to occur between them.  The nts between the stemloop and cleavage site 
are underlined.  The bold sequence downstream of the cleavage site represented 
the histone downstream element (HDE).   
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5’CTTCGGTCATTCATGGTATACAATGCATCTAACTTGCTGA
GCAAAATGCCAGACATGAAATAAATGTTAGCTATGGTAGAA
GAGCTACAGTAACAGGTAACCTGAAACAGGCTGATAGCTC
ATAGAAGGGCATGCTTGAATTCGGGGAAAAAAAAAATCTC
TGTTAAAATGGGATGCAAAACACTTTATACATTGCTTTTAC
AAAAGTTAGACTAATTTAAAGGAAAGTCTTCAAAAACAATC
CGTGATCGATAAAATTACAGAAAAAAATCAGGAAAGGGGG
AAATAATAAGGGAAGAAAGATTAGCAGAACAATCTTCCGC
CCCAGTAAAGAGGATTGAATTTTAACCAATGAGATCACAAG
TTTGAAAATTTCCTTTTCAGGCCCAATCAAGAGGAGACTAT
GTCTATAAATATGACTGCCTAGACCCTCTCCTATCAATGAG
ACAGCATGGCCCGTACTAAGCAGACTGCCCGCAAGTCGA
CCGGCGGCAAGGCCCCGAGGAAGCAGCTGGCTACCAAA
GCGGCCCGCAAGAGCGCGCCGGCCACGGGCGGGGTGAA
GAAGCCGCACCGCTACCGGCCCGGCACCGTGGCTCTGC
GGGAGATCCGGCGCTACCAGAAGTCTACGGAGCTGCTGA
TCCGCAAGCTGCCCTTCCAGCGGCTGGTACGCGAGATCG
CGCAGGACTTTAAGACGGACCTGCGCTTCCAGAGCTCGG
CCGTGATGGCGCTGCAGGAGGCCAGCGAGGCCTACCTG
GTGGGGCTGTTCGAAGACACGAACCTGTGCGCCATCCAT
GCCAAGCGCGTGACCATCATGCCCAAGGACATCCAGTTG
GCCCGCCGCATCCGCGGGGAGCGGGCCTAAGGCATATTT
TTAAGTGGTCGATCTAAAGGCTCTTTTCAGAGCCACTGCC
GTTTTCATCAAGAGCAGCTGTACCGGCTCTCCATCTGATG
TGCGTCTGCCTTGCGCAGCGGTCAGGGGCCAGGGGCACT
CGTGGTGGGTGA3’ 
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Figure 17.  Detection of uncapped histone mRNA by cRT-PCR upon inhibition 
of DNA synthesis reveals degradation intermediates with nonencoded 
uridines.  (A and B) cRT-PCR was performed on total cell RNA in the absence of 
TAP (see Figure 15, lanes 1 and 2).  The low levels of histone H3 mRNAs (A) 
HIST2H3A/C or (B) HIST2H3D that were not capped when treated with hydroxyurea 
were cloned and sequenced.  Primer 2 and 3 represent sites where I targeted 
amplification towards the 5’ and 3’ ends. ORF sequences between these 2 
oligonucleotides are missing. Numbers in parentheses are the number of times each 
clone was obtained.  (C and D) The 3’ ends from the largest HIST2H3A/C (panel C) 
and HIST2H3D (panel D) mRNA degradation intermediates are shown. The number 
of times each sequence was obtained is indicated by a number in parentheses. (E) 
Chromatogram from a HIST2H3D mRNA degradation intermediate containing 8 
untemplated U’s (T’s in the DNA sequence). The 3’ and 5’ ends are ligated (arrow) 
together.  (F) Summary of the distribution of various types of degradation 
intermediates observed.   
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Figure 18.   Model of histone mRNA degradation.   
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CHAPTER 3 
 
DEGRADATION OF HISTONE mRNA REQUIRES OLIGOURIDYLATION 
 
 
INTRODUCTION 
 Histone mRNAs are rapidly destabilized when cells are exposed to inhibitors 
of DNA synthesis and when cells are completing the DNA replication phase of the 
cell cycle.  It is clear the unique 3’ stemloop of metazoan replication-dependent 
histone mRNAs plays a critical role in regulating the rapid change in histone half-life 
(Graves et al., 1987; Pandey and Marzluff, 1987), although the precise mechanism 
is not known.  The stemloop binding protein (SLBP) binds the stemloop and is a 
significant component in proper regulation of histone protein biogenesis.  In addition 
to SLBP, other proteins such as the Lsm1-7 complex and the RNA helicase Upf1 
have been shown to be bound to histone mRNA and the 3’ mRNP that exists 
specifically under conditions when histone mRNA is degraded (Kaygun and Marzluff, 
2005a; Mullen and Marzluff, 2008), (Chapter 2).  The protein complex(es) that is 
(are) recruited to the 3’ end of histone mRNA appears to play a fundamental role in 
specifically targeted histone mRNA for rapid degradation under the appropriate 
cellular stimuli.  Following the recruitment of the appropriate positive regulators of 
histone mRNA degradation, histone mRNA molecules are targeted for bidirectional 
5’-3’ and 3’-5’ degradation (Mullen and Marzluff, 2008), (Chapter 2).    
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 In the last chapter I presented preliminary evidence showing the presence of 
short, untemplated uridine tracts on nearly full-length histone mRNA degradation 
intermediates.  This preliminary evidence suggests it is possible the cell uses 
terminal uridylyltransferase (TUTase) activity to post-transcriptionally modify the 3’ 
end of histone mRNA in the cytoplasm.  This modification could provide a 
mechanism to specifically target histone mRNA for degradation.   At the time I made 
this observation there were no cloned and characterized human enzymes with this 
activity.  However, it has been recognized for over 45 years that enzyme fractions 
from carcinoma cells and rat liver could incorporate uridine triphosphate into RNA 
(Burdon and Smellie, 1961; Klemperer, 1963).  Additionally, poliovirus encodes an 
RNA polymerase that requires a host factor required to prime viral replication 
(Dasgupta et al., 1980).  Biochemical fractionation of HeLa cells suggested that the 
host factor is in fact a TUTase that adds uridines to the 75 nt long 3’ poly(A) tail and 
this subsequently forms a hairpin that primes the viral RNA polymerase (Andrews 
and Baltimore, 1986).   
 The best example of the importance of TUTase activity occurs in the 
mitochondria of the kinetoplastid Trypanosoma bruceii  (Shaw et al., 1988).  RNA 
editing in trypanosomes involves the insertion or deletion of dozens to hundreds of 
uridylate residues by a complex series of enzymatic reactions that are carried out by 
enzymes encoded for in the nucleus (Stuart, 1991).  First, a specified guide RNA 
(gRNA) targets a substrate RNA sequence that is subsequently cleaved by an 
endoncuclease (Adler and Hajduk, 1997).   Next, either a TUTase adds a variable 
number of uridylate residues (Aphasizhev et al., 2003) or a 3’-U-exonuclease (Adler 
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and Hajduk, 1997) removes a variable number of uridylate residues.  Finally an RNA 
ligase (TbMP52 or TbMP48), specified by the gRNA, joins the 5’ and 3’ ends 
(Madison-Antenucci et al., 2002).  Together, the process of RNA editing in the 
mitochondria of trypanosomes functions to convert encrypted RNA sequences into 
functional open reading frames in order to assemble the electron transport 
machinery.   
 Another example of U-addition is the highly conserved splicesomal U6 
snRNA.   U6 snRNA is unique from other snRNAs in that uridine monophosphate 
residues are post-transcriptionally added to and removed from its 3’ end, 
presumably as a final maturation step or to regulate its incorporation into the 
spliceosomal snRNP (Lund and Dahlberg, 1992; Rinke and Steitz, 1985).  The U-
stretches vary in length from 5-12 residues (Terns et al., 1992).  Recent biochemical 
fractionation of HeLa extracts have purified a specific U6 snRNA TUTase activity 
(Trippe et al., 2003; Trippe et al., 1998), but at the time of my initial observation of 
short U stretches on the 3’ end of histone mRNA (July 2006), the identity of the 
TUTase had not bee elucidated.    
 This changed in August of 2006 when the Benecke lab reported the cloning of 
the U6 TUTase from human cells (Trippe et al., 2006).  The 93 kDa U6 TUTase 
enzyme is required for U6 snRNA maturation in vitro and in vivo and is required for 
cell viability.  Importantly, the cloning of the U6 TUTase provided some of the first 
insight into the domain structure of what we are quickly realizing is an entire family of 
TUTase-like enzymes in eukaryotes.  Specifically, U6 TUTase possesses a poly(A) 
polymerase associated-domain (PAPD) which is contained within a larger 
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overlapping topoisomerase-related function (TRF) domain (Trippe et al., 2006).  
These overlapping domains share significant sequence identity to the trypanosomal 
RET1 TUTase and to a lesser degree the canonical poly(A) polymerase α.   
 In this chapter I provide compelling evidence supporting a novel pathway for 
histone mRNA degradation that involves initial addition of uridines to the 3’ end of 
histone mRNA.  Treatment of cells with hydroxyurea (HU) results in a dramatic 
increase in oligouridylated histone mRNAs, and at the end of S-phase, cells also 
accumulate oligouridylated histone mRNAs.  In addition, a functional RNAi screen 
against 7 putative TUTases present in human cells identifies 2 putative TUTases 
that attenuate histone mRNA degradation in response to inhibition of DNA synthesis.  
Epitope-tagged versions of these 2 TUTases are localized to the cytoplasm of 
human cells.  Moreover, I present preliminary biochemical characterization of the 
TUTases believed to be involved in histone mRNA degradation.  These data, taken 
together with that from Chapter 2, present a novel mechanism of histone mRNA 
degradation.  
 
MATERIALS AND METHODS 
Cell synchronization  
  To detect oligo(U) on histone mRNA in response to inhibition of DNA 
synthesis, I used synchronized HeLa cells (see Chapter 2 for detailed Materials and 
Methods).  Fresh, warm media containing 5 mM HU was added 3 hours following 
release from the second thymidine block for 15, 30 and 60 minutes.  I harvested total 
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cell RNA using the methods previously described in Chapter 2 and DNase-treated 
the RNA samples following isolation to eliminate genomic DNA contamination.   
 In order to detect oligo(U) tails on the 3’ end of histone mRNA during the cell 
cycle (without inhibiting DNA replication) at the end of S phase, synchronized dishes 
were set up to follow the rapid degradation of histone mRNA at the end of S phase.  
The precise length of S-phase in cell synchrony experiments does vary from 
experiment to experiment (but is constant within an experiment) but typically I would 
observe histone mRNA rapidly disappear between 5-7 hours after release from the 
second thymidine block.   
Reverse transcription of oligo(U) tails on the 3’ end 
 RT reactions were performed on 4 µg of DNase-treated total RNA 
(Chomczynski and Sacchi, 1987) from the 0, 15, 30 and 60 minutes time points 
following HU treatment.  MMLV-RT (Invitrogen) was used in these reactions 
following the manufacturer’s protocol.  The oligo(U) tail was primed with an oligo(dA) 
oligo containing a T7 sequence (Table 3) on the 5’ end to use in the subsequent 
PCR step.   
PCR  
 Two rounds of PCR totaling 60 cycles was required for detection of 
oligouridylated tails on the 3’ end of histone mRNA.  This likely reflects the very low 
abundance of these degradation intermediates.  Histone genes have a high guanine 
and cytosine content (roughly 67% on average) and this made amplifying full-length 
histone cDNA initially difficult.  Therefore, for the first round of PCR I used a GC-rich 
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Pfu DNA polymerase (Invitrogen) where I targeted specific histone mRNAs with an 
oligo targeting the 5’ UTR and the T7 reverse primer (Table 3).  The non-allelic 
copies of each of the 5 classes of replication-dependent histone genes have ORFs 
that have little divergence at the nucleotide level and almost none at the protein level 
(Marzluff et al., 2002) so targeting individual genes of each class of histone mRNA 
requires targeting the 5’ UTR.  For the first round, I performed 30 cycles (95° C for 
30 seconds, 50-54° C for 30 seconds, and 72° C for 30 seconds) in a 50 µl PCR 
reaction containing 0.5 µl GC-rich DNA polymerase, 10 µl of 5X Buffer A supplied by 
the manufacturer (Invitrogen), 0.5 µl of each (5’ UTR oligo and T7 reverse), 1-2 µl of 
oligo(dA) RT, and 37.5 µl water.  No detectible amplicons from the first round of PCR 
using ethidium bromide staining were ever observed.   
 The second round of PCR used oligos that target the ORF of the respective 
histone mRNAs and the same T7 reverse oligo (Table 3).  I used 1 µl from the first 
round of PCR and identical cycling strategies (30 cycles) as in the first round.  This 
time however, Taq DNA polymerase, 5% DMSO, 10X Taq buffer (see above) was 
used in place of the GC-rich Pfu DNA polymerase.  This allowed me the opportunity 
to T/A clone the amplicons to confirm the position of the oligo(U) tails present on the 
3’ end of histone mRNA following inhibition of DNA synthesis.  PCR products were 
separated on 2% agarose gels containing ethidium bromide.  Amplification of the 
histone H2A 3’ end was performed using primer H2a/a O-1 (Table 3) and amplified a 
188 bp product while the H2a/a O-2 primer amplified a product 15 bp larger.  Both 
the H3 genes targeted amplified a product approximately 200 bp.  Common to the 
H3 oligo (dA) RT-PCR is a contaminating band of approximately 130 bp. This 
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nonspecific band contains the 5’ UTR oligo as well as the ORF oligo followed by a 
small amount of ORF sequence and then the T7 sequence.  No nonencoded 
uridines are seen in the clones of this nonspecific band, which is present in large 
amounts only when no oligo(U) tails on histone mRNA were detected.   
RNA interference  
 RNAi to TUTase mRNA was carried out as described in Chapter 2.  The 
siRNA sequences to the various TUTases are listed in Table 4.   
RT-PCR of TUTase mRNA   
 TUTases were downregulated by siRNA as described above.  Total RNA was 
isolated by Trizol reagent (Sigma) and 2 µg of RNA was reverse transcribed with 
MMLV-RT (Invitrogen) and random primers.  RT reactions were subjected to PCR 
with the oligos described in Table 5.  
Cloning of TUTases 
 TUTases were cloned by PCR from cDNA clones or by RT-PCR from total 
HeLa RNA and cloned into pCDNA4-myc3 or pCDNA3-flag vectors. Accession 
numbers of the TUTases are the following: TUTase-1 (BAB13981), -2 (BC04758), -3 
(Q8NDF8), -4 (XP_038288), -5 (AB005754), the U6 TUTase (BC110910) and 
TUTase-7 (BC032456).  
Immunofluorescence and confocal microscopy  
 HeLa cells plated on coverslips were transiently transfected with 0.5 µg 
pCDNA4-myc3-FLAG plasmids encoding the ORF of TUTases-1 and -3 for 48 
hours. Cells were prepared for immunofluorescence as described (Wagner and 
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Marzluff, 2006) and the N-terminal myc-epitope tag was detected with a monoclonal 
mouse anti-myc antibody (Upstate Biotechnology).  
Purification of epitope-tagged TUTases from human cells 
 TUTase ORFs were cloned into a modified pcDNA4 vector containing a single 
N-terminal FLAG tag and a β-globin intron upstream of the epitope tag (courtesy of 
Yi Zhang, University of North Carolina at Chapel Hill).  293T cells were plated (3 x 
106 cells) into 15 cm2 dishes and 70 µg of plasmid DNA transfected into cells using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s suggestions and 
following similar large-scale transfections for protein purification (Cazalla et al., 
2005).  Cells were harvested 48 hours following transfection and purified using M2-
FLAG antibody (single FLAG) conjugated protein resin (Sigma) similarly as 
previously described (Cazalla et al., 2005; Tsukada et al., 2006; Tsukada and 
Zhang, 2006).   
 Briefly, cells were pelleted at 1200 rpm for 5 minutes at 4°C and washed with 
PBS.  Cell pellets were frozen on dry ice, thawed on ice and resuspended in 10 ml of 
F lysis buffer (20 mM Tris pH 7.9, 500 mM NaCl, 4 mM MgCl2, 0.4 mM EDTA, and 
20% glycerol).   Resuspended pellets were homogenized in 40 ml dounces in 30 
minutes by stroking 10 times then letting homogenates rest for 10 minutes and doing 
this a total of 3 times.  Lysates were clarified by spinning at 11,000 rpm for 10 
minutes and the supernatant recovered.  Next, 6 ml of dilution buffer (20 mM Tris pH 
7.9, 10% glycerol, and 0.02% NP40) was added to dilute the NaCl and then protein 
inputs taken.  0.5-1.0 ml of activated FLAG resin (Invitrogen) was washed with 5 ml 
of F lysis buffer, the lysate added to the resin, and rotated for 3 hours at 4°C.   
 113 
Protein-bound resin was washed 3 times with 10 ml of F wash buffer (20 mM Tris pH 
7.9, 150 mM NaCl, 2 mM MgCl2, 0.2 mM EDTA, 15% glycerol and 0.01% NP40), 
then the resin transferred to a cold 1.5 ml microfuge tube.  Elution was carried out 
with  0.3 ml of 0.2 mg/ml (single) FLAG peptide in wash buffer for 30 minutes at 4°C.  
Elution was repeated and fractions analyzed by silver staining and Western blot 
analysis using anti-M2-FLAG antibody (Sigma).   
In vitro polymerization assays 
 Purified TUTase protein was used in an in vitro reaction to test for 
poly(U)/oligo(U) activity as previously described (Kwak and Wickens, 2007).  Briefly, 
20 µl reactions were incubated at 30°C for 1 hour.  Reactions contained 1 µCi of 32P 
α-UTP, an unlabelled 30 mer stemloop RNA, 20 mM Tris pH 7, 60 mM KCl, 0.2 mM 
EDTA, 0.5 mM DTT, 7.5 µg of BSA, 40 U RNase inhibitor (New England BioLabs), 
1.1 mM MgCl2  , approximately 100-300 ng of purified SpCid1 (courtesty of Jae Eun 
Kwak and Marvin Wickens, University of Wisconsin at Madison) or purified TUTase-
1, TUTase-3 (long isoform), or TUTase-7 (hCid1). 
Protein Identification  
 Protein bands were excised from gels and subjected to automated in-gel 
digestion with trypsin on a Genomic Solutions ProGest digestor.  After digestion, 
peptides were then extracted and spotted onto a MALDI target plate along with a 
solution of alpha-cyano 4-hydroxycinnamic acid matrix.  Once dried, MS and MS/MS 
spectra (MS/MS fragmentation was attempted on the top 20 intensity ions in each 
MS spectrum, with those of trypsin excluded) were acquired in an automated fashion 
on an Applied Biosystems 4800 MALDI-TOF/TOF Proteomics Analyzer mass 
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spectrometer. The resulting peptide mass fingerprint and MS/MS sequence tag data 
were then searched against the MSDB and NCBI databases using the Applied 
Biosystems GPS Explorer software employing the Mascot search engine to obtain 
the protein identifications. Hits that met the Mascot significance threshold were 
reported. 
 
RESULTS 
Histone H2A and H3 mRNAs acquire oligo(U) tails after addition of 
hydroxyurea 
 In order to detect mRNAs containing oligouridylated tails added to the 3’ end 
of histone mRNA, I developed a nested RT-PCR strategy, depicted in Figure 19A.  
First I primed reverse transcription with an oligonucleotide containing a T7 promoter 
sequence followed by 8 A’s to make cDNAs from all RNAs containing an oligo(U) 
sequence. A specific primer targeting the 5’ UTR of a histone gene and the T7 
primer were used for the first round of PCR. The nested PCR reaction used a 
histone ORF primer with the same reverse T7 promoter primer.  I targeted the same 
two H3 genes used in the cRT-PCR studies (Chapter 2) and in addition targeted an 
H2A mRNA (HIST2H2AA).  I prepared total RNA at 0, 15, 30 and 60 min after 
initiating histone mRNA degradation by treating double thymidine blocked cells 
released for 3 hours with HU to inhibit DNA synthesis.   
 At 0 time there is no amplicon of oligouridylated histone mRNA detected from 
either the HIST2H2AA mRNA or the HIST2H3A/C and HIST2H3D mRNAs (Fig. 19B, 
lane 2).  After 15 minutes a robust band is detected which subsequently declines in 
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intensity at 30 minutes and is almost entirely gone at 60 minutes coinciding with the 
near completion of histone mRNA degradation (Fig. 19B, lanes 3-5).   I cloned the 
amplicons from the 0 and 15 minute time points.  There was a striking difference in 
colony number on the transformed H2A plates, with only a few colonies present on 
the 0 minute plates compared to hundreds of colonies present on the 15 minute 
plates (Figure 19D), consistent with the increased amount of RT-PCR product after 
HU treatment.  These results imply that my RT-PCR approach is semi-quantitative.  I 
sequenced amplicons cloned after HU treatment and these all were derived from 
histone mRNAs containing oligo(U) tails at or near the 3’ end of these histone 
mRNAs. They contained 8 U’s (the number of U’s in the primer) which were added 
either to the very terminal end (3 nts after the stemloop) of the mRNA or somewhere 
within the stem loop (Figure 19C).  The latter observation suggests that multiple 
rounds of oligo(U) addition may occur near the 3’ end of the mRNA, possibly 
because degradation may stall in the stemloop and the degradation must be primed 
again.   
 In the HIST2H2A/C (Fig. 19B, middle panel, lane 2) and the HIST2H3D (Fig. 
19B, bottom panel, lanes 2 and 5) reactions, I detected a nonspecific band at the 0 
time point which was absent after HU treatment for 15 or 30 min, but was present at 
60 min when most of the histone mRNA has been degraded.  I sequenced clones 
from the 0 time point of the H3 oligo(dA) RT-PCRs and found the nonspecific band 
was a primer dimer sequence containing the two histone primers and a small 
sequence of H3 ORF followed by the reverse T7 promoter primer (primer-dimer of 3 
oligos).  They did not contain any oligo(U) sequence.   
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 In yeast, addition of adenosines to the 3’ end of many RNAs is a prerequisite 
to degradation of RNAs by the exosome in the nucleus (LaCava et al., 2005; 
Vanacova et al., 2005).  To test whether polyadenylation might also play a role in 
histone mRNA degradation I attempted to detect poly- or oligoadenylated histone 
mRNAs after inhibiting DNA replication by a similar strategy used to amplify the 
oligouridylated histone mRNAs.  As a positive control for the oligo(dT) oligo I used 
SLBP knockdown cells that have been shown to result in accumulation of some 
polyadenylated histone mRNA as a result of misprocessing (Narita et al., 2007).  I 
readily detected polyadenylated histone mRNAs in the SLBP knockdown cells 
(Figure 20A), but did not detect any oligoadenylated histone mRNAs in control cells 
or cells treated with HU (Figure 20B).  In addition my unbiased sequencing of 
circularized histone mRNAs (Chapter 2) never yielded oligoadenylated mRNAs. 
Oligouridylated histone mRNAs are present at the end of S-phase but not in 
mid S-phase 
 Histone mRNAs are rapidly degraded at the end of S-phase.  To determine if 
the oligouridylation is present normally at the end of S phase I synchronized HeLa 
cells by double thymidine block (Whitfield et al., 2000).  As a positive control I 
treated mid S-phase cells (3 hrs after release from the thymidine block) for 15 min 
with HU.  I prepared whole cell lysates for Western analysis and total RNA for 
Northern blot analysis and oligo(dA) RT-PCR at various times beginning from the 
middle of S phase but focusing particular attention to the end of S phase.  Figure 
21A is a Western blot showing that SLBP protein levels are high in S phase and 
decrease rapidly upon completion of DNA synthesis and increase in abundance 
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again when cells approach the subsequent S phase (Figure 21A, lane 14), (Whitfield 
et al., 2000).  I also determined cyclin A levels, a mitotic cyclin which is degraded at 
anaphase as cells exit mitosis. Northern blot analysis was performed for H2A mRNA 
using 7SK snRNA as a loading control (Figure 21B). Histone H2A mRNA is rapidly 
degraded upon the completion of S phase then re-accumulates upon entry into the 
subsequent S phase (Figure 21B, lane 15).  Figure 21C shows the results from 
oligo(dA) RT-PCR at various times in S phase and upon the completion of DNA 
sythesis.  At 0 and 3 hours following release from double thymidine block (DTB) 
there was little to no detection of olidouridylated HIST2H2AA or HIST2H3D mRNA 
(Figure 21C, lanes 1 and 2).  When HU is added for 15 minutes at 3 hrs 
oligouridylated HIST2H2AA and HIST2H3D mRNA accumulated (Figure 21C, lane 
3).  Starting 5 hrs after release into S-phase I detected oligouridylated histone 
mRNA (Figure 21C, lane 4) and the amount increased at 5.5-6 hrs for both 
HIST2H2AA mRNA (Figure 21C, lane 5) and HIST2H3D mRNA (Figure 21C, lane 
6).  The levels of oligouridylated histone mRNAs declined at 6.5 hours and were no 
longer detectable at 7 hours during G2 phase.  I sequenced oligouridylated RT-PCR 
products for both HIST2H2AA and HIST2H3D from the 5.5 and 6 hour time points.  
Consistent with the results after HU treatment (Figure 19B, 19C), I found 
oligouridylated tails present at the end of S phase on both the 3’ end of the histone 
mRNA as well as within the stemloop sequence (Figure 21D). Note that the oligo(U) 
tails were often interrupted by another nucleotide, which has recently been 
determined to be characteristic of other terminal transferases (Kwak and Wickens, 
2007). 
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Two putative cytoplasmic TUTases are required for efficient histone mRNA 
degradation  
 The addition of nontemplated uridines to the 3’ end of histone mRNA requires 
a 3’ terminal transferase activity.  I searched the human genome with the assistance 
of Hemant Kelkar (University of North Carolina at Chapel Hill) for putative TUTase 
enzymes that contain the PAPD/TRF domain, a domain found in the human CID1 
(Rissland et al., 2007) and U6 snRNA TUTase (Trippe et al., 2006).  We identified 7 
putative TUTases (one of them being the U6 TUTase) and I designed siRNAs 
targeting each one and knocked them down in HeLa cells. To demonstrate the 
efficiency of the siRNAs at the mRNA level I determined whether the siRNAs 
reduced the endogenous TUTase mRNA levels by RT-PCR.  I assessed the 
knockdown at the RNA level using 7SK snRNA as a loading control (Figure 22A).  In 
addtion, I assessed the degree of knockdown at the protein level by coexpressing 
myc-tagged TUTases and found that the siRNAs efficiently depleted the 
exogenously expressed TUTase-1, -3, and -5 (Figure 22B) by Western blotting.  
Knocking down the U6 TUTase was lethal as previously reported (Trippe et al., 
2006).  Of the remaining six TUTases, knocking down two (TUTase-1 and TUTase-
3) reduced the rate of histone mRNA degradation after HU treatment (Figure 23A 
and 23B).  Knocking down the other four enzymes, TUTases 2, 4, 5 and 7 (Figure 
23A and 23B) had no effect on histone mRNA degradation.   
 Since histone mRNAs are degraded in the cytoplasm, I determined the 
subcellular localization of the TUTases-1 and -3 by transiently transfecting HeLa 
cells with various doses of myc-tagged plasmids encoding these proteins followed 
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by confocal immunofluorescence.  TUTase-1 is exclusively cytoplasmic, while 
TUTase-3 is predominantly cytoplasmic but is also present in the nucleus in some 
cells (Figure 24). The localization is consistent with a role for these enzymes in 
histone mRNA degradation.  
 Note that the TRAMP complex that adds adenosines to nuclear RNAs to 
prime their degradation are in this same family of enzymes (Rissland et al., 2007; 
Vanacova et al., 2005).  I could not definitively determine which of the human family 
members correspond to the Trf4/5 enzyme.  However, since Trf4/Trf5 strictly 
nuclear, it is very unlikely that TUTase-1 or TUTase-3 are responsible for this 
activity.   A more comprehensive evaluation of the evolution of eukaryotic TUTases 
is included in Chapter 5.    
Preliminary biochemical characterization of TUTase-3 expressed in human 
293T cells 
 I chose to focus on the initial biochemical characterization of TUTase-3 for 
reasons mentioned in the Discussion section.  Baculoviral expression in Sf9 cells of 
histidine-tagged versions of a number of different TUTases was repeatedly 
unsuccessful and I could never observed detectable amounts of viral production or 
protein expression.  For this reason I attempted to purify FLAG-tagged versions from 
human cells.  Exogenously expressed FLAG-tagged TUTase-3 was purified from 
293T cells and the eluted fractions analyzed by Western blot and silver staining 
(Figure 25A and 25B).  A FLAG-tagged version of TUTase-7 was purified as a 
control.   The Western blot analysis shown in Figure 25A demonstrates that I could 
purify detectible amounts of both TUTase-3 and TUTase-7.    
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 In order to determine the quality of the purification I ran a duplicate gel and 
protein bands visualized by silver stain (Figure 25B).  A number of protein bands 
were observed and another duplicate gel ran and sent to the UNC Michael Hooker-
Duke Proteomics Facility for protein identification (see Materials and Methods).   The 
results from these experiments confirmed the identity of both TUTase-3 and 
TUTase-7 and identified some common copurifying contaminants (Hsp70 and two 
different forms of tubulin).  The TUTase-3 purification identified two potentially 
significant copurifying proteins:  protein arginine methyltransferase-5 (PRMT-5) and 
methylosome protein variant 50.    
 Next, I wanted to determine if TUTase-3 had any detectible oligo(U)/poly(U) 
activity in vitro.   I performed an in vitro polyuridylation assay (Kwak and Wickens, 
2007) using the two protein fractions from TUTase-3 at increasing concentrations.  A 
schematic of this assay is outlined in Figure 25C.  I used a recombinantly purified 
version of S. pombe Cid1 expressed in E. coli as a positive control and the 
incubation in the absence of protein served as a negative control.  Figure 25C, lane 
2 clearly demonstrates the ability of SpCid1 to efficiently and nonspecifically extend 
a histone 3’ end RNA substrate.   The TUTase-3 fraction did not exhibit nearly as 
robust extension as the positive control, however upon increasing concentrations 
TUTase-3-dependent UTP incorporation is clearly present (Figure 25D, compare 
lanes 3 and 4, compare lanes 5, 6 and 7).   These data supply preliminary evidence 
supporting the ability of TUTase-3 to add uridine residues in vitro to the 3’ end of a 
histone RNA substrate.    
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DISCUSSION 
 Histone mRNAs are degraded by both the 5’-3’ decay machinery and the 
cytoplasmic exosome.  In this chapter I have presented data that corroborate the 
evidence provided by the cRT-PCR experiments (Chapter 2), that histone mRNAs 
acquire oligo(U) tails when histone mRNAs are degraded.  The acquisition of the 
oligo(U) tails occurs both when DNA synthesis is inhibited as well as when cells are 
normally exiting S phase of the cell cycle.   
Model of histone mRNA degradation 
 Histone mRNA degradation in the cytoplasm is triggered by inhibition of DNA 
replication in the nucleus and when cells complete DNA replicaton. Previous work 
together with these results, allow me to propose an updated model for histone 
mRNA degradation (Figure 26).  The stemloop is the cis element responsible for 
histone mRNA degradation.  It must be located an appropriate distance from the 
termination codon and requires ongoing translation (Graves et al., 1987; Kaygun and 
Marzluff, 2005b).  The lab has postulated that inefficient translation termination is the 
critical event for triggering histone mRNA degradation (Kaygun and Marzluff, 2005b), 
as is the case for NMD in yeast (Amrani et al., 2004).  Histone mRNA degradation 
requires Upf1 which interacts with SLBP at the 3’ end of histone mRNA after 
treatment with HU (Kaygun and Marzluff, 2005a).  I postulate that the recruitment of 
Upf1 results in the recruitment of the appropriate TUTase and oligouridylation of 
histone mRNA.  Lsm1-7 then binds to the oligo(U) tail (and may be specifically 
recruited by the complex at the 3’ end of the mRNA).  Recent studies by Kiledjian 
and coworkers have shown that Lsm1-7 is the major complex that binds to oligo(U) 
 122 
in HeLa cell lysates (Song and Kiledjian, 2007), consistent with the proposed role of 
Lsm1-7 in histone mRNA degradation. 
 Following oligouridylation it is likely that SLBP is still bound to the histone 
mRNA, since SLBP and Lsm1 coimmunoprecipitate from HU treated cells, although 
the association is sensitive to RNase consistent with the Lsm1 being bound to the 
oligo(U) tail rather than to SLBP.  Once Lsm1-7 is bound, then the decapping 
complex can be recruited and histone mRNA is decapped and degradation initiated 
from the 5’ end. Alternatively the exosome may be recruited and the mRNA 
degraded from the 3’ end. My data strongly suggests that both of these events occur 
on most mRNAs, resulting in simultaneous degradation of the same molecule 5’ to 3’ 
and 3’ to 5’.  I cloned decay intermediates of single molecules by cRT-PCR, and 
obtained histone RNAs that had both their 5’ and 3’ ends shortened, demonstrating 
that individual molecules of histone mRNA are degraded from both the 5’ end and 
the 3’ end (Chapter 2).   
 Initially 3’ to 5’ degradation may be relatively inefficient (possibly because of 
the presence of SLBP bound to the stemloop), and I detect intermediates in which 
degradation has proceeded into the stem, and then the RNA is oligouridylated at that 
site. These molecules likely arise from stalling (and dissociation) of the exosome, 
requiring oligouridylation to reinitiate degradation 3’ to 5’.  
Candidate TUTases for histone mRNA degradation 
 There are a group of genes initially thought to encode poly(A) polymerases 
that were clearly distinct from the canonical poly(A) polymerase that adds poly(A) 
tails to mRNAs. These enzymes, such as Cid1 in S. pombe, were thought to be 
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poly(A) polymerases because they had some homology to the metazoan Gld2 
enzymes, which are responsible for cytoplasmic polyadenylation of mRNA in 
metazoan oocytes (Kwak et al., 2004; Stevenson and Norbury, 2006).  It is now 
clear that at least some of these enzymes are also uridylyl transferases (Kwak and 
Wickens, 2007).  S. cerevisiae lacks any proteins that are similar to Cid1, and has 
two family members, Trf4 and Trf5 which are clearly nuclear while many of the Cid1-
related proteins are cytoplasmic (Stevenson and Norbury, 2006).   
 Hemant Kelkar and I identified 7 human genes that encode putative terminal 
uridylyl transferases (TUTases) based on their homology to the U6 terminal 
transferase and the S. pombe Cid1 enzyme, and the same enzymes were very 
recently identified by Kwak and Wickens (2007).  Knocking down 2 of these 
enzymes, TUTase-1 and TUTase-3, but not the other five (including TUTase-7, the 
Cid1 homolog), resulted in a reduced rate of histone mRNA degradation (Figure 23). 
These two enzymes are cytoplasmic, and I postulate that one or both of them may 
be required for the oligouridylation that initiates histone mRNA degradation. It is 
possible that one enzyme is responsible for the initial terminal addition and the other 
is required for the addition to the partially degraded stem, which may be necessary 
to effectively complete histone mRNA degradation.   
 Benecke and coworkers recently isolated the enzyme that adds oligo(U) tails 
to U6 snRNA, an essential reaction in the maturation of U6 snRNA (Trippe et al., 
2006).  TUTase-1 has been previously implicated as the mitochondrial poly(A) 
polymerase (Nagaike et al., 2005).  However, Norbury and coworkers have shown 
that S. pombe Cid1 can add either uridine or adenosine to RNA in vitro and that the 
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specificity is likely conferred by proteins associated with the TUTase, since Cid1 
complexes immunoprecipitated from cells exclusively add uridine in vitro (Rissland et 
al., 2007).  Thus it is possible that TUTase-1 has multiple functions in the cell.  It is 
also possible our identification of TUTase-1 was a false positive.  For this reason, 
my initial biochemical characterization began with TUTase-3.   
 The potential interaction of TUTase-3 with PRMT5 and the methylosome 
requires additional functional studies.  This possibility is interesting since PRMT5 
and other methyltransferases have been implicated in the maturation of Sm class 
RNPs (Gonsalvez et al., 2007) including the histone-specific U7 snRNP (Azzouz et 
al., 2005b).  The initial in vitro uridylation activity exhibited by TUTase-3 is 
suggestive of its activity in vivo.  However, higher quantities of purified protein must 
be achieved in order to appropriately perform the experiment.  This is complicated 
by the fact that the C-terminal region of all the TUTases is highly unstructured and 
likely underlies the difficulty to achieve satisfactory recombinant expression in both 
E. coli and insect cells.  Additional future work into this technical problem will 
contribute significantly to understanding the biochemisty of these enzymes.   
Is oligouridylation important for other mRNA degradation pathways? 
 While addition of oligo(U) to a specific subset of mRNAs to initiate RNA 
degradation has not been previously reported in eukaryotic cells, there are examples 
of a potential role for oligouridylation in degradation of mRNAs following siRNA 
cleavage, and of terminal addition of nucleotides to prime degradation of RNAs in 
both the eukaryotic nucleus and in prokaryotes.  Shen and Goodman reported that 
following miRNA cleavage of mRNAs in plants, mouse and Epstein-Barr virus, they 
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could detect oligouridylated mRNA fragments corresponding to the 5’ cleavage 
products (Shen and Goodman, 2004). They suggested these were intermediates in 
the degradation of the 5’ mRNA fragments produced by miRNA cleavage. In the alga 
Chlamydomonas reinhardtii, Ibrahim and colleagues suggested the MUT68 protein, 
a poly(A) polymerase (CID12 ortholog in S. pombe) was responsible for 
oligoadenylation of RISC-induced cleavage products (Ibrahim et al., 2006) prior to 
cleavage. There is extensive evidence that degradation of improperly processed 
tRNAs and rRNAs are degraded in the nucleus by addition of oligo(A) by the 
Trf4/Trf5 complex followed by recruitment of the exosome (LaCava et al., 2005; 
Vanacova et al., 2005).  
 Bacterial mRNA degradation is initiated by addition of oligo(A) to the 3’ end of 
the mRNAs by a poly(A) polymerase which is homologous to Trf5. This oligo(A) tail 
can then bind the Hfq protein, a homologue of the eukaryotic Sm proteins (Valentin-
Hansen et al., 2004), and recruit the degradosome, a bacterial homologue of the 
exosome (Blum et al., 1999).  In bacterial mRNA degradation, there is addition of 
oligonucleotides to the 3’ end of the RNA whenever the degradosome pauses or is 
blocked by secondary structure of the mRNA. In bacteria this addition is catalyzed 
by polynucleotide phosphorylase (PNPase), which adds nucleotides non-specifically 
(although A’s predominate since ATP is the most abundant nucleotide) (Mohanty 
and Kushner, 2000). It is thought that the single-stranded tail then serves as a 
platform for the degradosome to reinitiate degradation of the mRNA, and that cycles 
of nucleotide addition followed by exonucleolytic degradation are characteristic of 
bacterial mRNA degradation (Kushner, 2004). Note that I also isolated mRNAs 
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which had oligo(U) tails added to mRNAs that had part of the stem sequence 
removed. It is possible that these result from partial degradation of histone mRNA, 
followed by stalling of the exosome, and then addition of oligo(U) to the degradation 
intermediate, allowing completion of mRNA degradation in a manner similar to that 
found in degradation of bacterial mRNAs. 
Summary 
 The evidence I have presented in this chapter points to oligouridylation as an 
initiating event in histone mRNA degradation.   However, it remains unknown how 
the TUTase(s) are specifically recruited to the 3’ end of histone mRNA.   
Nonetheless, it is an exciting time in RNA biology with the challenges that await the 
field to further our understanding of how terminal uridylyl transferase activity in the 
cytoplasm functions to regulate gene expression.   
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Table 3.  Oligonucleotides used in oligo(dA) RT-PCR detection of 
oligouridylated histone H2A and H3 mRNA.  
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Oligo 
name 
Specific 
Gene 
Target 
Application Sequence (5’ – 3’) 
H2a/a 5’ HIST2H2AA 
(5’ UTR) 
 
 
Oligo (dA) 
RT-PCR 
(1st) 
GACTACTATCGCTGTCATGTCTG 
H3/2a/2c 
5’ 
HIST2H3A 
(5’ UTR) 
HIST2H3C 
(5’ UTR) 
 
Oligo (dA) 
RT-PCR 
(1st) 
GGTAAGCCCTGTGTTTTGGTTCGC 
H3/2d 5’ HIST2H3D 
(5’ UTR) 
 
 
Oligo (dA) 
RT-PCR 
(1st) 
GAGACAGCATGGCCCGTACTAAG 
H2a/a 
O-1 
HIST2H2AA 
(C-term of 
ORF) 
 
 
Oligo (dA) 
RT-PCR 
(2nd) 
GAACTGAACAAGCCTGCTGGGCAAG 
 
H2a/a 
O-2 
HIST2H2AA 
(C-term of 
ORF 
Oligo (dA) 
RT-PCR 
(2nd) 
 
CCTGCAGCTAGCGATCCG 
T7 
oligo(dA) 
N/A 
 
 
Oligo (dA) 
RT 
GTAATACGACTCACTATAGGGAAAAAAAA 
T7 
oligo(dT) 
N/A Oligo (dT) 
RT 
GTAATACGACTCACTATAGGGTTTTTTTTT 
T7 
reverse 
N/A 
 
 
Oligo (dA) 
RT-PCR  
(1st & 2nd) 
GTAATACGACTCACTATAGGG 
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Table 4.  siRNA sequences used to knock down TUTases.   The table below 
details the sequences targeting the open reading frames of the indicated target 
TUTase  mRNA.  All siRNAs were synthesized from Dharmacon with d(T)d(T) ends.   
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Target Sequence Reference 
C2  
 
5’-GGUCCGGCUCCCCCAAAUG-3’  (Wagner and Garcia-
Blanco, 2002) 
TUTase-1  
 
5’-CGAGCACAUUCACUAACAA-3’ This paper 
TUTase-2 5’-CGUUAGUGCUGGUGAUUAA-3’ This paper 
TUTase-3 5’-GGACGACACUUCAAUUAUU-3’ This paper 
TUTase-4 5’-UGAUAGUGCUUCAGGAAUU-3’  This paper 
TUTase-5 5’-CUACGGUACCAAUAAUAAA-3’ This paper 
U6 TUTase 
 
5’-GCAGCCAAUUACUGCCGAA-3’   (Trippe et al., 2006) 
TUTase-7 5’-GAAAAGAGGCACAAGAAAA-3 This paper 
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Table 5.   Oligonucleotides for RT-PCR of endogenous TUTase mRNA.  Sense 
and antisense primers are indicated.  
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Target Oligo sequence 
TUTase-1 sense: 
5’-GAAGATCCTGTCTGTGTTAGGAG-3’, 
antisense:  
5’-GGAAGGTCGATCTGTATCTTCC-3’  
TUTase-2 sense:  
5’-GCAGACTTGTCTAGAGCTGTG-3’, 
antisense: 
5’-CTCGAATCAGCTGAGGTCTCTC-3’ 
TUTase-3 sense: 
5’-GAGTAACAGATGAAGTTGCCAC-3’), 
antisense:  
5’-GTTTGAGTTGTACCTTGGAAGC-3’ 
TUTase-4 sense:  
5’-GGCAACCAGTTTACAGGCAATAGC-
3’ 
antisense:  
5’-CGTCCGATACGTCTTCAATTCC-3’ 
TUTase-5 sense:  
5’-GGTCCTATCCAAACAGAGACG-3’ 
antisense:  
5’-GTTCCTTCTACACCAGCTTGTC-3’ 
TUTase-7 sense:  
5’-GGTTATAGGTGGCAAGACACAAG-3’ 
antisense:  
5’-CAGCCTCTGTTCCAAGTTCTC-3’ 
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Figure 19. Detection of oligouridylated histone mRNAs after inhibition of DNA 
synthesis. (A) RT-PCR strategy to detect oligo(U)-containing histone mRNA 
molecules. Total RNA from HeLa cells was primed for cDNA synthesis using an 
oligo(dA) primer fused to a T7 sequence. Two rounds of PCR (30 cycles each) were 
performed using oligos targeting the 5’ UTR (1st round) or the ORF (2nd round) and a 
primer complementary to the T7 sequence. (B) Oligo(dA) RT-PCR from 
HIST2H2AA, HIST2H3A/C and HIST2H3D treated with HU for 0, 15, 30 and 60 
minutes. The products were resolved by agarose gel electrophoresis and detected 
by ethidium bromide staining. * indicates a non-specific band. (C) Sequences from 
cloned oligo(dA) RT-PCR reactions from the HIST2H3D mRNA when treated with 
HU for 15 minutes.  The number in parentheses at the 3’ end of each sequence 
represents the number of clones observed.  (D) HIST2H2AA clones from nested 
oligo(dA) RT-PCR reactions. 2 µl of PCR product (0 minutes HU, 15 minutes HU) 
from the second round of PCR (+Taq) were TA cloned, transformed and plated onto 
kanamycin-containing LB agar plates.   
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 Figure 20. Oligo(dT) RT-PCR controls. (A)  Positive control for oligo(dT) RT-PCR. 
Knockdown of SLBP results in polyadenylated HIST2H2AA mRNA due to 
misprocessing of the pre-mRNA. Total RNA was subjected to oligo(dT) cellulose 
selection and 500 ng of the elution was random primed for reverse transcription. 2 µl 
of RT reaction was used for PCR similarly as in Figure 19. (B) Oligo(dT) control for 
HIST2H2AA mRNA from cells treated with hydroxyurea. Total RNA from the 
experiments performed in Figure 19 were random primed and subjected to MMLV 
reverse transcriptase.  PCR was performed identically to that in Figure 19 to detect 
HIST2H2AA mRNA.  The 110 bp product is too small to be HIST2H2AA mRNA and 
does not change in response to HU treatment. 
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Figure 21. Detection of oligouridylated histone mRNAs at the end of S phase.   
(A) HeLa cells were synchronized by double thymidine block (DTB) and released 
into S phase and protein samples collected at the indicated times. Western blot 
analysis of SLBP and cyclin A was performed.  (B) Total RNA was isolated from the 
same cells as in (A) and H2a mRNA and 7SK RNA levels measured by Northern 
blotting. (C) Oligo(dA) RT-PCR on total RNA from the middle and end of S phase 
into G2 phase of the cell cycle.  Total RNA from the indicated time points following 
release from DTB was subjected to the RT-PCR strategy depicted in (Figure 19A) to 
detect HIST2H2AA and HIST2H3D mRNA and resolved on a 2.0% agarose gel. HU 
was added at 3 hours for 15 minutes in lane 3 as a positive control for the oligo(dA) 
RT-PCR.  (D) The oligo(dA) primed RT-PCR products from the 5.5 and 6.0 hour time 
points were cloned and a number of clones from the HIST2H2AA and HIST2H3D 
mRNAs were cloned and sequenced.   
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Figure 22.  RNAi to 6 of 7 putative TUTases present in the human genome is 
effective both at the mRNA and protein level.  (A) The 7 TUTases were knocked 
down using specific siRNAs as in the experiments described in Chapter 2.  
Endogenous TUTase mRNA levels were measured by RT-PCR.  2 µg of total RNA 
was random primed and subjected to MMLV reverse transcriptase followed by PCR.  
The degree of knockdown, relative to 7SK RNA as a control, estimated by 
ImageQuant software is indicated.  (B) A representative experiment to determine the 
efficacy of TUTase-1, -3, and -5 siRNAs to knock down an exogenously expressed 
version of each TUTase.  Myc epitope-tagged TUTases were cloned and transfected 
at the time of the second hit of siRNA (Materials and Methods). Protein lysates were 
harvested 48 hours following the second hit and probed by Western using an anti-
myc antibody. Upf1 was used as a loading control.   Note:  The missing TUTase is 
the U6 snRNA TUTase.   As previously reported, treatment of cells with siRNA to U6 
TUTase is lethal to human cells (Trippe et al., 2006). 
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Figure 23. RNAi screen to seven TUTases present in the human genome 
identifies two putative TUTase involved in histone mRNA degradation.  (A) 
Knockdown of TUTases-1 and -3 stabilizes histone H2a degradation following 
inhibition of DNA synthesis by HU. A representative experiment demonstrating the 
effect on histone mRNA degradation when TUTase-1 and TUTase-3 are knocked 
down.  2 µg of total cell RNA from cells treated with 5 mM HU was resolved by urea 
acrylamide gel electrophoresis and analyzed with a mixture of histone H2a mRNA 
and 7SK snRNA probes.  The Western blot in Figure 22B demonstrating the efficacy 
of the siRNAs at the protein level is paired with this experiment.  (B) The rate of 
degradation of histone mRNA in 3 independent experiments where the different 
TUTases were knocked down. Lsm1 was included as a positive control.  Standard 
deviations are represented by vertical bars. The U6 TUTase is essential for cell 
viability and the effect on histone mRNA degradation could not be determined (see 
text for details).  
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Figure 24.  TUTase-1 and TUTase-3 are predominantly localized to the 
cytoplasm of HeLa cells.  TUTase-1 and -3 are localized predominantly in the 
cytoplasm of HeLa cells. Cells were transfected with myc-tagged clones of TUTase-
1 or TUTase-3 and the tagged proteins detected by immunofluorescence (red) 48 
hours following transfection using an anti-myc antibody.  
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Figure 25.  Biochemical characterization of TUTase-3.   (A) FLAG-tagged 
versions of TUTase-3 and TUTase-7 were batch purified from 293T cells.  Indicated 
percentages of total protein lysate are indicated.  8% of the total elution volume is 
present in lanes 5-8.   12% SDS-polyacrylamide gels were run, transferred, and the 
membrane probed for FLAG-tagged TUTases using an anti-M2-FLAG monoclonal 
antibody.  (B) Silver stain of fraction 2 from (A) and protein identification carried out 
by mass spectrometry (see Materials and Methods).  (C) Schematic of in vitro 
oligo/polyuridylation assay to assess TUTase-3 activity.  (D) TUTase-3 shows 
oligouridylation activity in vitro.  Increasing concentrations of TUTase-3 protein 
fractions from (A) were used in the in vitro assay (lanes 3-7).  Lane 1 has no protein 
added and lane 2 contains 200 ng of recombinantly expressed S. pombe Cid1 as a 
positive control.  The arrow indicates increasing incorporation of UTP with increasing 
concentrations of TUTase-3.  
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Figure 26.  Current model of histone mRNA degradation.  
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CHAPTER 4 
EXPRESSION OF STEMLOOP BINDING PROTEIN (SLBP) IS CRITICAL FOR 
PROPER METABOLISM OF HISTONE mRNA, INCLUDING PROPER HISTONE 
mRNA TURNOVER 
 
INTRODUCTION 
 The replication-dependent histone mRNAs are the only eukaryotic cellular 
mRNAs that are not polyadenylated, ending instead in a conserved stemloop 
(Marzluff, 2005).  These mRNAs lack any introns and undergo a single processing 
reaction cleaving the nascent pre-mRNA from the DNA template. The cleavage 
reaction requires the stemloop (SL) 5’ of the cleavage site and a purine-rich region, 
the histone downstream element (HDE) located about 10 nts 3’ of the cleavage site 
(Marzluff and Duronio, 2002).  The HDE basepairs to a small nuclear RNA termed 
the U7snRNA, which is a component of the ribonucleoparticle the U7snRNP (Mowry 
et al., 1989; Mowry and Steitz, 1987).  The stem loop binding protein (SLBP) binds 
to the SL and helps stabilize the interaction of U7 snRNP with the pre-mRNA.  
Several lines of evidence support this model.  First, pulldown of biotinylated histone 
pre-mRNA from nuclear extracts results in the concomitant pulldown of the 
U7snRNA (Dominski et al., 1995).  The U7snRNA fails to come down with histone 
pre-mRNA if SLBP is immunodepleted from the extract.  Second, in vitro processing 
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of histone pre-mRNA is absolutely dependent on SLBP if the HDE is weakened in its 
capacity to basepair to U7 snRNA (Dominski et al., 1999).  If the HDE can basepair 
strongly with the U7snRNA, the need of SLBP for the cleavage reaction is abrogated 
resulting in SLBP-independent processing of the pre-mRNA (Dominski et al., 2001; 
Dominski et al., 1999; Scharl and Steitz, 1994).  Finally, a presumed bridging factor 
has been identified (ZFP100) that interacts with both the SLBP/SL complex as well 
as the U7snRNP specific Sm-like protein, Lsm11 (Azzouz et al., 2005a; Dominski et 
al., 2002; Wagner et al., 2006).   
 The requirement of SLBP for in vitro processing of histone pre-mRNA is not 
absolute, but rather conditional.  Extracts depleted of SLBP are incapable of 
processing the H1t histone pre-mRNA but are fully competent to process the H2A-
614 histone pre-mRNA (Dominski et al., 2001).  The differences between these two 
substrates lie in the ability of the U7 snRNP to basepair to the HDE.  H2A-614 can 
form several more hydrogen bonds with the U7 snRNA than H1t, thus a substrate 
with a high affinity for the U7 snRNP does not require SLBP for processing. The 
major evidence in support of a role for SLBP in processing in vivo is from studies in 
Drosophila.  It has been found that flies that are hypomorphic or null for SLBP have 
significant (although not exclusive) misprocessing of endogenous histone pre-mRNA 
(Lanzotti et al., 2002) and RNAi-mediated knockdown of SLBP in S2 cells 
phenocopies this misprocessing (Wagner et al., 2007). In these flies, the normal 
cleavage site is not recognized and the polymerase transcribes down to cryptic 
cleavage and polyadenylation sites resulting in the formation of polyadenylated 
histone mRNA (Lanzotti et al., 2002).   Flies that are null for the U7snRNA gene 
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contain exclusively polyadenylated histone mRNA (Godfrey et al., 2006).  
Surprisingly, these flies are viable but males and females are sterile.  The former 
result suggests the presence of a poly(A) tail on histone mRNA is permissive for fly 
development but may be toxic for proper spermatogenesis and oogenesis.  The 
cause of this toxicity is not known. 
 Once the U7snRNP is bound to the HDE, a cleavage factor is recruited 
containing at least CPSF73, CPSF100, and Symplekin (Dominski et al., 2005a; 
Kolev and Steitz, 2005).  CPSF73 is the endonuclease that cleaves the histone pre-
mRNA from the DNA template (Dominski et al., 2005a).  Other CPSFs and CstFs 
are not required for histone pre-mRNA processing although biochemical data 
suggests that they might be associated with the cleavage factor (Kolev and Steitz, 
2005).  Regardless, the molecular interactions between the cleavage factor and the 
U7snRNP/SLBP/SL complex have not been elucidated. 
 The molecular events that follow processing in the nucleus and are prior to 
the translation of histone mRNA in the cytoplasm are less understood.  What is clear 
is that the histone mRNA is rapidly exported and this export in S2 cells is dependent 
on the expression of Nxf1, which is the fly homolog of the RNA export factor TAP 
(Erkmann et al., 2005a).  Early in S phase, SLBP localization is strictly nuclear, 
presumably participating in the processing reaction at the Cajal Body (Marzluff and 
Duronio, 2002) although discrete localization of SLBP at the Cajal Body has not 
been observed.  As S phase progresses, SLBP begins to accumulate in the 
cytoplasm and is present along with histone mRNA in the large polyribosome 
fraction on glycerol gradients (Whitfield et al., 2004).  The correlation of SLBP and 
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histone mRNA localization on polysomes is likely a functional interaction as the 
treatment of HeLa cells with cycloheximde results in an increase in SLBP on 
polyribosomes and a decrease in the nucleus (Whitfield et al., 2004).  Inhibition of 
DNA replication with HU results in a rapid degradation of histone mRNA and rapid 
relocalization of SLBP to the nucleus (Whitfield et al., 2004). Furthermore, SLBP 
interacts with a novel protein called SLIP1, which interacts with eIF4G and plays a 
role in translating histone mRNA and possibly other cellular mRNAs (Cakmakci et 
al., 2008).  In Xenopus oocytes, the expression of SLBP protein stimulates the 
translation of luciferase reporter genes ending in a stemloop (Sanchez and Marzluff, 
2002).  These data are all consistent with a role of SLBP in the translation of histone 
mRNA.   
  In late S phase, as DNA replication is concluding, the levels of histone mRNA 
are downregulated as are thelevels of SLBP protein.  This reduction in histone 
message is a result of rapid decay of the existing histone mRNA pool in the 
cytoplasm, reduced transcription of the histone genes, and the reduced processing 
efficiency of the histone pre-mRNA, and the (Chapter 1).  The reduced transcription 
of histone genes is likely a consequence of reduced CyclinE-cdk2 activity on the 
histone transcription factor NPAT, whose localization to histone genes is dependent 
on its phosphorylation status (Ma et al., 2000).  Reduced processing efficiency seen 
in very late S phase or G2 phase is due to a reduced level of SLBP as G2 nuclear 
extracts, which are unable to process a histone pre-mRNA in vitro, can be restored 
to full processing activity by supplementation with recombinant SLBP (Dominski et 
al., 1999).   
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 The rapid decay of existing histone mRNA is executed through a surprising 
mechanism that I described in Chapters 2 and 3 (Mullen and Marzluff, 2008).  In late 
S phase, histone mRNA is oliguridylated at the 3’ end resulting in a histone mRNA 
containing 8-15 uridines.  It is not clear if SLBP is required for this reaction.  SLBP is 
known to be destroyed in late S phase through phosphorylation of two threonine 
residues and mutation of these residues to alanines results in robust expression 
throughout the end of S phase as well as G2 phase (Zheng et al., 2003).  
Surprisingly, in the presence of this stable mutant SLBP, histone mRNA is still 
degraded appropriately and with similar kinetics consistent with SLBP being required 
for histone mRNA degradation.   
 In order to understand the critical roles of SLBP in cells, Kelly Sullivan, Eric 
Wager and myself knocked down SLBP using RNA interference in U2OS cells.  
Previously, Eric Wagner and the Müller lab had shown independently that this 
treatment in HeLa cells results in a reduction in the rate of cell growth and an 
accumulation of cells in S-phase (Wagner et al., 2005; Zhao et al., 2004).  However, 
a thorough molecular analysis of the histone mRNA has not been done.  Here I 
present data from Kelly, Eric and myself that show the major lesion in histone mRNA 
metabolism as a result of knocking down SLBP is not in histone pre-mRNA 
processing, but in the export of histone mRNA to the cytoplasm.  Loss of SLBP 
results in a reduction in the amount of histone protein synthesis, and hence 
chromatin assembly, which leads to a decreased rate of DNA replication and 
activation of an S-phase cell cycle checkpoint response.  Over the course of SLBP 
knockdown there is a reduction in the histone:DNA ratio in the cells.  The rapid 
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alteration of histone mRNA half-life in response to hydroxyurea is also impaired in 
SLBP knockdown cells since the normal site of histone mRNA degradation is the 
cytoplasm.  Together these results implicate SLBP as having a critical histone 
mRNA export function necessary for proper histone gene expression and cell 
division.   
 
MATERIALS AND METHODS 
RNA interference   
 RNAi was performed using a two-hit method as previously described using 
Lipofectamine 2000 (Invitrogen) (Mullen and Marzluff, 2008; Wagner and Garcia-
Blanco, 2002).  Briefly, 110,000 U2OS or 95,000 HeLa cells were plated into 24 well 
plates and the following day, siRNAs were transfected into cells.  A day following the 
first hit of siRNA, cells were replated into 6 well dishes, allowed to grow an additional 
day and then transfected with the second hit of siRNA.  Cells were harvested 48-72 
hours following the second hit for analysis.  The siRNA sequences of the C2 
(control) and S2 (SLBP) were the same as previously described (Wagner et al., 
2005). 
DNA synthesis and mitotic index measurements by FACS 
 I quantified the percentage of bromodeoxyuridine (BrdU) labeled cells in S 
phase and phospho-histone H3 in mitosis as previously described (Doherty et al., 
2003).  The HU controls for these assays were done by incubating cells in a final 
concentration of 5 mM HU for 1 hour.  To measure DNA synthesis in S phase, RNAi-
treated cells were pulsed with a 1 mM stock solution of BrdU (10 µM final 
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concentration) for 1 hour.  Cells were harvested with trypsin and spun down at 1,400 
rpm for 5 min. at room temperature.  The supernatant was removed and the cell 
pellet was resuspended in 1.5 ml cold PBS with vortexing.  The resuspended cell 
pellet was then fixed by adding 3 ml of cold 100% ethanol.  Cells were pelleted 
briefly by centrifuging at 1000 rpm for 5 min. in the cold room.  The supernatant was 
aspirated and the cell pellet was incubated with 3 ml of 0.08% pepsin in 0.1 N HCl 
and incubated at 37°C for 20 min.  Pelleted nuclei were suspended in 1.5 ml of 2 N 
HCl and incubated at 37°C for 20 min. Next, 3 ml of 0.1 M sodium borate was added 
to neutralize the pH and the nuclei pelleted.  Nuclei were washed with 2 ml of IFA 
(10 mM HEPES pH 7.4, 150 mM NaCl, 4% FBS, 0.1% NaN3) plus 0.5% Tween-20 
and incubated in the dark, on ice for 30 minutes and then pelleted. Nuclei were 
resuspended with 100 µl of a solution containing α-BrdU antibody conjugated to 
FITC (Becton Dickinson) diluted 1:5 in IFA plus 0.5% Tween-20 and incubated in the 
dark, at room temperature for 2 hours.   Following the incubation, 2 ml of IFA plus 
0.5% Tween-20 was added and nuclei pelleted.  Nuclei were resuspended with 500 
µl of the IFA plus 0.5% Tween solution containing 5 µg/ml RNase A and 50 µg/ml 
propidium iodide.  Nuclei were incubated overnight at 4°C and analyzed on a 
Becton-Dickinson (Becton Dickinson) FACScan using Summit Software (Dako 
Cytomation).  
 To measure mitotic index by phospho-histone H3, RNAi treated cells were 
harvested as above and fixed with 1% formaldehyde in PBS for 30 minutes.  Fixed 
cells were pelleted at 1200 rpm for 5 minutes at 4°C and the supernatant removed.  
Cells were resuspended in 1.5 ml PBS and then 3 ml of cold 100% ethanol was 
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added and cells stored at 4°C overnight.  The fixed cells were pelleted by 
centrifugation at 1,200 rpm for 5 min. at 4°C.  The supernatant was removed and cell 
pellets washed with 2 ml IFA plus 0.5% Tween and then centrifuged.  Washed cells 
were resuspended in 100 µl of a solution containing 0.5 µg of phospho-histone H3 
(serine 10) antibody (Upstate Biotechnology) and 5 µg/ml RNase A in IFA plus 0.5% 
Tween-20 for 2 hours at room temperature.  Following the incubation 2 ml of IFA 
plus 0.5% Tween-20 was added, the cells centrifuged, and the supernatant 
removed. The cell pellet was resuspended in 100 µl of the IFA plus 0.5% Tween-20 
solution containing an anti-rabbit secondary antibody conjugated to FITC (Santa 
Cruz Biotechnology) for 1 hour at room temperature.  Following the incubation, 2 ml 
of IFA plus 0.5% Tween-20 was added and the cells centrifuged.  The secondary 
antibody was removed and the cell pellet resuspended in 500 µl of the IFA plus 0.5% 
Tween solution containing 5 µg/ml RNase A and 50 µg/ml propidium iodide.  Cells 
were analyzed by FACS as above.   
Northern blot analysis and S1 nuclease protection assays  
 Northern blot analysis to replication-dependent histone genes and 7SK 
snRNA was performed as described previously (Mullen and Marzluff, 2008).  Briefly, 
2 µg of total RNA was run on 6% urea-polyacrylamide gels, transferred to Hybond 
N+ nitrocellulose (Amersham Biosciences), and probed in QuickHyb (Stratagene) 
overnight at 60°C.  Probes were generated by random primed, α32P-dCTP labeling 
(PrimeIt II Kit, Stratagene) of PCR products generated to the ORF of cloned histone 
genes.  
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 S1 nuclease protection assays to map the 3’ ends of histone H2A 
(HIST2H2AA) and H3 (HIST2H3A/C) were performed as previously described 
(Kaygun and Marzluff, 2005a).  Briefly, 5-20 µg of total RNA was hybridized to 3’ 
end-labeled probes at 56°C overnight and then digested with S1 nuclease 
(Promega) at room temperate for 60 minutes.  H2A probes for 3’ end labeling were 
generated by AscI (New England BioLabs) restriction enzyme digestion of a cloned 
HIST2H2AA plasmid and probes for H3 were generated by BssHI (New England 
BioLabs) restriction enzyme digestion of a cloned HISTH3A/C plasmid.  Digested 
plasmid DNA was 3’ end labeled with α32P-dCTP and Klenow (New England 
BioLabs) as previously described.  Protected fragments were resolved on 6% urea-
polyacrylamide gels.   
Western blot analysis 
 Protein lysates from RNAi treated cells were harvested and the 
concentrations quantified using Bradford reagent (BioRad).  Primary antibodies used 
in this study include SLBP anti-rabbit, symplekin anti-rabbit (BD Biosciences), 
fibrillarin anti-mouse (Abcam), Hsp90 anti-mouse (Cell Signaling Technology), 
histone H3 anti- (Abcam).   
 Labeling and acid extraction of RNAi-treated cells 
 Pulse labeling experiments were performed as previously described (Whitfield 
et al., 2000).  Breifly, cells were starved for 45 minutes in media lacking methionine 
prior to being pulsed for 15 min. in media supplemented with 35S methionine.  Cells 
were washed in PBS, collected by scraping and pelleted by centrifugation.  Pellets 
were resuspended  in nuclear isolation buffer (250 mM sucrose, 1 mM CaCl2, 2 mM 
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MgCl2,  1% Triton X-100, 10 mM Tris pH 8.0, 2 mM PMSF) and lysed on ice for 1 
hour.  Nuclear pellets were acid extracted with HCl for 30 min. Proteins were TCA 
precipitated overnight at -20° C, washed in acetone, and resuspended in SDS 
loading buffer.  Protiens were resolved on a 15% polyacrylamide gel and relative 
histone amounts were quantified by PhosphorIMage analysis (GE Healthcare) and 
ImageQuant software. 
Cell fractionation 
 HeLa cells were fractionated as previously described (Lerner and Nicchitta, 
2006; Lerner et al., 2003) and RNA isolated by Trizol reagent (Invitrogen).   
Histone mRNA degradation 
 HeLa cells were treated with a final concentration of 5 mM hydroxyurea for 
various times as described previously (Kaygun and Marzluff, 2005a; Mullen and 
Marzluff, 2008).  Total RNA from samples were isolated using Trizol reagent 
(Invitrogen).  We used PhosphorImager (GE Healthcare) analysis to calculate the 
percent of histone H2a mRNA remaining following HU treatment. H2a mRNA levels 
were normalized to levels of the 7SK snRNA loading control.   
In Situ hybridization 
 In situ hybridizations were performed similarly as described (Erkmann et al., 
2005a).  RNAi treated cells were grown on coverslips and washed with PBS and 
fixed in 3.7% PFA in PBS for 10 minutes at room temperature.  Cells were then 
washed again and permeabilized in 0.5% Triton X-100 in PBS.  Pre-hybridization 
was performed for 10 minutes at 37°C using a solution of 4x SSC and 50% 
formamide pre-heated to 37°C.  Cover slips were inverted onto a 5-10 µl drop of 
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hybridization solution (50% deionixed formamide, 10% dextran sulfate, 1x 
Denhardt’s solution, 4x SSC, 1 mg/ml E. coli tRNA) containing 1 ng/µl DIG labeled 
H2A or H3 probe.  Probes were denatured for 5 min. at 80ºC and cooled on ice prior 
to addition to hybridization solution.  Hybridizations were performed overnight at 
37ºC in a humidified chamber.  Cells were washed once with 2X SSC at 37 ºC, 3X 
60% formamide in 0.2x SSC at 37ºC, 2X SSC at room temperature, and three times 
with 0.5% Tween-20 in 4X SSC.  Coverslips were inverted onto 8 µl drops of 0.5% 
Tween-20 in 4X SSC containing mouse Cy3 α-DIG antibody diluted 1:200 and 
incubated at 37ºC for 1 hour in a humidified chamber.  Coverslips were washed 3X 
with 0.5% Tween-20 in 4X SSC and inverted onto 8 µl drops of with 0.5% Tween-20 
in 4X SSC  containing Cy-3 α-mouse secondary antibody diluted 1:200.  Secondary 
incubation was performed for 45 minutes at 37ºC in a humidified chamber.  
Coverslips were washed 3 times with 0.5% Tween-20 in 4X SSC before being fixed 
with 3.7% PFA in PBS for 5 minutes at room temperature.  After a PBS wash, 
conversplips were DAPI stained and mounted onto slides using Fluorsave reagent 
(Calbiochem).  Images were acquired using a Zeiss LSM 510 confocal microsocope 
and analyzed using ImageJ software. 
 
RESULTS 
SLBP knockdown cells are viable and continue to increase in number but at a 
slower rate than normal   
 SLBP has been shown previously to have roles in a number of different 
processes involved in the metabolism of histone mRNA (Marzluff, 2005; Marzluff and 
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Duronio, 2002).  In the current study, Kelly Sullivan, Eric Wagner and myself set out 
to determine the essential function(s) of SLBP by transiently knocking it down in 
U2OS cells using a double-stranded siRNA that specifically targets SLBP mRNA.   
Kelly and Eric began by performing an RNAi timecourse experiment to gain insight 
determine the length of time following the second hit of siRNA at which we could 
assay cells for histone mRNA metabolic defects, while still maintaining efficient 
SLBP knockdown.  In Figure 27A, Eric Wagner used Western blotting to monitor 
SLBP protein levels over various times throughout the RNAi transfection.  U2OS 
cells were plated in 24 well dishes and the following day, transfected with either 
control (C2) or SLBP (S2) siRNA.  The day after the first transfection (24 hours, 
Figure 27A, lanes 1-3), SLBP protein levels were slightly lower in C2 treated cells 
after 24 hours than in untransfected cells (Figure 27A, compare lanes 1 and 2).  This 
decrease is likely due to the high cell density used to achieve effective transfection.  
The expression of SLBP protein is limited to S-phase while many of the cells are 
confluence-arrested at the 24 hour time point, leaving fewer cells in S-phase.  The 
24 hour time point in Figure 27A represents when we split the cells out of the 24 
wells, and replated them into 6-well tissue culture dishes.  After 48 hours, we 
transfected another dose of siRNA and waited up to 3 days after (120 hours) to 
assay for defects in histone mRNA metabolism.  It is clear that from 72 to 120 hours 
following the initial hit of siRNA, SLBP proteins levels are markedly downregulated 
(Figure 27A, lanes 4-11).   
 As previously shown, knockdown of SLBP to this level results in an increase 
in the number of cells in S-phase (Wagner et al., 2005).  Kelly Sullivan next wanted 
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to determine the cell number during each of these conditions since it appeared that 
SLBP knockdown cells were not growing as well as the C2 control cells.  Cell 
number was determined using a hemacytometer following trypsinization and viability 
assessed by Trypan Blue staining.  Figure 27B is a graphical representation of the 
total number of cells in the SLBP knockdown wells compared to the C2 negative 
controls.  Although the cells remained viable and continued to increase in number, 
they did so at a slower rate than normal.   It is apparent from this data there are 30-
40% fewer cells in the SLBP (S2) knockdown population due to their slower rate of 
growth.   
Reducing the levels of SLBP decreases the rate of DNA synthesis and 
activates an S-phase cell cycle checkpoint 
  
 Since SLBP knockdown cells did not appear to be growing as well as control 
cells, and since Eric had previously shown there was an accumulation of SLBP 
knockdown cells in S phase, I sought to determine the biological mechanism 
responsible for these preliminary phenotypes.  To assess the ability of SLBP 
knockdown cells to synthesize DNA, I pulsed U2OS cells that had been transfected 
with control (C2) or SLBP (S2) siRNA with bromodeoxyuridine (BrdU), a thymidine 
analog, for 30 minutes and analyzed incorporation by FACS.  As a control I treated 
cells transfected with C2 (control) siRNA with 5 mM hydroxyurea (HU) for 1 hour to 
block DNA replication.  The DNA content as measured by propidium iodide staining 
revealed what Eric had observed previously that SLBP knockdown cells 
accumulated in S-phase of the cell cycle (Figure 28A, top panel).  From the FACS 
analysis of BrdU-incorporation (Figure 28A, bottom panel), it is clear that SLBP 
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knockdown cells do not incorporate BrdU as much as control cells.  In the control 
RNAi (C2) cells, there is efficient incorporation of BrdU as detected by a FITC-
conjugated antibody to BrdU.  The characteristic arc of BrdU incorporation is present 
in the control cells, with only a small percentage of cells under the arc not 
incorporating BrdU.  In contrast, the SLBP knockdown cells (S2) have a markedly 
lower BrdU-FTIC signal overall and lack the characteristic arc observed in control 
cells (Figure 28A, bottom panel), suggesting to me that their rate of DNA synthesis is 
reduced.  In support of this, a C2 control-treated set of cells treated with HU lacks 
any incorporation of BrdU since DNA synthesis has been inhibited.   
 I also used the BrdU FACS analysis to better quantify the cell cycle phase 
distribution in the SLBP knockdown cells compared to the C2 control (Figure 28B).  I 
quantified the G1 and G2 phases as the populations at 2N and 4N (respectively) that 
do not incorporate BrdU.   I separated S phase into two phases, early and late, by 
quantifying the two populations that represent these points during DNA replication as 
those cells expressing incorporated BrdU.  It is apparent from this representation of 
the data (Figure 28B) that S2 cells accumulate most BrdU in the early part of S 
phase and are having difficulty completing S phase since there are more late S 
phase levels compared to control, while levels of G2 cells are reduced by 40%.   
 The BrdU FACS analysis (Figure 28A and 28B) suggested that cells were not 
synthesizing DNA as efficiently as control cells and that cells were having difficulty 
completing S phase of the cell cycle.  To support these data, I determined the mitotic 
rate of SLBP knockdown cells using an antibody to phosphorylated histone H3 
(serine 10) as a mitotic marker.  Positive cells were measured by FACS and positive 
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cells quantified as a percentage of the control (Figure 28C).  It is clear from the 
mitotic index data that SLBP knockdown cells are going through mitosis at 
approximately half the rate of C2 control cells, consistent with the 50% reduction in 
growth rate.  This reduction is comparable to C2 control cells that were treated with 
HU for 1 hour, further lending support that SLBP knockdown cells are not 
synthesizing DNA efficiently.  
 In order to assess the degree of knockdown in these experiments, I used 
Western blotting of SLBP knockdown lysate and compared it to a serial dilution 
series of the C2 control lysate (Figure 28D).  As can be seen from Figure 28D, the 
level of knockdown of SLBP was greater than 95%.  This level of knockdown using 
the S2 siRNA was typical for experiments carried out 48 to 72 hours following the 
second transfection of siRNA.   
 I next determined whether the reduced rate of DNA replication resulted in 
activation of the S-phase checkpoint, a consequence of defective chromosome 
replication, damaged DNA, and environmental stress (Sancar et al., 2004).  I was 
particularly interested in this since it has been shown previously that overexpression 
of a dominant negative chromatin assembly factor 1 (CAF1) produces a similar DNA 
replication phenotype as knocking down SLBP (Ye et al., 2003a).  I hypothesized 
that reducing the levels of SLBP might ultimately result in impaired histone protein 
biosynthesis and hence mimic the defective chromatin assembly phenotype since 
the chromatin assembly machinery would not have enough histone proteins to 
properly assemble chromatin. 
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 I assessed the phosphorylation of Chk1, a kinase that is activated by the ATR 
kinase when DNA replication stress is sensed in S-phase cells.  As a control, I again 
used C2 control cells treated with HU for 1 hour since HU treatment is known to 
activate the DNA replication checkpoint and result in Chk1 phosphorylation (Sancar 
et al., 2004).  There was increased Chk1 phosphorylation on both serine 345 (S345) 
and serine 317 (S317) in response to SLBP knockdown (Figure 28E).  The levels of 
Chk1 phosphorylation on both of these serine residues was similar to that present in 
the HU-treated C2 siRNA population, supporting the notion that reducing the levels 
of SLBP results in a DNA replication phenotype that is directly sensed by the cell 
cycle checkpoint sensor and effector molecules.  I did not detect phosphorylated 
Chk2 under these conditions using an antibody to threonine 68.   
Histone mRNA levels are reduced in SLBP knockdown cells and the majority 
that remains is properly processed 
 Since SLBP is essential for histone mRNA biosynthesis, I used Northern blots 
to determine histone mRNA levels for all four, core replication-dependent histone 
genes as well as for the linker histone H1 (Figure 29A).  I used radiolabeled probes 
generated by PCR targeting the open reading frame (ORF) to detect histones H2A, 
H2B, H3, H4 and H1 and used 7SK snRNA as a loading control.  The Northern blots 
shown in Figure 29A indicated that the abundance of histone H2A, H2B, H3, and H4 
is reduced only about 50% in the SLBP knockdown cells when compared to the C2 
negative control.  This is consistent with a previous report (Zhao et al., 2004) where 
we observe roughly half (ranging from 37% to 70%) as much histone mRNA in the 
SLBP knockdown cells compared to the control siRNA.  The exception was histone 
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H1 mRNA, where steady state levels appeared to be approximately 10% higher than 
the control.  It was quite surprising that I saw histone mRNA accumulate at all since  
SLBP is required for histone mRNA processing. 
 It was particularly interesting to observe a slower migrating band in the 
histone H4 Northern blot (Figure 29A, fourth panel).  I hypothesized this represented 
misprocessed histone mRNA since the role of SLBP in histone pre-mRNA 
processing has been recently established in flies and human cells (Lanzotti et al., 
2002; Narita et al., 2007).  I therefore performed both S1 nuclease protection assays 
and Northern blots using total cell RNA and oligo(dT) selected total cell RNA, 
respectively.  I was able to detect a small amount of misprocessed histone H2A 
mRNA by S1 nuclease protection assay but not histone H3 (Figure 29B).  Northern 
analysis to histone H4, using oligo(dT) selected RNA, revealed that the slower 
migrating band shown in Figure 29C  was indeed misprocessed, polyadenylated 
histone H4 mRNA.   Despite the observation of some misprocessed histone H3 and 
H2A mRNA, most of the histone mRNA that was present was properly processed. 
Histone protein levels are reduced in SLBP knockdown cells and the normal 
regulation of histone mRNA degradation is impaired.   
 The results from the above experiments were surprising since there existed a 
reasonable amount of properly processed histone mRNA for all the core histone 
genes, including the linker histone H1 gene.  Previous structure-function studies on 
SLBP have shown the protein to possess a critical domain essential for histone 
mRNA translation (Cakmakci et al., 2008; Sanchez and Marzluff, 2002).  Due to the 
modest decrease in properly processed histone mRNA in SLBP knockdown cells, 
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Kelly Sullivan hypothesized that perhaps the translation function of SLBP was more 
important for histone metabolism than its pre-mRNA processing function.  He 
therefore investigated the levels of histone protein in SLBP knockdown cells.  Figure 
30A shows Western blot analysis from whole cell protein lysates.  He performed the 
Western blot with a serial dilution of the control C2 siRNA lysate to estimate 
differences between the control (C2) and SLBP siRNA (S2) treated cells, using 
Symplekin, a scaffold protein involved in 3’ end formation (Kolev and Steitz, 2005), 
as a loading control.  The levels of SLBP were decreased by more than 90% of the 
control C2 lysate (Figure 30A).  When Kelly probed using an anti-histone H3 
antibody, he could see that in the SLBP knockdown cells, total histone H3 was 
reduced by 50-75% relative to the level seen in control treated cells (Figure 30A). 
 To directly test the SLBP knockdown cells’ ability to translate histone mRNA 
Kelly Sullivan next pulse-labeled them by adding 35S-labeled methionine in the 
culture media for 15 minutes as previously described (Cakmakci et al., 2008; 
Whitfield et al., 2000).  Both the Coomassie stain and autoradiograph of this 
experiment are presented in Figure 30B.  The Coomassie stain (Figure 30B, left 
panel) is consistent with a reduction in total protein levels for all four core histones, 
consistent with the previous Western results for histone H3.  The autoradiograph of 
the same experiment (Figure 30B, right panel) further demonstrates that in fact the 
rates of translation for histones H2A and H3 are decreased by approximately 40% in 
the SLBP knockdown cells when compared to control C2 cells.  We concluded that 
the amount of histone mRNA (properly processed or misprocessed) present in the 
SLBP knockdown cells is not enough to meet the histone protein demands of the 
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replicating U2OS cell and, at least in part, contributes to the DNA replication and 
growth defects we observed.   
 Histone mRNA half-life is coordinately regulated with the rate of DNA 
synthesis, whereupon the completion of S phase or inhibition of DNA synthesis 
results in rapid degradation of histone mRNA.  Histone mRNA degradation is a 
regulated process that involves the addition of an oligo(U) tail to the 3’ end in order 
to recruit specific decay factors for rapid, bidirectional decay of the mRNA (Chapters 
2 and 3).  Since reducing SLBP protein levels produced defects in DNA synthesis 
and normal histone gene expression, I asked if downregulation of SLBP had an 
effect on histone mRNA degradation.  I inhibited DNA replication with 5 mM HU in 
both C2 control cells and SLBP knockdown cells for 30 and 60 minutes.  A 
representative Northern blot analysis of histone H2A mRNA is presented in Figure 
30C (left panel) and reveals the rate of histone mRNA degradation is decreased 
when SLBP protein levels are downregulated by siRNA.  7SK snRNA is used as a 
loading control to normalize the percentage of histone H2a mRNA remaining 
following the two time points of HU treatment.  Histone mRNA in the C2 control is 
rapidly degraded at the 30 minute time point and is barely detectible at the 60 minute 
time point (Figure 30C, lanes 2 and 3).  In the SLBP knockdown cells, histone 
mRNA degradation is stabilized roughly 1.6 fold on average at the 30 minute time 
point (Figure 30C, graph on right which represents 3 independent experiments) and 
roughly 2.3 fold at the 60 minute time point (Figure 30C).  Together these data 
support the evidence obtained from examining histone mRNA levels in the SLBP 
knockdown, that the decreased amount of histone mRNA corresponds to a 
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decreased pool of histone protein in the cell.  Moreover, the HU time course 
experiments suggest that SLBP is necessary for histone mRNA degradation and in 
its absence the normal pathway of histone mRNA degradation is impaired.      
In situ hybridization to histone mRNA reveals that histone mRNA is retained in 
the nucleus in SLBP knockdown cells   
 We next wanted to determine the subcellular localization of the properly 
processed histone mRNA in SLBP knockdown cells.  To address this question 
further, Kelly Sullivan performed in situ hybridization on control and SLBP 
knockdown cells with histone H3 mRNA using paraformaldehyde-fixed U2OS cells.  
In untransfected and the control C2 siRNA cells, histone H3 and H2A mRNA 
localization revealed a halo-like appearance in the cytoplasm in both U2OS and 
HeLa cells (respectively), surrounding the perinuclear region of the cell (Figure 32A 
and 32B).  This is consistent with histone mRNA’s presence on the endoplasmic 
reticulum (ER), since S1 nuclease protection assays I performed to histone H2A and 
H3 on RNA from subcellular fractionations, reveals that replication-dependent 
histone mRNAs are exclusively localized to the ER and not in the remaining cytosol 
(Figure 31).  In contrast, when SLBP protein levels are dramatically reduced, in situ 
hybridization to histone H3 mRNA reveals a strong, if not exclusive, localization to 
the nucleus of cells (Figure 32C, bottom panel in red).  This pattern was also 
observed in SLBP knockdown cells when in situ hybridization to histone H2A was 
performed (Figure 32B).  Interestingly the histone mRNA that accumulates in the 
nucleus is properly processed, as the misprocessed RNA which is polyadenylated is 
presumably exported via the conventional poly(A) RNA export pathway.   As a 
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control to demonstrate the specificity of the in situ hybridization probes, Kelly 
synchronized HeLa cells by double-thymidine block and released them into S phase 
for 3 hours.  He added HU for 0, 15, 30 and 60 minutes and harvested cells for in 
situ hybridization.  Figure 32A demonstrates the presence and localization of H2A 
mRNA and its disappearance as time of HU exposure increases.   
 As an alternative approach to confirm the presence of histone mRNA in the 
nucleus, Kelly Sullivan and Eric Wagner fractionated C2 control and S2 knockdown 
cells into nuclear and cytoplasmic fractions.  They harvested protein and total RNA 
from these fractions as well as from a portion of the starting material.  Figure 32D 
presents a Western blot showing relative cellular fractionation.  Hsp90 and fibrillarin 
were used as cytoplasmic and nuclear markers respectively (Figure 32D). 
Consistent with their reported subcellular localization, Kelly and Eric see almost all 
the fibrillarin protein concentrate to the nuclear fraction whereas they see almost 
exclusive cytoplasmic localization of Hsp90 (Figure 32D).   
 Kelly and Eric next analyzed the RNA portions of the fractionation and 
simultaneously probed for histone H3 and U1 snRNA as a control using probes 
generated by PCR (Figure 32E).   Consistent with the nuclear localization of 
splicosomal snRNA, they observed that U1 was concentrated in the nuclear fraction 
of both the C2 control and S2 knockdown (Figure 32E, lanes 2 and 5).  A residual 
amount of U1 was detected in the cytoplasm (Figure 32E, lanes 3 and 6).  Histone 
H3 mRNA was concentrated in the cytoplasm of C2 control cells (Figure 32E, lane 3) 
but its abundance diminished from the cytoplasm when SLBP was knocked down 
(S2, Figure 32E, compare lanes 3 and 6).  Comparison of the ratio of histone H3 in 
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the nucleus and cytoplasm from the C2 and S2 RNAi treatments, reveals it is 
apparent that the ratio of histone H3 mRNA is greater in the nuclear fraction of the 
S2 knockdown when compared to the ratio of the compartments in the C2 control 
cells (Figure 32E).  Sequestration of histone mRNA in the nucleus upon loss of 
SLBP is consistent with the decrease in histone protein synthesis due to decreased 
translation.  Several factors may influence the stability of histone mRNA in SLBP 
knockdown cells; first, translation is required for degradation of the mRNA and 
second, the normal compartment for degradation is the cytoplasm.  
 
DISCUSSION 
 SLBP plays a role in a number of different aspects of histone mRNA 
metabolism (Marzluff and Duronio, 2002).  Null flies for SLBP are embryonic lethal 
and the larva produces only polyadenylated mRNAs (Godfrey et al., 2006) and 
hypomorphic flies produce histone mRNAs that are polyadenylated and not cell 
cycle regulated (Lanzotti et al., 2002).   Evidence from worms and flies suggests 
SLBP expression is necessary for histone gene expression in early embryonic 
development since depletion of SLBP results in chromatin condensation defects in 
these embryos (Pettitt et al., 2002; Sullivan et al., 2001).  Recent evidence from 
human cells has demonstrated that SLBP and the transcription negative elongation 
factor (NELF) function together to properly process replication-dependent histone 
genes in a cotranscriptional manner (Narita et al., 2007).  Additionally, RNAi to SLBP 
results in an S phase and cell growth defect (Wagner et al., 2005; Zhao et al., 2004).  
Moreover, the role of SLBP in translation has been documented (Cakmakci et al., 
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2008; Sanchez and Marzluff, 2002).  Although a number of studies have defined 
distinct roles for SLBP in various aspects of histone mRNA metabolism, no 
comprehensive molecular study in human cells exists.  In this study we used RNAi to 
SLBP to determine the critical function of SLBP in human cells.   I was particularly 
interested in the role of SLBP in histone mRNA degradation.   
 In this chapter, I have presented a number of different findings from our 
studies.  First, SLBP plays a surprisingly minor role in proper histone gene 
expression since reduction of SLBP protein by 98% decreased the amount of total 
histone mRNA in the cell by 50% and results in only a small portion of histone 
mRNA becomes polyadenylated.  Second, histone mRNA translation is reduced in 
SLBP knockdown cells and total histone H3 protein levels in the cells are 
consequently decreased.  Third, since SLBP participates in a number of aspects that 
ensure proper histone gene expression, the biological effect on the DNA synthesis 
machinery results in a cell growth defect that activates an S-phase checkpoint.  
Next, reduced expression of SLBP attenuates the cell’s ability to rapidly degrade 
processed histone mRNA in response to inhibition of DNA synthesis.  Most 
surprisingly, SLBP expression is critical for proper histone mRNA export since 
reducing SLBP protein levels resulted in the aberrant accumulation of histone mRNA 
in the nucleus.  This latter result clearly underlies the aforementioned phenotypes 
we observed and argues that one of the critical functions of SLBP in human cells is 
to accompany histone mRNA to the cytoplasm where its translation and half-life can 
be properly regulated to ensure sufficient histone protein levels are produced for the 
chromatin assembly machinery.   
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Eukaryotic mRNA export is coupled to transcription, pre-mRNA processing 
and 3’ end formation 
 Evidence over the past decade has revealed direct links between the distinct 
processes of gene expression (Maniatis and Reed, 2002).   Together with mRNA 
surveillance systems such as nonsense-mediated decay and the general nuclear 
and cytoplasmic decay pathways (Chapter 1), coupling of even the earliest (e.g. 
transcription and 5’ capping) and latest steps (e.g. mRNA export and translation) in 
gene expression ensures the proper expression of genes (Maquat, 2004; Maquat 
and Carmichael, 2001).  Evidence from the Silver lab has demonstrated that the 
yeast mRNA export hnRNP protein Npl3 (Nab1) and another export factor Yra1 are 
cotranscriptionally recruited to chromatin at early and late steps, respectively, in the 
transcriptional process (Lei et al., 2001).  Other evidence suggests that transcription 
and pre-mRNA splicing are coupled (Ge et al., 1998; Goldstrohm et al., 2001; Lai et 
al., 2001).  Huang and Steitz have described two serine/arginine-rich (SR) splicing 
factors SRp20 and 9G8 that bind a 22 nt sequence element in the ORF of the 
intronless histone H2A gene and are required for proper mRNA export of mRNAs 
containing this conserved sequence (Huang and Steitz, 2001).  SR proteins are 
evolutionarily conserved splicing factors in metazoans that shuttle between the 
nucleus and cytoplasm (Graveley, 2000).  Recent genome-wide evidence from the 
Silver lab has found that both the DNA and RNA surveillance systems are coupled to 
global mRNA export when both nucleic acids are damaged by UV irradiation 
(Casolari et al., 2004; Hieronymus et al., 2004).  The evidence we have gathered by 
reducing the expression of SLBP by RNAi in human cells provides an example of an 
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RNA binding protein involved in both 3’ end processing and translation of histone 
mRNAs that is required for proper mRNA export, likely by coupling 3’ end formation 
with efficient mRNA export.   
Model of SLBP function in histone mRNA metabolism 
 Figure 33 presents a model of SLBP-dependent histone mRNA export.  
Normally, when sufficient levels of SLBP are present in the nucleus, SLBP functions 
first to cotranscriptionally process the 3’ end of histone mRNAs (Narita et al., 2007).  
The SR protein 9G8 and SLBP bound to histone mRNA likely form an mRNP that 
together or independently interact with the mRNA export protein TAP to facilitate 
transit through the nuclear pore complex (Erkmann et al., 2005a; Huang and Steitz, 
2001).  The exported mRNA is initiated for translation in the cytoplasm where 9G8 is 
displaced by the initiating ribosome.   SLBP remains bound to the mRNA, likely to 
regulate efficient translation termination and efficient ribosome recycling (Kaygun 
and Marzluff, 2005b).   When normal histone mRNA is translated and SLBP is 
present, then the rapid alteration of histone mRNA half-life at the end of S phase or 
upon inhibition of DNA synthesis is intact.   
 When the expression of SLBP is reduced to very low levels the remaining 
SLBP must be utilized exclusively for processing.  There is an accumulation of 
misprocessed, polyadenylated histone mRNA that is not cell cycle regulated 
suggesting limited SLBP results in efficient processing (Lanzotti et al., 2002; Narita 
et al., 2007), (Figure 29).  The remaining amount of SLBP (1-4% of control) still 
present within the nucleus provides some pre-mRNA processing function (Dominski 
et al., 2001) or possibly another snRNP (Friend et al., 2007).  We postulate that as a 
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result of the reduced levels of SLBP, SLBP dissociates from the histone mRNA, 
resulting in improper export even though the mRNA accumulates to substantial 
levels.  However, in the absence of wild-type levels of SLBP protein there is an 
insufficient amount of SLBP protein to recruit 9G8 protein binding to the mRNA for 
9G8/SLBP-dependent export.  Alternatively, 9G8 binding may be unimpaired but not 
sufficient for proper histone mRNA export and that the SLBP/TAP interaction is 
additionally required to recruit histone mRNA to the nuclear pore complex and out of 
the cytoplasm.   
The fate of nuclear-retained histone mRNA 
 Reducing the expression of SLBP results in a nuclear-retained histone 
mRNAs (Figure 32).  The nuclear exosome functions to eliminate defective 
noncoding RNAs such as pre-tRNAs, pre-snoRNAs, pre-rRNAs, U6 snRNA, and 5S 
rRNA (Houseley et al., 2006).   The degradation of these RNAs in budding yeast is 
mediated by the TRAMP complex of proteins that function to polyadenylate the 3’ 
end to specifically target their degradation in the nucleus by the exosome (LaCava et 
al., 2005).   The polyadenylation is carried out by the two noncanonical poly(A) 
polymerases, Trf4 and Trf5, found in S. cerevisiae (Houseley et al., 2007; Houseley 
and Tollervey, 2006; LaCava et al., 2005).   
 In this chapter, when SLBP was knocked down the rate of histone mRNA 
degradation in response to HU was reduced (Figure 30).  This data taken together 
with the nuclear localization of histone mRNA under these conditions (Figure 32), 
suggest that histone mRNA is mislocalized and no longer has access to the 
cytoplasmic machinery required to regulate its rapid degradation (Chapter 2).  
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However it is clear that histone mRNA does turnover, just not as rapidly as a control-
treated cell.  The small amount of misprocessed histone mRNA likely is exported to 
the cytoplasm via the poly(A)-dependent export pathway but is not cell cycle 
regulated.  It therefore could be possible that the properly processed, nuclear-
retained histone mRNA is being degraded within the nucleus by the nuclear 
exosome.  These mRNAs would likely be either polyadenylated or polyuridylated to 
direct specific targeting of the histone mRNA for degradation by the exosome.    
Continued investigation into this possibility is required to determine the fate of 
nuclear-retained histone mRNA as well as to the precise machanism that prevents 
histone mRNA from leaving the nucleus in the absence of SLBP.  However, unlike 
defective mRNAs the processed histone mRNA are surprisingly stable in the 
nucleus. 
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Figure 27.  SLBP knockdown cells are viable but grow at a slower rate than 
control cells.  (A) SLBP protein is efficiently knocked down in U2OS cells using a 
double-hit method to deliver siRNA.  U2OS cells were transfected in 24 well dishes 
with siRNAs to either control (C2) or SLBP (S2).  The day following the first 
transfection (24 hours), cells were split into 6 well dishes and transfected with a 
second dose of siRNA (48 hours) and followed for 3 days (72 hours to 120 hours).  
Protein lysates were prepared at each indicated time point to monitor SLBP protein 
levels.  (B) Total cell number of control (C2) and SLBP (S2) RNAi populations.  
siRNAs were delivered to U2OS cells as in (A) and enumerated at the indicated time 
points.     
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Figure 28.  RNAi to SLBP results in cell cycle defects and activation of Chk1 
kinase. (A) The rate of DNA synthesis in SLBP knockdown cells is decreased.  C2 
and S2 treated U2OS cells were grown in a final concentration of 10 µM 
bromodeoxyuridine (BrdU) for 1 hour and harvested for DNA synthesis or mitotic 
index assays.  Hydroxyurea (HU, 5 mM) was added as a control to a parallel culture 
of C2 cells during BrdU incorporation (1 h).  Cells were fixed and BrdU incorporation 
detected with an anti-BrdU antibody conjugated to FITC.  Labeled cells were 
analyzed using a FACScan device and Summit software.  (B) SLBP knockdown cells 
accumulate in S phase.  Cell cycle phase distribution (G1, early and late S phase, 
and G2/M) was quantified from the data in (A), (C2, grey bars; S2, black bars) from 3 
independent experiments.  Quantities are expressed as a percentage of the C2 
control cells.  (C) Mitotic index in SLBP knockdown cells is reduced.  Parallel 
cultures from (A) were fixed, stained with an antibody to the mitotic marker phospho-
histone H3, and the antibody detected with a secondary antibody conjugated to 
FITC.  Cells were analyzed similarly as in (A) and the population of cells with 
fluorescent signal above the G2 population was quantified.  Quantities are 
expressed as a percentage of the C2 control cells.  (D) SLBP protein is markedly 
reduced in U2OS cells.  Western blot analysis on cell lysates from (A) is shown.  A 
serial dilution of the C2 control lysate was performed as indicated and compared to 
the SLBP (S2) protein lysates.  The asterisk indicates a cross reacting band that 
serves as a loading control. (E) SLBP knockdown results in the activation of a Chk1-
dependent cell cycle checkpoint.  Protein lysates from (A) were analyzed for the 
predominant signal transduction pathway that responds to replication stress.  Total 
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Chk1 protein and phospho-specific Chk1 (serines 317 and 345) was analyzed by 
Western blot analysis.  HU was used a positive control for Chk1 activation.   
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Figure 29.  Histone mRNA levels in SLBP knockdown cells are reduced and 
only a small portion of the mRNA is misprocessed and polyadenylated. (A) 
Histone mRNA levels are decreased in S2 treated cells.   Northern blot analysis was 
performed on 2 µg of total RNA from C2 and S2 treated cells.  7SK snRNA is used 
as a loading control.  A slowly migrating product reacting with the histone H4 probe 
is detected.  The percentage of histone mRNA present in the S2 treated cells was 
quantified using PhosphorImager analysis and ImageQuant software and 
normalizing mRNA to the 7SK snRNA levels. (B) S1 nuclease protection assays to 
map the 3’ ends of histone H2A (HIST2H2AA) and histone H3 (HIST2H3A/C).  The 
asterisk (*) on the H2A gel reveals a small amount of polyadenylation.  (C) Oligo(dT) 
selected total RNA reveals histone H4 is polyadenylated in SLBP knockdown cells.  
Northern blot analysis to histone H4 was performed on total RNA and RNA that had 
been oligo(dT) selected.  The asterisk (*) signifies polyadenylation. 
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Figure 30.  Histone protein levels are decreased in SLBP knockdown cells and 
the normal histone mRNA degradation in response to HU is impaired.  (A) Total 
histone H3 protein levels are decreased in SLBP knockdown cells.  A serial dilution 
Western blot analysis of C2 and S2 protein lysates is shown. Antibodies to SLBP 
and histone H3 protein are used and an antibody to Symplekin is used as a loading 
control.  (B) Total histone protein as well as histone mRNA translation is reduced in 
SLBP knockdown cells.    U2OS cells were treated as in (A) but pulse-labeled with 
35S-methionine following growth in media depleted of methionine.   Cells were 
harvested and nuclear pellets acid-extracted and proteins resolved on 15% 
polyacrylamide.  Gels were Coommassie stained (left panel) or 35S detected by 
PhosphorImage analysis (right panel).  The core histone proteins are indicated 
(arrows) and the percent H2A/H3 proteins expressed as a percentage compared to 
the control (C2).  (C) Histone H2A mRNA is not degraded as efficiently in SLBP 
knockdown cells compared to control cells.  HeLa cells were treated with the 
indicated siRNAs and a Northern analysis performed (left panel) with probes to H2A 
mRNA and 7SK snRNA as a loading control.  The right panel represents the results 
from 3 independent experiments.  Standard deviations are represented by vertical 
bars.   
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Figure 31.  Properly processed replication-dependent histone mRNAs are 
localized to the endoplasmic reticulum.  S1 nuclease protection assay to histone 
H2A, H3 and H3.3 mRNA.  Total RNA from the ER and non-ER fractions (cytosol) of 
HeLa cell fractionations were simultaneously probed for the polyadenylated histone 
H3.3 mRNA and either replication-dependent histone H2A or H3 mRNA.     
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Figure 32.  Histone mRNA in SLBP knockdown cells is retained in the nucleus.  
(A) In situ hybridization to H2A mRNA is specific to the target histone mRNA.  HeLa 
cells synchronized by double-thymidine block were released into S phase for 3 hours 
and treated with 5 mM hydroxyurea (HU) for 0, 15, 30 and 60 minutes.  Cells were 
fixed and prepared for in situ hybridization.  DAPI (blue), histone H2A mRNA (red).  
(B)  Histone H3 mRNA is localized to the nucleus/nucleoli of HeLa cells when SLBP 
is knocked down.  Logarithmically growing HeLa cells were treated with the indicated 
siRNAs and in situ hybridization performed to H3 mRNA.  (C)  Histone H3 mRNA is 
localized to the nucleus of U2OS cells when SLBP is knocked down.  U2OS cells 
were treated with the indicated siRNAs and in situ hybridization performed to H3 
mRNA as in (B).  (D) Western blot control of fractionated U2OS cells treated with 
siRNA in (E).  Total, nuclear, and cytoplasmic protein fractions were separated by 
12% polyacrylamide gel electrophoresis and probed for Hsp90 and fibrillarin.  (E)  
Histone H3 mRNA is enriched in the nuclear fraction of SLBP knockdown cells.  
Total RNA from cell fractionations from (D) were analyzed by Northern blot analysis 
and  histone H3 mRNA and U1 snRNA simultaneously detected using a mixture of 
radiolabelled probes.   
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Figure 33.  Model of SLBP-dependent histone mRNA export. 
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CHAPTER 5 
SUMMARY AND CONCLUSIONS 
 
INTRODUCTION 
 The post-transcriptional regulation of histone mRNA metabolism in 
metazoans serves an important role in regulating histone protein synthesis to ensure 
proper chromatin formation.  Evidence from fungi to humans clearly shows that 
altered histone gene expression is detrimental to the eukaryotic cell (Meeks-Wagner 
and Hartwell, 1986; Sullivan et al., 2001; Zhao et al., 2004).   The rapid change in 
histone mRNA half-life that occurs when DNA replication is complete or when DNA 
synthesis is inhibited provides the cell the ability to balance the appropriate levels of 
histone protein synthesis with the demands of DNA synthesis.  In this final chapter, I 
summarize the major findings from my dissertation and highlight some of the 
intriguing questions that my data raises.  Additionally, I will provide a brief overview 
of the family of enzymes that possess terminal uridyltransferase activity and discuss 
the exciting, potentially widespread, contributions these enzymes may play in gene 
expression.   
  In this dissertation I have described evidence that has revealed a surprising 
mechanism of how histone mRNA degradation is regulated (Chapters 2 and 3).   
Together it suggests the initial step in histone mRNA degradation is the addition of 
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short uridine tails to the 3’ end of histone mRNA.  The addition of the oligo(U) tail is 
carried out by an enzyme with terminal uridyltransferase activity, likely by TUTase-1 
and/or TUTase-3 (Chapter 3).   Direct evidence from cRT-PCR and cloning 
experiments provide compelling data that individual molecules of histone mRNA are 
simultaneously degraded from both the 5’ and 3’ ends (Chapter 2).  Although I have 
identified a number of the components required for histone mRNA degradation 
(Chapters 2 and 3), how all the parts specifically function to regulate histone mRNA 
degradation is not clear.  
 
LSM1-7:  AN UNLIKELY PLAYER IN HISTONE mRNA DEGRADATION 
 The Lsm1-7 complex is a positive regulator of decapping and 5’-3’ 
degradation in eukaryotes (Tharun et al., 2000; Tharun and Parker, 2001).  
Surprisingly, Lsm1 is required for histone mRNA degradation (Chapter 2).  RNAi-
mediated knockdown of Lsm1 resulted in a dramatic stabilization of histone mRNA 
when DNA synthesis was inhibited (Chapter 2).  I was very surprised by this 
evidence since genetic studies show the Lsm1-7 complex functions following 
deadenylation and prior to decapping (Tharun and Parker, 2001).  Biochemical 
experiments have shown Sm-like proteins have an affinity to A-rich and U-rich RNA 
sequences and in support of this, Lsm1-7 has been shown to bind to short stretches 
of adenine or uridine and mixtures of both (AU-rich) (Chowdhury et al., 2007; Wilusz 
and Wilusz, 2005).   Since replication-dependent histone mRNAs are not 
polyadenylated and do not contain remarkable AU-rich elements in the 3’ UTR, the 
initial finding was puzzling.  It was the Lsm1 finding that subsequently allowed me to 
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develop a hypothesis-driven approach to further understand histone mRNA 
degradation.   
 The initial finding prompted me to ask if Lsm1 (and likely the Lsm1-7 
complex) was present in a complex with SLBP at the 3’ end of histone mRNA under 
conditions where histone mRNA is rapidly degraded.  Immunoprecipitation of an HA-
tagged SLBP coprecipitated Lsm1 in a hydroxyurea-dependent manner, but this 
interaction was sensitive to RNase treatment suggesting Lsm1-7 binds directly to the 
3’ end of histone mRNA (Chapter 2).  I initially hypothesized Lsm1-7 was either 
binding the 3’ stemloop or somewhere else in the 3’ UTR.  Based on the literature at 
the time, it was also possible that A tails were added (Kwak et al., 2004; LaCava et 
al., 2005; Sanchez and Marzluff, 2004).  Scant evidence also suggested it was 
possible that short U tails could also be added post-transcriptionally to regulate 
mRNA stability (Shen and Goodman, 2004).  To determine precisely the 3’ end of 
histone mRNA under conditions where histone mRNA was degraded, I used a cRT-
PCR and cloning strategy.  As discussed in chapters 2 and 3 of this dissertation the 
cRT-PCR approach combined with a complimentary oligo(dA) RT-PCR strategy 
produced a number of interesting findings, including the immutable presence of 8-15 
nonencoded uridine residues on the 3’ end of histone mRNA degradation 
intermediates that were decapped, but nearly full-length (Chapter 2).   Together this 
evidence provided a model in which the oligo(U) tail is added and Lsm1-7 
subsequently binds the oligo(U) tail to regulate the recruitment of the 5’-3’ and 3’-5’ 
degradation machinery (Chapter 3).   
 
 194 
REPLICATION-DEPENDENT HISTONE mRNA DEGRADATION:  
EVOLUTIONARY REMNANTS OF BACTERIAL mRNA DEGRADATION? 
 The mechanism of histone mRNA degradation is strikingly reminiscent of the 
bacterial mRNA degradation pathway.  Bacterial mRNAs often have structured 
stemloop structures on the 3’ end, presumably to function in protecting the 3’ end 
from degradation (Kushner, 2004).  Bacterial mRNA degradation is initiated by 
polyadenylation of the 3’ end where the poly(A) tail length is regulated by PNPase 
(Kushner, 2004).  The activity of PNPase and the Sm-like heptameric complex Hfq 
recruit subsequent degradation from the 3’ end by the degradosome, an exosome-
like complex of 3’-5’ exonucleases (Mohanty and Kushner, 2000; Wilusz and Wilusz, 
2005).  Multiple rounds of adenylation followed degradation are required to degrade 
the highly structured 3’ ends present on bacterial mRNAs, and this readenylation 
functions to re-prime the degradosome.   
 The above mechanism is analogous to the strategy human cells use to rapidly 
degrade replication-dependent histone mRNA.  In place of the addition of a poly(A) 
tail to target bacterial mRNAs for degradation, histone mRNAs are oligouridylated to 
specify their targeted destruction.  In both pathways, an Sm-like complex associates 
with the nontemplated addition of A or U to the 3’ end and this protein complex (Hfq 
or Lsm1-7) subsequently coordinates the recruitment of the degradation machinery.  
Moreover, I frequently obtained clones that had oligo(U) tails added within the 
stemloop sequence, suggesting that the human exosome likely needs to be re-
primed to degrade through the structured 3’ end of histone mRNAs, as has also 
been reported for bacterial mRNAs. 
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 As Carol and Jeff Wilusz have suggested (Wilusz and Wilusz, 2008), the 
mechanism of histone mRNA degradation may also function to regulate the stability 
of structured noncoding RNAs such as rRNA and tRNAs, that are also not 
polyadenylated.  Another interesting possibility proposed (Wilusz and Wilusz, 2008), 
is that oligouridylation could additionally act as an innate immune defense 
mechanism against flaviviruses such as Hepatitis C, Dengue, and West Nile viruses.  
The viral transcripts of these viruses are not polyadenylated but rather have 
stabilizing secondary structures at their 3’ end (Gritsun and Gould, 2007).  It is 
possible the host cell uses the same machinery used to degrade histone mRNA to 
also prevent viral infection by flaviviruses.  In addition to the above speculation, 
there is a good likelihood that other mRNAs in the cell are substrates for 3’ 
oligouridylation.   Most cDNA libraries that exist were produced by oligo(dT)-primed 
reverse transcription to obtain expressed mRNAs that were polyadenylated.  It would 
be interesting to ponder the potential abundance of clones that would exist if cDNA 
libraries from different cell types were to be made by oligo(dA)-primed reverse 
transcription.   
 
BIDIRECTIONAL DECAY IN MAMMALS:  THE PREDOMINANT MECHANISM? 
 In Chapter 2 I showed that individual histone mRNA molecules are 
simultaneously degraded from both the 5’ and 3’ ends.  The functional requirement 
of components from both pathways (Lsm1, Dcp2, Xrn1, Rrp41, PM/Scl-100) as well 
as trapping histone mRNA degradation intermediates by cRT-PCR and cloning 
provided this evidence (Chapters 2 and 3).   Although this provides the first direct 
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evidence for bidirectional decay of a physiologically important mRNA, two other 
reports suggest that mammalian cells use both pathways for mRNA degradation 
(Lejeune et al., 2003; Murray and Schoenberg, 2007).  Even though both pathways 
exist in budding yeast, the 5’-3’ pathway has been suggested to predominate (Cao 
and Parker, 2001, 2003).  Despite the estimated importance of the 5’-3’ pathway in 
yeast, evidence suggests the 5’-3’ and 3’-5’ are partially redundant (He et al., 2003; 
Houalla et al., 2006).  There also likely exists some redundancy in humans, but the 
small amount of evidence that exists at this time points to the mammalian cell 
utilizing both pathways in a concerted manner to rapidly and efficiently degrade 
mRNA (Lejeune et al., 2003; Mullen and Marzluff, 2008; Murray and Schoenberg, 
2007).  Bidirectional decay might simply be a necessary requirement of mammals 
due to the increased size of mammalian genomes compared to fungi.  The 
increased genome size combined with the increased importance of alternative 
splicing in mammals likely presents a more complex set of total mRNAs in need of 
regulation.  Bidirectional mRNA degradation may then represent an efficient 
mammalian strategy to rapidly and irreversibly eliminate the expression of a given 
mRNA.  This could be particularly important in the nervous system where mRNA 
translation and stability contribute to the synaptic plasticity that underlies learning 
and memory (Giorgi et al., 2007; Schratt et al., 2006; Sutton and Schuman, 2006). 
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A FAMILY OF POLY(A) POLYMERASES / TERMINAL URIDYLTRANSFERASES 
EXISTS IN EUKARYOTES 
 The past 18 months have revealed the presence of a family of noncanonical 
poly(A) polymerases in eukaryotes that contain members that are not poly(A) 
polymerases at all, but are instead terminal uridyltransferases (Kwak and Wickens, 
2007; Rissland et al., 2007; Trippe et al., 2006).  In this section I will review the 
known functions of this family enzymes that exist in both yeast and humans and 
attempt to provide insight into the TUTases identified that potentially add oligo(U) to 
the 3’ end of histone mRNAs.   
Budding Yeast 
 Two noncanonical poly(A) polymerases (PAPs) exist in the genome in S. 
cerevisiae (Houseley et al., 2007; Houseley and Tollervey, 2006).  This number is 
small in contrast to S. pombe and humans where their genomes possess 6 and 7 
related proteins, respectively (Tables 6 and 7).  The two PAPs present in S. 
cerevisiae include Trf4 and Trf5 that collectively function in a nuclear RNA 
surveillance complex known as TRAMP (Houseley et al., 2007; Houseley and 
Tollervey, 2006).  The TRAMP complex is composed of Trf4, Trf5, Air1, Air2, and 
Mtr4 and together polyadenylate aberrant noncoding RNAs in the nucleus for 
subsequent degradation by the exosome (LaCava et al., 2005).  S. cerevisiae Trf4 
and Trf5 are strictly localized to the nucleus, particularly the nucleolus (Dez et al., 
2006).   
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Fission Yeast 
 The fission yeast S. pombe has evolved 6 similar enzymes (Table 6).  The 
majority of theses enzymes are localized in both the nucleus and cytoplasm, with 
some possessing strict cytoplasmic localization (Table 6).  None of the members 
exhibit the strict nuclear localization observed by Trf4 and Trf5 in budding yeast, 
suggesting more diverse roles for these enzymes in the cytoplasm.  The founding 
and best-characterized member of this family of proteins is Cid1 (caffeine-induced 
death suppressor), which was originally identified in a screen to identify components 
of the replication checkpoint (Wang et al., 1999).  It was originally suspected Cid1 
was a DNA polymerase that somehow functioned in regulating DNA synthesis and 
the replication checkpoint (Wang et al., 1999).  However, Cid1 is strictly localized to 
the cytoplasm (Read et al., 2002).  Later work then showed Cid1 functioned to 
stabilize subsets of mRNAs in the cytoplasm by polyadenylation upon replication 
stress such as hydroxyurea exposure and DNA damage (Read et al., 2002).  
However in this same paper Read and colleagues showed that in addition to 
possessing substantial poly(A) activity in vitro, recombinantly expressed and purified 
Cid1 possessed substantial poly(U) activity, but not poly(C) or poly(G) (Read et al., 
2002).  The significance of the poly(U) activity was overlooked until Rissland, 
Norbury and coworkers recently resolved this biochemical complexity (Rissland et 
al., 2007).  It was shown that when Cid1 was purified from S. pombe cells and not 
from E. coli, Cid1 purified from yeast was now strictly a poly(U) polymerase in vitro 
and possessed minimal, unremarkable poly(A) activity (Rissland et al., 2007).   
These results strongly imply that copurifying cofactors that originate from intact yeast 
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cells are responsible for dictating the uridine specificity of Cid1 in vivo.  No 
convincing physiologic target mRNA substrates of Cid1 have been characterized.  
 The Moazed lab has defined the nuclear roles for Cid12 and Cid14, although 
both proteins also localize to the cytoplasm (Table 6).  Cid12 and Cid14 function in 
distinct processes that work to silence heterochromatin in S. pombe (Buhler et al., 
2007; Buhler et al., 2006; Motamedi et al., 2004).  Cid12 functions as a poly(A) 
polymerase in an RNA-directed RNA polymerase complex (RDRC) that also 
contains the RNA helicase Hrr1 (similar to human Upf1), the histone 
methyltransferase Clr4, and the RNA-dependent RNA polymerase Rdp1 (Motamedi 
et al., 2004).  The RDRC complex interacts with the RNAi-induced transcriptional 
silencing complex (RITS) that together function to silence noncoding centromeric 
transcripts (Motamedi et al., 2004).  In an alternative pathway to silence centromeric 
transcripts, Cid14 is present in a TRAMP-like complex with Air1 and Mtr4 in the 
nucleus and has been show to polyadenylate centromeric transcripts for direct 
degradation by the exosome (Buhler et al., 2007; Buhler et al., 2006).  Cid14 
polyadenylated transcripts can also be silenced by the Cid12-containing RDRC 
dependent mechanism (Buhler et al., 2007; Buhler et al., 2006).    
 Cid13 has been shown to be a cytoplasmic poly(A) polymerase that is 
important in DNA replication and genome maintenance (Saitoh et al., 2002).  Saitoh 
and coworkers have shown that Cid13 functions to stabilize SUC22 mRNA, which 
encodes a subunit of ribonucleotide reductase that maintains the pool of dNTPs 
present in the cell (Saitoh et al., 2002).  When wild-type fission yeast are treated with 
HU over time, the length of SUC22 poly(A) tail length increases, suggesting Cid13 
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stabilizes a small set of mRNAs in the cell upon replication stress.  In support of this, 
yeast mutant for Cid13 have slightly shorter SUC22 poly(A) tails (Saitoh et al., 
2002).  Additionally, myc-tagged Cid13 purified from yeast cells has poly(A) 
polymerase activity in vitro, but not any remarkable poly(U), (C), or (G) activity 
(Saitoh et al., 2002).  The above evidence from fission yeast implies a recurring role 
for the Cid-family of enzymes in DNA replication, replication stress, and genome 
integrity.  Although it is not clear which Cid protein the TUTases (TUTase-1, 
TUTase-3) in humans I identified represent, it is possible there exists an evolutionary 
significance to these similarities.  Modulation of gene expression at the post-
transcriptional level could be a widespread mechanism for the eukaryotic cell to fine 
tune the complex process of DNA replication to ensure the fidelity of both the DNA 
and chromatin formation.   
 Cid11 and Cid16 have no defined roles in fission yeast.  However a genome-
wide cellular localization study has shown that Cid11 is localized to both the 
cytoplasm and nucleus while Cid16 is localized strictly to the cytoplasm (Matsuyama 
et al., 2006).  As I have explained, a number of studies conducted in fission yeast 
have revealed significant poly(A) activity in vitro for the Cid1 family of proteins and 
because of these studies it has led to the initial characterization of these enzymes as 
noncanonical poly(A) polymerases (Stevenson and Norbury, 2006).   However, 
recent evidence from Xenopus oocytes (Kwak and Wickens, 2007) and even more 
recent from human cells (Gonzales et al., 2008; Mellman et al., 2008; Mullen and 
Marzluff, 2008), ensure the story is much more exciting.      
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Metazoans 
 Homologs of the “noncanonical poly(A) polymerases” that exist in fission 
yeast are also found in higher eukaryotes.  Kwak and Wickens identified several 
homologs in plants, worms, and humans and tested their ability to add poly(A), (U), 
(C) and (G) using a combination of an MS2-tethering assay in Xenopus oocytes and 
molecular biology (Kwak and Wickens, 2007).  Surprisingly, they found that 3 of the 
7 PAPD-containing proteins in humans (TUTase-4, -7 and the U6 TUTase) exhibited 
poly(U) polymerase activity in their Xenopus system and in vitro using purified 
peptides (Kwak and Wickens, 2007), (Table 7).  In Chapter 3, I identified TUTase-1 
and TUTase-3 as putative TUTases that are required for histone mRNA degradation 
(Mullen and Marzluff, 2008) and provided preliminary biochemical activity 
demonstrating TUTase-3 had oligo(U) activity in vitro (Chapter 3).    
 Attempts to predict the closest orthologs of TUTase-1 and TUTase-3 in fission 
yeast by sequence alignment and phylogenetic analysis has not revealed any 
definitive insight into their potential function (Figure 34).  SpCid1 and TUTase-7 have 
been shown to be functional homologs (Rissland et al., 2007), although significant 
sequence divergence exists and prevents them from reliably grouping with one 
another in phylogenetic analyses (Figure 34), at least using distrance matrix 
algorithms.  Based on Figure 34, the closest S. pombe relatives appear to be Cid14 
and Cid12.  Cid14 has been shown to function in a nuclear TRAMP-like complex to 
silence heterochromatin at centromeres (Buhler et al., 2007; Buhler et al., 2006).  
However, Cid14 is also localized to the cytoplasm (the site of histone mRNA 
degradation in human cells) and no cytoplasmic role for Cid14 exists at this time.  
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Cid12 functions in the nucleus in the RDRC-RITS complex to polyadenylate 
centromeric repeat transcripts for subsequent silencing of ongoing centromeric 
transcripts via the production of small dsRNAs (Motamedi et al., 2004).  
Interestingly, recombinantly expressed and purified Cid12 exhibits robust poly(U) 
activity in vitro (but not poly(C) or poly(G)), in addition to the established poly(A) 
activity (Mario Halic and Danesh Moazed, personal communication).  Therefore, it is 
possible the unpublished poly(U) activity of Cid12 could be reserved for its function 
in the cytoplasm.   
 TUTase-1 reproducibly scored positively in an RNAi screen to the 7 putative 
TUTases in the human genome (Chapter 3).  TUTase-1 has been fairly well 
characterized in humans to be a poly(A) polymerase that is required for 
polyadenylation of mitchonridal mRNAs (hmtPAP) (Nagaike et al., 2005; Tomecki et 
al., 2004).  Many mitochondrial mRNAs terminate in a single U and polyadenylation 
in the mitochondria has been suggested to provide the UAA stop codon (Slomovic et 
al., 2005).  hmtPAP/TUTase-1 has also been shown to colocalize in subcellular foci 
that overlap with a mitochondrial marker (Nagaike et al., 2005; Tomecki et al., 2004).  
Moroever, it has been predicted that Cid16 represents the homolog of 
hmtPAP/TUTase-1 (Table 5) (Stevenson and Norbury, 2006).  The phylogenetic tree 
in Figure 34 supports this prediction since TUTase-1 closely groups with SpCid16.  It 
is possible that TUTase-1 screened falsely positive in my RNAi screen (Chapter 3).  
Like many of the PAPD-containing proteins, hmtPAP/TUTase-1 lacks an RNA 
recognition motif (RRM) and these enzymes likely require other cofactors to impart 
their RNA specificity.  That said, it is equally possible that TUTase-1 has dual 
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functions in the cell, one being outside of the mitochondria and specified by a unique 
set of proteins that define its specificity.  Equally possible is that TUTase-1 functions 
in the mitochondria to coordinate the replication of mitochondrial DNA and its proper 
packaging.  Further work is required to determine the role TUTase-1 plays in histone 
mRNA degradation.   
 The best characterized of the human PAPD-containing enzymes is the U6 
TUTase.  Trippe and coworkers cloned and characterized the U6 TUTase and 
showed that the U6 TUTase specifically added uridine residues to the U6 snRNA 
(Trippe et al., 2006).  Most recently however, a thought provoking study from 
Mellman and coworkers suggest the U6 TUTase can also function as a poly(A) 
polymerase (Mellman et al., 2008).  StarPAP is the same enzyme as the U6 TUTase 
and can be regulated to be a PAP by phosphatidylinositol 4,5 bisphosphate 
(PtdIns4,5P2), a phospholipid that functions in lipid signaling in the cell (Mellman et 
al., 2008).   Only when starPAP is bound to PtdIns4,5P2, but not other 
phospholipids, does starPAP exhibit poly(A) polymerase activity in vitro (Mellman et 
al., 2008).  In agreement with Trippe et al., starPAP also possesses poly(U) activity 
in vitro but when bound by PtdIns4,5P2, starPAP exhibits exclusive ATP 
incorporation (Mellman et al., 2008).   
 The group shows starPAP is required as an alternative PAP when human 
cells are exposed to oxidative stress (Mellman et al., 2008).  starPAP interacts with 
the cleavage and polyadenylation stimulating factors (CPSFs; CPSF73, CPFS100, 
and Symplekin as well as RNA pol II) and is required to polyadenylate and stabilize 
particular mRNAs that encode factors essential to elicit the cell’s oxidative stress 
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response (Mellman et al., 2008).  Strangely, their functional experiments using RNAi 
did not result in the cell lethality that I and Trippe et al. had observed when knocking 
down the U6 TUTase (Mullen and Marzluff, 2008; Tsukada et al., 2006).  It is 
possible their transfection efficiency or siRNA sequence resulted in inefficient 
knockdown of starPAP/U6 TUTase and this serendipitously provided an ideal 
hypomorphic phenotype to elucidate the enzyme’s role in alternative nuclear 
polyadenylation.   
 It is interesting to speculate that phospholipids play critical functions in 
regulating RNA enzymes.  Recent crystallographic studies from Macbeth and Bass 
have revealed the adenosine deaminase 2 (ADAR2), an RNA editing enzyme in 
eukaryotes, contains an inositol hexakisphosphate (IP6) molecule that is buried in 
the enzyme core and contributes to the protein fold (Macbeth et al., 2005).  
Functional experiments show that the amino acids that make contact with IP6 as well 
as IP6 itself are required for ADAR2 editing activity (Macbeth et al., 2005).  
Therefore, it could be possible that lipid signaling events that sense the end of S 
phase or the inhibition of DNA replication could impact the enzymatic activity of 
TUTase-1 and/or TUTase-3 to specifically add uridine residues to the 3’ end of 
histone mRNAs as well as potentially other unidentified mRNA substrates.   
 
SUMMARY 
 My dissertation has revealed new insight into the mechanism that regulates 
the rapid degradation of histone mRNA.  Despite the fact that we now know a 
number of the factors that regulate histone mRNA degradation, we still do not know 
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specifically how translation termination factors, Upf1, a TUTase, Lsm1-7 and the 5’-
3’ and 3’-5’ degradation enzymes specifically function to result in efficient decay of 
histone mRNA.  It is likely the SURF complex containing SMG-1, Upf1, eRF3, and 
eRF1 is recruited to the 3’ end of histone mRNA when translation is terminated 
under conditions when histone mRNA is signaled for degradation.  The RNA 
helicase activity of Upf1 could help remodel the mRNP present on the 3’ end of 
histone mRNA by interacting with SLBP and provide the TUTase access to the 3’ 
end for subsequent oligouridylation.  At this point, my data suggests it is Lsm1-7 that 
likely binds the oligo(U) tail to regulate decapping and Xrn1, as well as the exosome 
activity, to the mRNA.  How exactly are the 5’-3’ decay machinery and exosome 
recruited to act on the same histone mRNA molecule?  Yeast mutant for Lsm1 have 
stabilized mRNAs that have their 3’ ends trimmed, suggesting that Lsm1-7 blocks 
the 3’-5’ activity of the exosome (He and Parker, 2001).  It is possible that Lsm1-7 is 
rapidly dissociated following activation of the 5’ decapping enzymes (Dcp1/Dcp2) by 
the exosome and access to the 3’ end unhindered at this point.  It is also possible 
Lsm1-7 is required for recruitment of both decapping activity as well as the exosome 
since biochemical approaches have shown that Lsm1 and other components of the 
Lsm1-7 complex physically interact with subunits of the exosome (Lehner and 
Sanderson, 2004).  SLBP does appear to be required for histone mRNA degradation 
since downregulation of SLBP protein by RNAi reduced the rate of histone H2A 
mRNA degradation compared to a control (Chapter 4).  Since reduced expression of 
SLBP protein resulted in nuclear retention of processed histone mRNAs, I was not 
able to conclude any specific role that SLBP plays in histone mRNA degradation.  
 206 
However, the SLBP:Upf1 interaction that occurs on the 3’ end under conditions of 
histone mRNA degradation (Kaygun and Marzluff, 2005a)  suggests SLBP plays an 
important role, likely by playing a central role in the formation of a histone mRNP 
that is primed for degradation under the appropriate cellular circumstances.     
 As the past 4 years have shown (Kaygun and Marzluff, 2005a, b; Mullen and 
Marzluff, 2008; Muller et al., 2007), we have made major strides towards 
understanding a detailed mechanism of how the half-life of mammalian replication-
dependent histone mRNAs is regulated both when DNA synthesis is inhibited and 
upon the completion of DNA replication.   Through my dissertation work I have 
uncovered a novel mechanism that regulates the rapid degradation of histone mRNA 
and involves oligouridylation followed by bidirectional degradation of the mRNA.   In 
time, the pursuit by fellow colleagues and other scientists will likely reveal how the 
different components function to rapidly degrade histone mRNA.   
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Table 6.  List of the Cid family of enzymes present in S. pombe.  (C. e.) C. 
elegans, (S. c.)  S. cerevisiae,  
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Noncanonical 
PAP/TUTase 
Presumed 
orthologues 
Localization Function/Activity Reference 
Cid1 Cid1 (C.e.), 
TUT-7, Hs2 
Cytoplasmic Checkpoint 
response to 
replication block, 
TUTase 
Rissland et al., 
2007 
Cid11 Unknown Nuclear and 
cytoplasmic 
Unknown Matsuyama et 
al., 2006 
Cid12 RDE-3 (C.e.) Nuclear and 
cytoplasmic 
RNAi-dependent 
transcriptional 
silencing, PAP, 
TUTase? 
Motamedi et 
al., 2004 
Cid13 Unknown Nuclear and 
cytoplasmic 
Maintains dNTP 
pools via 
ribonucleotide 
reductase mRNA,  
Saitoh et al., 
2002 
Cid14 S.c. Trf4, Trf5 Nuclear and 
cytoplasmic 
Exosome 
mediated 
degradation of 
RNAs, 
heterochromatic 
gene silencing, 
PAP 
Buhler et al., 
2007; Win et 
al., 2006 
Cid16 hmtPAP Cytoplasmic, 
mitochondrial? 
unknown Matsuyama et 
al., 2006; 
Stevenson and 
Norbury, 2006 
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Table 7.  List of poly(A) polymerase-associated domain (PAPD)-containing 
proteins present in the human genome.  The proteins listed are characterized 
terminal uridylyltransferases (TUTase), poly(A) polymerases (PAP), or currently 
uncharacterized.    
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TUTase Other Names Localization Activity 
 
Reference 
TUTase-1 PAPD1, 
mtPAP, 
Q9NVV4 
Mitochondrial, 
cytoplasmic 
Mitochondrial PAP, 
putative histone 
TUTase 
Nagaike et al., 
2005; Tomecki 
et al., 2004, 
Mullen and 
Marzluff, 2008 
TUTase-2 PAPD4, GLD2, 
Q6PIY7 
Cytoplasmic Cytoplasmic PAP Kwak et al., 
2004 
TUTase-3 PAPD5, 
Q8NDF8, 
TRF4-2 
Cytoplasmic and 
nuclear, 
predominantly 
cytoplasmic 
Putative histone 
TUTase 
Mullen and 
Marzluff, 2008 
TUTase-4 Hs3, Q5TAX3 Unknown TUTase Kwak and 
Wickens, 2007 
TUTase-5 Pol sigma, 
TRF4-1,  
Unknown Unknown  
U6 TUTase PAPD2, Hs5, 
starPAP 
Nucleolar, 
nuclear 
TUTase for U6 
snRNA, 
PAP for stress 
response 
Trippe et al., 
2006; Mellman 
et al., 2008 
TUTase 7 PAPD6, Hs2, 
ZCCHC6, 
Cid1,  
Cytoplasmic TUTase Rissland et al., 
2007; Kwak and 
Wickens, 2007 
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Figure 34.  Phylogenetic tree comparing the PAPD-containing proteins present 
in the genomes of humans, budding yeast, and fission yeast.   Pairwise amino 
acid sequence alignments were performed using ClustalW software and a rooted 
phylogenetic tree constructed using distance matrix algorithms.  The canonical 
human poly(A) polymerase α (PAPα) was used as the outgroup.  (Sp), S. pombe; 
(Sc), S. cerevisiae.   
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